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Abstract
Apoptosis is a form of programmed cell death that is essential for the elimination
of damaged or unneeded cells in multicellular organisms. Inactivation of apoptotic cell
death is a necessary step in the development of cancer, while hypersensitivity to
apoptosis is a factor in degenerative diseases. Many of the molecular components
controlling apoptosis have been identified, including the central effectors of apoptosis, a
family of proteases known as caspases that efficiently dismantle the cell when active.
While many of the molecular details of apoptotic regulators are now understood,
a major challenge is to integrate this information to understand quantitatively how
sensitivity to apoptosis and the kinetics of death are determined, in both single cells and
populations of cells. We have approached this problem with a combined experimental
and computational approach. Using single-cell observations, genetic and
pharmacological perturbations, and mechanistic mathematical modeling, we have
dissected the mechanism by which cells make a binary decision between survival and
apoptosis. We identified conditions under which the apoptotic decision system fails,
allowing cells to survive with caspase-induced damage that may result in damage to the
genome and oncogenesis. We further used live-cell imaging to identify and characterize
a kinetic threshold at which slow and variable upstream signals are converted into rapid
and discrete downstream caspase activation. Lastly, we examined the integration of
multiple pro-and apoptotic signal transduction pathways by constructing a principal
component-based model that linked apoptotic phenotypes to a compendium of signaling
measurements. This approach enabled the identification of the molecular signals most
important in determining the level of apoptosis across a population of cells. Together,
our findings provide insight into the molecular and kinetic mechanisms by which cells
integrate diverse molecular signals to make a discrete cell fate decision.
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1.1 Cell death and the organism
Cell death is an essential process in the life of multicellular organisms. This fact
can be easily appreciated by considering that each day in the human body, billions of new
cells are created by cell division; without a corresponding subtraction of old cells, the
total number of cells in the organism would quickly expand and lead to uncontrolled
growth of various tissues. This balance of life and death has been appreciated by
physiologists for over 100 years (Clarke and Clarke 1995) and has led, in the modern era
of biology, to an intense study of the molecular mechanisms of cell death.
In animals, there are several routes to cell death (Golstein and Kroemer 2005).
The most commonly recognized types of cell death are necrosis, apoptosis, and
autophagy (Edinger and Thompson 2004). In general, necrosis is considered an
uncontrolled form of cell death resulting from gross insults to the cell, whereas apoptosis
is a more orderly process in which the cell is deliberately dismantled by a network of
specific molecular effectors in response to pro-death signals from within the cell or from
its environment. The role of autophagy in cell death has come to light only recently, and
much remains unknown about why this adaptive response to nutrient limitation seems to
serve as an alternative mechanism of cell disposal (Lum et al. 2005). These classes of
cell death are not clear-cut; in many instances cells display characteristics of more than
one type of cell death, such as "necroptosis" which combines features of apoptosis and
necrosis (Degterev et al. 2005). It is also often observed that inhibition of one type of
cell death does not prevent the cell from dying, but forces it to die by a different process
(Chipuk and Green 2005). This is most strikingly observed in mice in which central
effectors of apoptosis have been knocked out; although there is high embryonic mortality,
the individuals that survive to adulthood appear normal, probably because autophagic cell
death compensates for the lack of apoptosis (Lindsten et al. 2000; Shimizu et al. 2004).
Thus, the understanding of how cell death occurs and is regulated within living organisms
continues to evolve, covering an increasingly rich spectrum of cytological processes.
Nevertheless, the large majority of cell death research has focused on apoptosis and the
molecules controlling it. Much is now known about this form of cell death, and its
importance in development and disease is clear.
Apoptosis plays a role in controlling the shape and size of developing tissues
(reviewed in (Jacobson et al. 1997)). Two frequently cited examples of this role are the
development of digits and the central nervous system in mammals. In the first example,
the cells between developing digits die by apoptosis, leaving each digit separate from the
next (Zou and Niswander 1996). In the case of the central nervous system, many more
neurons are born than will eventually make up the adult brain; the final size and
connectivity of the brain is achieved by the apoptotic cell deaths of neurons that do not
form proper synapses. In fact, this process is one reason for the high mortality observed
in many mouse knockouts of apoptotic genes; if the number of neurons is not
successfully reduced, the developing brain cannot fit inside the skull, leading to pre- or
peri-natal death (Hakem et al. 1998; Kuida et al. 1998).
Apoptosis is also a factor in many diseases. The most obvious example of this is
cancer, where a lack of cell death enables a hyperplasia to grow unchecked (Green and
Evan 2002). Moreover, apoptosis is responsible for eliminating cells with damaged
DNA; preventing apoptosis is necessary to allow damaged cells to survive and
accumulate the mutations that eventually lead to malignancy (reviewed in (Zhivotovsky
and Kroemer 2004)). In the treatment of cancer, chemotherapy and radiation therapy are
directed at inducing the death of tumor cells. There is much hope that by understanding
the mechanisms of apoptosis, more effective means of killing cancer cells may be
developed. In other disorders, excessive apoptosis can lead to degeneration of critical
tissues. Some of the damage resulting from ischemia is a result of apoptosis, because
cells peripheral to the site of the primary injury receive pro-death signals (Cheng et al.
1998). Pharmacological inhibitors of apoptosis are being evaluated as treatments for
reducing the extent of ischemic injury to brain and cardiac tissue. Thus, there is great
interest in understanding apoptosis from a clinical perspective.
1.2 Identification of cell death genes
Despite the long-standing appreciation of the necessity of cell death for
homeostasis, nearly all of the specific connections between apoptosis and disease have
been made only in the last 20 years. The enabling factor for these discoveries was the
groundbreaking identification of a core set of genes necessary for apoptosis in the
nematode worm Caenorhabditis elegans (Ellis and Horvitz 1986; Hengartner et al. 1992).
Remarkably,. the essential features of this core apoptotic machinery were found to be
conserved throughout vertebrates. The first molecular link between apoptosis and cancer
was made when it was discovered that the oncogene B-cell lymphoma 2 (Bcl-2) did not
affect the proliferative capacity of cells but instead promoted their survival (Vaux et al.
1988). It was subsequently discovered that Bcl-2 was homologous to one of the C.
elegans cell death genes, ced-9 (Hengartner and Horvitz 1994). Also among the cell
death genes of the worm was ced-3; this gene was found to encode a cysteine protease,
leading to the identification of the caspases, the core effectors of apoptosis in all animal
cells (Yuan et al. 1993).
Although much was learned from the C elegans cell death pathway, the apoptotic
pathway in mammalian cells has turned out to be significantly more complex than the
simple linear pathway found in the worm (Danial and Korsmeyer 2004). Additional
families of proteins, not present in the worm, add layers of regulation to apoptosis in
mammalian cells. Moreover, the families of apoptotic genes present in the worm have
expanded significantly throughout evolution. In the worm, the caspase family is
represented by one gene and the Bcl-2 family by two; in humans, there are I I known
caspases and over 20 Bcl-2 family proteins. In the next section, I review the major
classes of apoptotic effector and regulatory proteins in mammalian cells.
1.3 The apoptosis parts list
1.3.1 Effector Caspases
Caspases- 3, -6, and -7 are known as the effector caspases, because these
proteases cleave a broad set of cellular substrates to induce cell death. Caspases-3 and -7
are the most closely related and cleave very similar sets of substrates, with an optimal
substrate cleavage sequence of DEVD, while caspase-6 cleaves a different set of
substrates, with an optimal substrate cleavage sequence of VEID (Talanian et al. 1997;
Thornberry et al. 1997). Over 300 substrates for the effector caspases have been
identified, and these include proteins involved in signal transduction, metabolic
regulation, DNA repair, and cellular structure (Fischer et al. 2003). One key substrate is
ICAD, the inhibitor of caspase-activated DNAses. This protein is typically bound to the
DFF40/CAD, the caspase-activated DNAse; when ICAD is cleaved, CAD is released and
creates double-stranded breaks in chromosomal DNA, resulting in genomic degradation
(Liu et al. 1998; Inohara et al. 1999). Perhaps the best-known substrate of the effector
caspases is poly-ADP-ribose polymerase (PARP), a caspase-3/7 substrate. Since this was
one of the first identified effector caspase substrates, its cleavage has long been used as
an indicator of caspase activity (Kaufmann 1989; Tewari et al. 1995).
Effector caspases are normally present in the cell as inactive dimers (Pop et al.
2001). The transition to the active form requires main-chain cleavage of each monomer
at a site that separates the N-terminus from the C-terminus. This cleavage enables a
conformational change in the caspase dimer (which is converted to a hetero-tetramer by
the cleavage of each monomer) that opens the active site and increases activity by 200-
fold (Tewari et al. 1995; Bose et al. 2003). The activating cleavage of effector caspases
is performed by the initiator caspases (discussed below), or by granzyme B (Darmon et
al. 1995; Li et al. 1997; Abreu et al. 2001). While it was long thought that effector
caspases might process their own precursors autocatalytically to form a feedback
amplification loop, this hypothesis has been disproven (Liu et al. 2005). However, it has
been observed that effector caspases may activate certain initiator caspases (see next
section), forming a more extended positive feedback loop (Slee et al. 1999; Fujita et al.
2001; Cowling and Downward 2002).
1.3.2 Initiator caspases
These caspases act mainly as signal transducers. Caspases 2, 8, 9, and 10 can be
activated by numerous stimuli; once active, they activate the effector caspases as
discussed above. Initiator caspases can be activated by proteolytic cleavage (Sohn et al.
2005), but they can also be stimulated by conformational changes in the absence of
cleavage when they are forced to form homo-dimers (Boatright et al. 2003; Chang et al.
2003b; Donepudi et al. 2003). In contrast to effector caspases, initiator caspases are
normally monomeric, and contain one or more domains that mediate interaction with
upstream regulators. These domains allow the initiator caspases to be recruited to protein
complexes, where dimerization is induced and allosteric activation occurs. Several
initiator caspase-activating complexes have been identified. The most well known is the
apoptosome, in which the adaptor protein Apaf-l recruits and activates caspase-9 (Li et
al. 1997); this complex is stimulated by the release of cytochrome c from the
mitochondria, which is discussed below. Caspase-8 is primarily activated by the Death-
Inducing Signaling Complex (DISC), which is formed by death receptor activation,
leading to the recruitment of the adaptor protein FADD (Kischkel et al. 1995; Medema et
al. 1997). FADD recruits caspase-8 via a homotypic death effector domain (DED)
interaction; allosteric activation of caspase-8 within the DISC leads to its autocatalytic
processing and the release of mature, active caspase-8 into the cytosol (Chang et al.
2003a).
1.3.3 Inhibitor of Apoptosis Proteins (IAPs)
The Inhibitor of Apoptosis Proteins (IAPs) are inhibitors of caspases, that occur in
many species and play a particularly important role in apoptosis in Drosophila. IAPs are
characterized by containing one or more Baculoviral IAP repeat (BIR) domains.
However, while nine BIR-containing genes have been identified in the human genome,
only one of these, X-linked inhibitor of apoptosis (XIAP), is a direct inhibitor of
caspases. XIAP, containing 3 BIR domains, is a potent inhibitor of caspases-3, -7, and -
9, binding to each of these caspases with a Kd of I nM or less (Deveraux et al. 1997).
The mode of XIAP inhibition of caspase-9 differs from that of caspases-3/7. In the case
of caspase-3/7, the linker region between BIR2 and BIR3 occupies the active site of the
caspase, but cannot be cleaved because it lies in the opposite direction of natural peptide
substrates (Huang et al. 2001; Shiozaki et al. 2003). In the case of caspase-9, XIAP binds
to the homodimerization interface to prevent activation of caspase-9 by the apoptosome
(Shiozaki et al. 2003). Other human IAP proteins, including ML-IAP, ILP, clAP-I, and
clAP-2 also appear to regulate apoptosis, but are not direct inhibitors of caspases
(Eckelman and Salvesen 2006) . Instead, these proteins appear to antagonize negative
regulators of XIAP such as Smac (Shin et al. 2005; Vucic et al. 2005), and they may play
a role in regulating the activity of the DISC. Other IAP proteins, such as Survivin,
display very weak inhibition of apoptosis, and their role in regulating apoptosis is still
unclear. Some IAPs, such as XIAP, also carry RING domains and have been shown to
act as ubiquitin E3 ligases for the caspases they inhibit, targeting these caspases for
degradation by the proteasome (Suzuki et al. 2001; Chen et al. 2003). However, IAPs
also appear to regulate their own levels by auto-ubiquitination (Yang et al. 2000). The
ultimate importance of these ubiquitination reactions remains unclear, but it may explain
in part why proteasome inhibitors can act potently both as inhibitors and as sensitizers to
apoptosis (Sohn et al. 2006).
1.3.4 Proteins of the mitochondrial intermembrane space
A number of pro-apoptotic proteins typically reside in the mitochondrial
intermembrane space, where they pose no threat to the cell. However, in response to
many apoptotic stimuli, the mitochondrial outer membrane undergoes a permeability
transition, allowing these intermembrane space proteins to be released into the cytosol.
The first such protein to be identified was cytochrome c, a component of the electron
transport chain. When released into the cytosol, cytochrome c transiently interacts with
Apaf-I to induce a conformational change, allowing Apaf- to assemble into a complex
known as the apoptosome (Li et al. 1997; Kim et al. 2005). Procaspase-9 is also recruited
to the apoptosome, where it is activated by enforced dimerization. Thus, assembled
apoptosome complexes act as activation platforms for procaspase-9 (Rodriguez and
Lazebnik 1999). Apoptosomes assembled in vitro are remarkably large heptameric
complexes (Yu et al. 2005); however, the stoichiometry of apoptosomes in vivo is likely
somewhat different (Hill et al. 2004; Twiddy et al. 2004). Another important protein
released from the mitochondrial compartment is Smac, which binds to XIAP to prevent
XIAP from inhibiting caspases (Du et al. 2000; Verhagen et al. 2000). Other proteins,
such as Omi!HtrA2 and Apoptosis Inducing Factor (AIF), are also released when
mitochondrial permeabilization occurs; however, the importance of these proteins in the
apoptotic program is still debated.
1.3.4 Bcl-2 family proteins
Permeability of the mitochondrial outer membrane is controlled by the Bcl-2
family of proteins. This family contains both pro- and anti-apoptotic proteins, which are
identified by containing one or more Bcl-2 homology (BH) domains (Spierings et al.
2005). The pro-apoptotic members are further subdivided into effector (also known as
multidomain), activator, and sensitizer categories, and the identification of these subtypes
has refined the widely-held "rheostat" model of the mitochondrial pathway (Korsmeyer
et al. 1993; Letai et al. 2002; Certo et al. 2006). In this model, the effectors Bax and Bak
are required for the induction of large, non-selective pores in the mitochondrial outer
membrane, which allow the release of proteins such as Smac and cytochrome c into the
cytosol (Wei et al. 2001; Kuwana et al. 2002). To induce permeabilization, Bax and Bak
must be activated by one of the activator class of pro-apoptotic Bcl-2 proteins, which
include Bid and Bim (Wei et al. 2000). However, the anti-apoptotic Bcl-2 family
proteins, which include Bcl-2, Bcl-XL, and Mcl-I, block the effects of both effector and
activator pro-apoptotic family members by binding to them (Oltvai et al. 1993; Cheng et
al. 2001). Therefore, the levels of anti-apoptotic Bcl-2 proteins are thought to set a
threshold for permeabilization; pores will be formed only when pro-apoptotic family
members are in excess of the anti-apoptotic family members. However, this threshold
can be altered by the sensitizer family members. Sensitizers are structurally similar to
activators, containing only a single BH domain, but they cannot directly activate Bax and
Bak. Instead, sensitizers bind to free anti-apoptotic Bcl-2 proteins, preventing the anti-
apoptotic proteins from binding to other activators or effectors, and effectively lowering
the threshold. Together, this control system is thought to constitute the "central control
point" for apoptosis (Spierings et al. 2005).
1.3.5 The death receptors
The death receptors are members of the Tumor Necrosis Factor (TNF)
superfamily of receptors and include Fas (receptor for FasL), TNF-RI and TNF-R2 (for
TNFa), and DR4/DR5 (for TRAIL). Both death receptors and death ligands form homo-
trimers (Smith and Baglioni 1987). Binding of a trimeric ligand to its receptor induces
receptor activation, but it is not yet clear whether binding induces receptor trimerization,
or instead induces a conformational change in a pre-formed receptor trimer (Siegel et al.
2000). In either case, ligand binding stimulates the recruitment to the receptor of several
adaptor proteins to form the DISC (Death-inducing signaling complex)(Kischkel et al.
1995; Medema et al. 1997); interaction of receptors and adaptor proteins is mediated by
homotypic interactions of death domains, which are present in both the cytoplasmic
region of the receptor and in the adaptor proteins. It the cases of Fas, DR4, and DR5, the
only adaptor protein recruited is FADD (Fas-associated, death domain-
containing)(Chinnaiyan et al. 1995; Chaudhary et al. 1997); in the case of TNF, TRADD
(TNF receptor-associated, death domain containing) is first recruited and then
subsequently recruits FADD and the TRAF (TNF receptor-associated factors) family of
adaptors (Rothe et al. 1994; Hsu et al. 1995; Hsu et al. 1996). Once FADD has been
recruited to the DISC, it recruits caspases-8 and -10 through the homotypic interaction of
death effector domains (DEDs), which occur in both FADD and in the caspase -8 and -10
prodomains. Inside the DISC, caspases-8 and -10 are first activated by conformational
changes resulting from induced dimerization (Boatright et al. 2003; Donepudi et al.
2003). Autocatalytic processing of the initiator caspases then ensues, resulting in the
release of activated caspase-8 or -10 dimers into the cytosol (Chang et al. 2003a). This
activation of caspase-8/10 is regulated by Flip, a protein that is highly similar to
caspases-8 and -10, but which lacks catalytic activity (Irmler et al. 1997). Regulation of
caspase-8/10 activation by Flip is bi-functional; at low concentrations Flip can be
recruited to the DISC to serve as a dimerization partner for caspase-8 or -10, allowing
activation of that caspase, but at high concentrations Flip inhibits caspase-8/1 0 activation
by competing for binding to the DISC (Chang et al. 2002; Micheau et al. 2002).
1.4 The core pathways of apoptosis
1.4.1 The extrinsic pathway
The extrinsic apoptotic pathway refers to induction of effector caspase activity by
the death ligands. In some cells, this pathway is thought to be relatively simple.
Activation of the death receptor leads to DISC formation and caspase-8 activation.
Caspase-8 then activates caspases-3 and -7 to kill the cell. However, in a number of cell
types, this linear cascade is not sufficient for cell death (Scaffidi et al. 1998). In such
cells, the mitochondrial pathway must also be activated through caspase-8/1 0-mediated
cleavage of the pro-apoptotic Bcl-2 family protein Bid (Li et al. 1998; Luo et al. 1998).
Once Bid has been cleaved, it activates Bax to induce mitochondrial permeabilization.
The mitochondrial pathway is likely required either to amplify the amount of cleaved
caspase-3 when caspase-8 acitivity is very weak (Scaffidi et al. 1998; Scaffidi et al.
1999), or to remove the inhibitory effect of XIAP on caspase-3 by the release of Smac
(Zhang et al. 2001; Deng et al. 2002; Li et al. 2002; Sun et al. 2002). Thus, in many
cells, essentially all of the apoptotic regulators discussed above come into play when the
death receptors are stimulated.
1.4.2 The intrinsic pathway
The intrinsic apoptotic pathway refers to induction of apoptosis in response to
DNA damage, changes in pH, growth factor withdrawal, and other cellular stresses. In
general, apoptotic signaling under these circumstances begins with the mitochondrial
pathway. p53 activation in response to DNA damage or loss of growth factor signaling
result in changes in the relative levels of pro- and anti-apoptotic Bcl-2 family proteins,
leading to mitochondrial permeabilization (Miyashita and Reed 1995; Maurer et al.
2006). Thus, in these cases, caspases are activated only downstream of the mitochondrial
release of cytochrome c and apoptosome formation. However, in heat- and stress-
induced apoptosis, caspase-2 is activated upstream of the mitochondria and is required
for mitochondrial permeabilization (Lassus et al. 2002; Tu et al. 2006).
1.5 Regulation of apoptosis by pro-survival signaling
The molecules discussed above consititute the central machinery responsible for
either dismantling the cell or directly holding back the destructive caspases when not
necessary. However, many more molecular pathways have been found to influence the
entry of the cell into apoptosis. Among these molecules are kinases and transcription
factors that impinge directly upon the core machinery; kinases phosphorylate and thereby
alter the activity of certain components of the machinery, while transcription factors
adjust the expression levels of core components. These changes can affect the sensitivity
of a cell to apoptosis, determining whether or not a given pro-apoptotic stimulus is
sufficient to induce apoptosis. Thus, these pathways form an additional layer of
regulation surrounding the core machinery of apoptosis. Among these pathways are
some of the central signal transduction pathways of the cell, such as the mitogen-
activated protein kinase (MAPK), phosphoinositide-3 kinase (PI3K), and NF-KB
pathways, which also control cell growth, proliferation, and stress response. Thus, this
outer layer of regulation serves to connect the apoptotic decision process to other central
cellular processes. With such pervasive routes of regulation, it could be argued that few,
if any, functions of the cell are not connected to apoptosis in some way.
1.5.1 The PI3K pathway
The PI3K/Akt pathway is perhaps the best-known survival signaling pathway, and
it affects apoptosis through numerous connections. Akt is known to phosphorylate Bad, a
Bcl-2 family pro-apoptotic sensitizer protein (Datta et al. 1997; Datta et al. 2002). When
phosphorylated by Akt, Bad can be bound by 14-3-3 proteins, which sequester Bad away
from the mitochondria and prevent it from exerting its pro-apoptotic effect (Datta et al.
2000). Similarly, Akt phosphorylates the Forkhead family of transcription factors; this
phosphorylation results in sequestration away from the nucleus by 14-3-3 proteins
(Brunet et al. 1999). Since the Forkhead family transcriptionally activates pro-apoptotic
genes such as FasL, phosphorylation by Akt again produces an anti-apoptotic effect. Akt
can also inactivate caspase-9 by directly phosphorylating it (Cardone et al. 1998), and can
stabilize XIAP through direct phosphorylation (Dan et al. 2004). Akt can also
phosphorylate and inactivate GSK3 (Cross et al. 1995); it was recently found that GSK3
can target the anti-apoptotic Bcl-2 family member Mcl-I for ubiquitin-mediated
degradation by phosphorylating it (Maurer et al. 2006). Thus, Akt activation would lead
to an increase in protective Mcl-I levels. Together, the many anti-apoptotic functions of
Akt make it a potent pro-survival signal; aberrant up-regulation of this pathway is central
to the ability of tumor cells to resist apoptosis.
1.5.2 The NF-KB pathway
NF-KcB is a transcription factor that upregulates numerous anti-apoptotic genes at
the mRNA level. Among its transcriptional targets are XIAP, cIAPl/2, Bcl-2, and Flip
(Stehlik et al. 1998; Tsukahara et al. 1999; Micheau et al. 2001). NF-KB is typically kept
inactive because it is held in the cytoplasm by the constitutively bound Inhibitor of kB
(IKB). However, the IKB family of kinases (IKKs) stimulate NF-KB translocation to the
nucleus by phosphorylating IkB and targeting it for proteasome-mediated degradation
(Ghosh and Baltimore 1990). The nuclear translocation of NF-KB leads to
transcriptional activation of its target genes. This pathway is activated by numerous
cytokines, such as TNF and the interleukins, and is usually associated with inflammation.
Recent work has demonstrated that NF-KB can play an important role in cancer cell
survival as well (reviewed in (Karin 2006)).
1.5.3 MAPK pathways
The mitogen-activated protein (MAP) kinases also play a central role in
controlling apoptosis. It was initially reported that the ERK MAPK pathway played a
pro-survival role and the p38 and JNK MAPK pathways played a pro-apoptotic role (Xia
et al. 1995), but subsequent studies have been conflicting. For example, the ERK 1/2
pathway is an important survival pathway; its targets include caspase-9, which it inhibits
by direct phosphorylation (Allan et al. 2003), and Bad, which is a substrate of the ERK
target ribosomal S6 kinase (RSK) (Bonni et al. 1999). It has also been reported that ERK
inhibits death receptor signaling upstream of caspase-8, although the direct target for this
function remains unknown (Tran et al. 2001; Soderstrom et al. 2002). However, ERK
has also been found to play a pro-death role in some situations, such as in neuronal
degeneration associated with Parkinson's disease (Kulich and Chu 2001). Even more
ambiguous are the roles of the JNK and p38 MAPK pathways. While these pathways are
required for pro-apoptotic signaling in many cases (Kuan et al. 1999), in other contexts
they appear to act as pro-survival factors (Yu et al. 2004). Thus, it appears that the roles
of MAPK pathways in regulating apoptosis, while very important, are complex and
highly context-dependent.
1.6 Apoptosis at the population and single cell level
To be understood fully, apoptosis must be studied at both the population and the
single-cell level. Within a population, each individual cell may or may not commit
apoptosis. Therefore, it is typical to study apoptosis using assays that distinguish
between healthy and apoptotic cells, thus allowing the percentage of apoptotic cells
within the population to be quantitated. This measure, also known as the "apoptotic
index" of a tissue or population, is commonly reported as a measure of the response to a
particular stimulus or genetic alteration. As is often noted, this is not a perfect measure,
because it depends on the rate at which apoptotic cells break down or are cleared from the
tissue and the rate at which healthy cells are produced by cell division; these rates can
vary with time and context. Moreover, the heterogeneity of individual cellular responses
complicates the use of biochemical methods such as immunoblotting that homogenize the
entire population; such methods must be used with the caveat that both healthy and
apoptotic cells are included within the cell lysates being analyzed. Thus, a number of
studies have focused on apoptosis in single cells and have observed the real-time
dynamics of apoptotic events at this level. These studies have led to interesting insights
into how apoptosis is executed. However, it is difficult to assess the sensitivity to
apoptosis by observing a single cell, which either dies or does not. To accurately
compare the sensitivity of cells under two or more conditions, it is more useful to
compare the apoptotic indices measured across larger populations. Thus, understanding a
process like apoptosis necessitates the use of both population- and cellular-level
measurements.
Numerous apoptotic events have been imaged in single living cells.
Morphological changes such as cell shrinkage and membrane blebbing are visible via
basic light microscopy (Goldstein et al. 2000a). Other changes, such as DNA
fragmentation, membrane permeablization, or mitochondrial depolarization, can be
imaged using fluorescent dyes. Specific molecular events involving proteins can be
detected using the appropriate green fluorescent protein (GFP) fusions, and this approach
has been the most informative in observing the dynamics of apoptotic signaling. For
example, a cytochrome c-GFP fusion revealed that cytochrome c release from the
mitochondria during apoptosis is always a rapid and complete event, taking only 5-10
minutes to complete once it begins (Goldstein et al. 2000b; Goldstein et al. 2005).
Subsequent studies have shown that this dynamic behavior is also true of Smac and other
proteins of the mitochondrial intermembrane space and that all of these proteins are
released simultaneously when mitochondrial permeabilization occurs (Rehm et al. 2003;
Munoz-Pinedo et al. 2006). Interestingly, however, mitochondrial membrane
depolarization is a distinct event from cytochrome c/Smac release. Depolarization
follows cytochrome c release and is dependent on the downstream activation of caspases
(Munoz-Pinedo et al. 2006).
Single-cell studies have also revealed much about the regulation of caspases.
Most of these studies have employed GFP-based F6rster resonance energy transfer
(FRET) sensors sensitive to caspase activity. These sensors are constructed by linking
together two fluorescent proteins capable of undergoing FRET (CFP and YFP are the
most common) with a caspase cleavage sequence in between; the proximity of the two
fluorescent proteins within the fusion protein enables FRET to occur. When the caspase
specific for the cleavage sequence is active, it cleaves apart the two fluorescent proteins
and the FRET interaction is lost, resulting in a shift in the ratio of intensities of CFP and
YFP emission. Using this technique it was found that, like cytochrome c/Smac release,
the cleavage of a caspase-3 FRET substrate begins suddenly after a delay phase and is
rapidly completed (within 5-10 minutes) (Tyas et al. 2000; Rehm et al. 2002). Moreover,
this rapid cleavage follows the release of Smac by 10-15 minutes (Rehm et al. 2003).
Morphological changes such as cell shrinkage quickly follow effector caspase activation.
Thus, single cell studies indicate that once the mitochondrial outer membrane is
permeabilized, downstream events occur in rapid succession; the execution of the cell is
complete within 10 minutes in some cases (Green 2005).
Live-cell studies have also shown that the time preceding mitochondrial
permeabilization is variable and can be at least as long as 12 hours. Much less is known
about the dynamics of signaling during this period. Several attempts have been made to
observe caspase-8 activity, but these have produced conflicting results (Luo et al. 2003;
Kawai et al. 2004). It has also been reported that a transient increase in cellular calcium
can be observed prior to permeabilization, but the role of this signal is unclear. Thus,
signaling dynamics upstream of the mitochondrial pathway remain obscure.
1.7 Quantitative challenges in apoptosis
The emerging field of systems biology seeks to develop a quantitative, system-level
understanding of biological pathways and networks. A central approach in systems
biology is to create/ models that capture system-level behavior while retaining the details
of the underlying molecular mechanisms. Apoptosis presents a rather unique quantitative
challenge for systems biology. It is not a gross oversimplification to state that apoptosis
is a cell fate that is ultimately linked directly to a single quantity: the effector caspase
activity in the cell. All apoptotic signals eventually converge on the effector caspases,
and the extent to which these enzymes become active determines whether the cell lives or
dies (at least in the cases where other forms of cell death are not available). In contrast,
in a differentiation circuit, rather than converging on one effector, the signal diverges to
many effectors, such as genes that are transcriptionally activated, most of which are still
unknown, making accurate mechanistic modeling a distant goal. However, it is currently
realistic to consider mechanistic modeling of the time-dependent activity of an enzyme
such as caspase-3. Mathematical models for systems controlling enzymatic activity are
well-developed, and the structure of the biochemical pathways regulating effector
caspase activity have been well described, to some extent even in quantitative terms It
should thus be possible to construct a model that accurately describes the enzymatic
activity of the effector caspases. Indeed, several attempts have been made to capture
caspase regulation by mathematical modeling (Fussenegger et al. 2000; Bentele et al.
2004; Eissing et al. 2004; Bagci et al. 2005; Stucki and Simon 2005). These models have
begun to address a number of interesting questions in apoptosis, but as of yet have
provided few definitive answers. However, by approaching apoptosis from a quantitative
perspective, these studies have helped to raise a number of interesting unanswered
questions in the field of apoptosis. Some of these questions have not yet been considered
by those approaching apoptosis from a traditional biology perspective. Thus, there is
much interesting work to be done in applying mathematical modeling to apoptosis.
1.7.1 Quantitating the lethality of caspases
How much effector caspase activity is needed to cause a cell to die? In other
words, what percentage of effector caspases in each cell must be activated, and for how
long must they remain active, in order to ensure cell death? A complementary question
is, what percentage of effector caspase substrates must be cleaved to kill the cell? These
are essentially experimental questions; to answer them will require the examination of
cells in which caspases have been activated at different levels and the determination of
their resulting fates. To date, this has not been possible, because all stimuli examined
appear to activate caspases in an all-or-none manner, regardless how low of a stimulus
concentration is used. Thus, to answer this question, a method will have to be developed
to bypass all-or-none caspase activation. Doing so will likely require an understanding of
the mechanism of all-or-none caspase activation. However, it will be essential to answer
this question in order to connect quantitative models of caspase activation to cell fate.
1.7.2 All-or-none caspase activation
Why is caspase activation all-or-none? It is probably important for the cell to
avoid partial activation of caspases, since this would lead to an uncertain cell fate. Some
formal hypotheses for all-or-none mechanisms have been proposed by the caspase
models constructed so far. One hypothesis is that this results from the positive feedback
loop mediated by caspase-6 (Eissing et al. 2004). Positive feedback has been shown to
mediate all-or-none behavior in other systems (Ferrell and Xiong 2001). A second
possibility is that some type of allosteric regulation of the caspases is involved. For
example, it has been proposed that the assembly of the heptameric apoptosome may be a
highly cooperative event that combines with positive feedback to form a bistable caspase
switch (Bagci et al. 2005). A third possibility, based on single-cell data, is that the all-or-
none release of cytochrome c and other proteins from the mitochondria drives all-or-none
caspase activation (Goldstein et al. 2000b; Green 2005). However, it is still unknown
why cytochrome c release is all-or-none; since it is released by Bax-mediated pores, it
might be expected that the rate of release would be dependent on the number of Bax
proteins present in the mitochondrial membrane. Differentiating among these
possibilities will likely require both single-cell experimentation and quantitative
modeling.
1.7.3 Integration of apoptotic signals
As described above, many pathways regulate apoptosis in some way, but caspase
activation is still all-or-none. How is all of this information integrated, and which
pathways are the most important for the fate of the cell? One hypothesis is that this
integrating function is performed by the Bcl-2 family proteins of the mitochondria
(Spierings et al. 2005). In this scenario, pro and anti-apoptotic signals increase and
decrease the levels of pro and anti apoptotic Bcl-2 family proteins accordingly; if the
number of activated pro-apoptotic Bcl-2 exceeds the number of anti-apoptotic proteins,
then the release of cytochrome c and other mitochondrial proteins occurs rapidly and
completely. Thus, each signal gets a number of "votes" corresponding to the number of
pro- or anti-apoptotic proteins it produces or inactivates, with the mitochondria serving as
the ballot box. It is also interesting to ask how all regulatory pathways affect apoptosis
in such a way that all-or-none caspase activation is maintained. This would appear to be
important, if it is indeed true that partial caspase activation is detrimental.
1.7.4 Thresholds in apoptosis
Given that apoptosis is an all-or-none event, there must be some threshold for pro-
apoptotic signaling that must be crossed to initiate apoptosis. One model has suggested
that the number of Flip molecules in the cell creates a threshold for death ligand
concentration (Bentele et al. 2004). Other work has suggested that the number of anti-
apoptotic Bcl-2 family members in the cell sets a threshold for the release of cytochrome
c (Certo et al. 2006). It is quite possible that there is more than one threshold; there may
be multiple points in the pathway at which the signal must exceed a certain value in order
to trigger downstream events. However, answering this question will require an
understanding of how thresholds are created in general. In an ideal threshold, the output
response for a given signal is zero below a certain level of signal, and non-zero above
that point. It is often tempting to state that an inhibitory molecule "sets a threshold" for
the signaling molecule that it inhibits; for example, in the FLIP threshold model, each
Flip binds to and inhibits one activated receptor. If this mechanism created an ideal
threshold, then the presence of 103 Flip molecules in the cell would imply that the
downstream signaling from the receptor would remain off until greater than 103 receptors
had been activated. However, a simple binding reaction like this creates an effective
threshold only when the Kd of the association reaction is extremely tight (< 1 nM).
Indeed the, Flip model assumes a Flip-receptor Kd of 1 pM. However, protein-protein
interactions are rarely this tight. Thus, it is unlikely that simple binding reactions are
responsible for most biological thresholds. Instead, thresholds likely arise in more
complex ways, such as through distributed phosphorylation (Gunawardena 2005) or zero-
order ultrasensitivity (Goldbeter and Koshland 1981). It will be important to definitively
identify components of the apoptotic pathway that create thresholds.
1.7.5 The relationship between timing of death and apoptotic sensitivity
Quantifying the sensitivity of a given cell type to apoptosis is an important
question. This is particularly critical in relation to clinical studies, where the goal may be
to identify treatments stimuli that effectively induce death in a particular cell type, such
as tumor cells (Lowe et al. 2004). In many studies, the sensitivity of cells to a particular
is assessed by treating cells continuously with a pro-apoptotic stimulus and measuring the
apoptotic index at one or several time points afterwards. One criticism of this approach is
that it does not reveal the true fate of cells. To determine whether cells ultimately live or
die in response to a stimulus, it is necessary to examine their long-term behavior; this can
be done by colony-forming assays, for example. However, such assays should not be
considered the final word; it is highly unlikely that cells in vivo are subjected to a single,
continuous dose of a given stimuli for days or weeks. Since apoptotic stimuli are likely
transient, the timing of cell death in response to a given stimulus is also an important
aspect of the cellular response. Thus, the response of a population of cells to a given
apoptotic stimulus cannot be summarized by a simple percentage or rate. Summarizing
the apoptotic response can best be done by mathematical models that consider both the
timing and extent of cell death, and perhaps the rates of other processes such as mitosis
(Byrne et al. 2006).
1.7.6 Asychronicity and variability in individual responses.
The apoptotic response is known to be highly variable from cell to cell (Tyas et al.
2000). It is not yet clear whether this is a feature unique to apoptosis, or whether it is
simply more obvious in apoptosis then in other cellular processes due to the distinctive
morphology of apoptotic cells. Moreover, recent studies have also revealed significant
cell-to-cell variability in the NF-KB and p53 signaling systems, which feed into the
central apoptotic pathways (Nelson et al. 2004; Geva-Zatorsky et al. 2006). Thus, cell-
to-cell variability plays an important role in apoptotic responses. It can been
hypothesized that this is a beneficial feature, allowing populations of cells in the body to
respond in a graded manner to stimuli. However, it is also possible that the high level of
heterogeneity observed in cell death is an artifact of the deranged tumor cell lines used in
many in vitro studies of apoptosis. Quantifying this heterogeneity and understanding its
mechanism and function will be essential for building accurate models of apoptotic
responses.
1.7.7 Interaction networks with high combinatorial complexity
Many steps in apoptotic signaling involve the formation of protein complexes,
such as DISC and apoptosome formation, and the interaction of Bcl-2 pro- and anti-
apoptotic proteins. In many of these cases, the number of possible different combinations
of subunits is very high. For example, in the Bcl-2 family there are at least 8 pro-
apoptotic proteins and 6 anti-apoptotic proteins, making for 48 possible heterodimer
combinations. Recent studies have undercovered binding preference profiles for several
of these proteins (Chen et al. 2005; Kuwana et al. 2005). However, the temptation has
been to view these binding profiles as binary - e.g. Bak binds to Mcl-I and Bcl-XL, but
not to Bcl-2 - rather than taking into account the Kd for each interaction. As this
biochemical interaction data continues to be improved, mathematical models may be able
to predict the abundance of each of the possible heterodimers, and hopefully will improve
understanding of which interactions are critical and which are less important. This has
already been attempted on a smaller scale by one study that concluded that Bcl-2 likely
exerts its anti-apoptotic effect by binding to both Bax and Bid rather than either one alone
(Hua et al. 2005).
1.8 Conclusion
To achieve the goal of improving treatments for diseases such as cancer, apoptosis
must be understood at multiple levels. At the molecular level, the challenge is to
understand the molecular details of enzyme reactions and protein interactions so that the
effects of mutations can be understood and so that inhibitors can be designed to target
specific functions. At the single-cell level, the challenge is to understand how apoptosis
is successfully executed or carefully suppressed, so that the cell accurately and certainly
chooses the fate that is required of it; failure of even a single damaged cell to die can
result in cancer. At the tissue level, the challenge is to understand how the death and
survival of many cells are coordinated accurately, so that the right number of cell deaths
occurs to maintain homeostasis. These levels of organization are interconnected; for
example, individual cells must be calibrated properly so that they respond in the correct
proportion to tissue-level signaling. Thus, future advances in the field of apoptosis will
rely on approaches that can integrate quantitative information across multiple levels of
organization. Thus, as much as apoptosis is an interesting challenge for systems biology,
systems modeling may become an essential tool in understanding cell death.
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2.1 Abstract
Caspases, the proteases that dismantle apoptotic cells, are normally regulated via an all-
or-none switch that enforces an unambiguous choice between life and death. To
understand the operation of this switch in quantitative terms we constructed a
mathematical model using mass-action kinetics and verified it by observation of single
cells perturbed by protein depletion, over-expression, or inhibition. Receptor-mediated
cell death is characterized by rapid caspase activation and efficient caspase substrate
cleavage, but only after a remarkably long delay (up to 12 hr), whose mean duration and
variance depend on ligand dose. Modeling must therefore account for both snap-action
behavior and variable delay: it is not sufficient that all processes be fast. Moreover,
activation reactions operating on distinct time scales must be reconciled with the
requirement that caspases be held safely in check under most circumstances. Our
analysis establishes that cell death is dependent on a multi-step feed-forward circuit
involving several parallel processes, rather than on simple feedback. Through simulation
and experimentation we identify distinct failure modes in the apoptosis switch and
suggest that at least one has the potential to promote genomic instability and oncogenic
transformation.
2.2 Introduction
Activation of executioner caspases (caspases-3 and-7; hereafter C3), the hallmark
of apoptosis, is triggered by intracellular events such as DNA damage, oxidative stress,
and chemical insult (intrinsic cell death), and by extracellular stimuli such as TNF
(Tumor necrosis factor), TRAIL (TNF -related apoptosis-inducing ligand), and Fas ligand
(extrinsic cell death). Apoptosis is essential for many developmental processes but is
misregulated in diseases as diverse as cancer and autoimmunity (Green and Evan 2002).
Caspases directly cleave essential cellular proteins and activate specialized DNAses,
thereby dismantling both the proteome and genome (Fischer et al. 2003). At the single-
cell level, caspase activation occurs in an all-or-none manner (Tyas et al. 2000; Rehm et
al. 2002) ensuring that once begun, DNA and protein degradation are carried to
completion. Otherwise, sub-lethal cellular damage, indeterminant physiological states,
and severe genomic instability might result. Quantitative understanding of all-or-none
caspase activation is incomplete, despite a variety of competing informal and
mathematical models that seek to explain the regulation of cell death (Fussenegger et al.
2000; Bentele et al. 2004; Eissing et al. 2004; Bagci et al. 2005; Hua et al. 2005; Stucki
and Simon 2005).
In this paper we combine time-resolved measurement of apoptosis in single
TRAIL- or TNF-treated cells with perturbation of specific proteins by RNAi or over-
expression to construct an experimentally-validated mathematical model of receptor-
mediated apoptosis. We use simulation to derive insight into the control of extrinsic
apoptosis under normal circumstances and concepts derived from the engineering field of
failure analysis (failure mechanism modeling) to understand how control can break down.
We identify several distinct forms of failure with the potential to contribute to human
disease.
2.3 Results
2.3.1 A quantitative description of caspase activation in single cells
As a first step in describing receptor-mediated apoptosis quantitatively, we
measured the response of cells to TNF and TRAIL. When HeLa cell cultures were
exposed to either ligand, a graded dose-dependent response was observed in which the
number of dead cells increased gradually over a period of -24 hr (see also Chapter 4)
(Janes et al. 2005). However, when C3 activation was monitored by fluorescence
microscopy of cells carrying a FRET-based cleavage reporter, all-or-none activation was
observed at the single-cell level. FRET reporter cleavage occurred within a few minutes
of morphological manifestations of apoptosis, such as cell shrinkage and membrane
blebbing, demonstrating that C3 activation was indeed concomitant with death (Fig
2.1 A,B) (Rehm et al. 2002). As previously shown, the amount of C3 substrate cleaved in
single cells at time t can be represented by a Boltzman equation with three parameters:
Td, the delay time preceding cleavage; Ts, the switch time from minimum to maximum
cleavage; andf, the final fraction of substrate cleaved (Eq 1; Fig 2.1 C):
[cPARP(t)] = Eq. 1 (Rehm et al. 2002)
-4.0.t1
l+e
Td, Ts, andf were determined by monitoring FRET signals in cells exposed to TNF or
TRAIL at concentrations ranging from saturating to roughly physiological (with >100
cells monitored per condition). Ts was found to be short and nearly constant (15-30 min,
see Table Si for actual values) andf high (-1.0) regardless of the concentration or
identity of the ligand (Fig 2.1D). Conversely, Td was highly variable from cell to cell (60
- >720 min) and both its mean and variance were sensitive to ligand concentration (Fig
2.1 E). Low doses of TRAIL were associated with long and variable Td relative to
saturating TRAIL, as were all concentrations of TNF (Fig 2.1 E, Table S 1). Thus, the
caspase activation network triggered by TNF and TRAIL constitutes a switch that waits
for a variable interval before transitioning rapidly and irreversibly from open to closed -
a so-called irreversible, snap-action, variable-delay switch. Integration of live-cell
imaging data over many cells reveals the importance of variability in Td for a graded
response to death ligand at the population level, given that Ts and fare essentially
constant (Fig. S1). The importance of these findings from the perspective of modeling is
that they impose more complex requirements on the apoptosis regulatory circuit than
rapid caspase activation alone.
Live-cell imaging allows the behavior of single cells to be monitored in detail but
is relatively low-throughput relative to flow cytometry, another single-cell technique.
Flow cytometry also allows cleavage of endogenous substrates (rather than artificial
reporters) to be monitored, albeit with loss of information on the history of single cells
(Irish et al. 2006). When cells were treated with TNF or TRAIL over a range of
concentrations, stained with antibody against the cleaved form of the endogenous C3
substrate PARP (cPARP) (Li and Darzynkiewicz 2000), and subjected to flow cytometry,
a bimodal distribution was observed in which PARP was entirely full length in a subset
of cells and entirely cleaved in others (Fig. IF). Very few cells (<5%) were present in
which a fraction of PARP was cleaved. Application of a simple data model to the flow
cytometry results (see Fig. 2.S2) made it possible to derive switching values (Ts - 20
min, Td - 60-400 min, and f-1.0 Fig. IF) that were very close to values obtained by live
cell imaging, thereby confirming that data derived from the two methods can be fused.
Very similar results were obtained by flow cytometry with an antibody against cleaved
cytokeratin, another C3 substrate (data not shown), suggesting that the behavior of
cPARP is generally representative of endogenous executioner caspase substrates.
Data modeling also revealed that flow cytometry profiles for cPARP should show
distinctive changes with variation in Td, Ts, orf (Fig 2.S2): (i) when Td increases with Ts
andfconstant, so that efficient snap-action switching is retained, cPARP-positive cells
accumulate more slowly, but there is no increase in cells with intermediate cPARP; (ii) if
Ts increases withf constant, there is a breakdown of snap-action behavior and the
appearance of cells in which PARP is partially cleaved at short, but not at long, times (f
-- 1.0 as t--oo); (iii) iff decreases with or without changes in Td and Ts, a steady
accumulation of cells with partially cleaved PARP is observed. Scenario (i) corresponds
to effective regulation of cell death, albeit at an altered sensitivity to death ligand,
whereas scenarios (ii) and (iii) represent failure modes.
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Figure 2.1. Properties of receptor-mediated cell death in single cells. A. Ratiometric
images of HeLa cells carrying a stably expressed caspase reporter, in which cleavage
alters the FRET signal, treated with 50 ng/ml TRAIL. Loss of FRET signal, indicative of
substrate cleavage, is shown by a shift in color from blue to yellow. B. Plots of substrate
cleavage for individual cells treated with varying amounts of TRAIL or TNF (as
indicated by color code). The slow rise in FRET signal prior to a sudden increase appears
to represent a photobleaching effect that is independent of caspase activation C.
Idealized time course of substrate cleavage in a single cell as represented by the
Boltzmann equation (see Eq. 1 in text). D,E. Ts and Td were measured by live-cell
microscopy of HeLa cells treated with varying concentrations of death ligand (n> 100 for
each condition); frequency distributions based on a binning interval of 30 min. F.
cPARP levels were measured by flow cytometry at various timepoints after treatment
with TNF or TRAIL as indicated. The colored regions underlying each histogram
represent cells with approximate levels of PARP cleavage of <5% (green), 5-20%
(yellow), or >20% (grey). Bar graphs below each set of histograms represent a
discretization of the flow data in which the percent of cells falling into each PARP
cleavage class are quantitated. G. Schematic diagram of TRAIL-induced apoptotic
pathways; the major features of the network are indicated as large colored arrows: beige -
receptor module; red - direct caspase cascade; grey - positive feedback loop; blue -
mitochondrial feedforward loop. H. Simulation of Td, Ts, andf values as functions of
ligand concentration using our ODE model.
2.3.2 A mathematical model of extrinsic cell death
To determine how caspases and their regulators set Td, Ts, andf we constructed a
mathematical model of protein pathways activated by TNF and TRAIL receptors. The
model was based on mass-action chemical kinetics involving uni- or bi-molecular
elementary reactions as represented by a coupled set of non-linear ordinary differential
equations (ODEs; see Section 2.6). No arbitrary or fitted algebraic forms were
introduced that might generate cooperativity or ultrasensitivity a priori. Moreover, since
ODE models are very sensitive to errors in connectivity, we included only well-
substantiated reactions in the model, at the cost of excluding some interesting processes.
The ODE model included four sets of reactions whose components and connectivity were
derived from the literature (Fig 2.1G): (i) a lumped-parameter receptor module linking
binding of TNF and TRAIL ligands to their cognate receptors and then to activation of
caspase-8 (C8) to form cleaved caspase-8 (C8*); (ii) an enzyme cascade in which C8*
cleaves C3 and activates it to form C3*, which then cleaves PARP to form cPARP; (iii) a
positive feedback loop in which caspase-6 (C6) is cleaved by C3* to form C6*, which
then activates additional C8; and (iv) a mitochondrial feed-forward pathway, in which
C8*, via its substrate Bid, promotes formation of Bax-containing pores in the
mitochondrial membrane, through which cytochrome c (CyC) and Smac translocate to
the cytosol to form the apoptosome (which also generates C3*) and neutralize the C3*
inhibitor XIAP. In its granularity, the model aims to be reasonably complete with respect
to biochemical mechanism, but three simplifications were made to reduce the number of
biochemical species and associated free parameters. First, receptor-dependent "death-
inducing signaling complexes" (DISCs) were not modeled in detail; second, proteins with
similar biochemical activities were lumped into a single species (e.g. C8 and C10 are
represented by C8 alone; C3 and C7 by C3 alone; see Section 2.6); and third,
transcription was omitted because all experiments were performed in the presence of
cycloheximide (which is commonly used to sensitize cells to the action of TNF but in our
experiments serves to simplify the overall reaction network). Values for kinetic
parameters and initial protein concentrations were determined from the literature, by
direct measurement, and by induction, as described in detail in Section 2.7. It is important
to note however, that our model, like virtually all physico-chemical models of
mammalian cell signaling, has not yet been formally calibrated against data so as to
rigorously constrain parameter values. Thus, in the absence of other information, kinetic
rate constants and initial conditions in the model were set to intermediate values within a
range that was physically plausible. The final model contained 58 species (corresponding
to 18 distinct gene products with non-zero initial conditions, and 40 additional species
representing complexed, cleaved, or differentially localized forms) and 28 reactions
described by 70 non-zero rate constants (including forward, reverse, and catalytic rates
for each reaction).
To ensure that our model accurately reflected the mechanisms of snap-action
switching in Hela cells, we applied an iterative process of experimental perturbation and
model regression. Experimentally, proteins throughout the network were depleted by
siRNA (typically, three independent siRNA oligos were examined for each gene) or were
stably overexpressed as retroviral constructs under the control of a viral promoter. For
each perturbation, levels of depleted or over-expressed proteins were determined by
immunoblotting (Fig 2.S3), and Td, Ts, andf were estimated by flow cytometry following
treatment with TRAIL. Changes in protein concentrations correspond in the model to
changes in the initial concentration of that species (denoted as [X]o for species X). Thus,
for each experiment, the initial conditions in the model were adjusted to reflect measured
changes in concentration of a depleted or overexpressed protein, and changes in Td, Ts,
andf were determined by simulation. Importantly, the final model correctly predicted the
dependence of Td, and independence of Ts andf, on ligand dose (Fig 2.1 H). The
constrained model was therefore studied further for insight into the mechanisms and
failure modes of C3 regulation, as described in detail below.
2.3.3 Feedforward control of snap-action behavior
Because positive feedback plays a role in many all-or-none biological transitions
(Ferrell and Xiong 2001; Eissing et al. 2004), we examined the role played by the C6
positive feedback loop in C3 activation (Cowling and Downward 2002). 10-fold
depletion of C6 by RNAi did not significantly alter the dynamics of cPARP accumulation
in cells treated with TNF or TRAIL (relative to control depletions; Td,-70 min; Ts,-20
min;.f~- 1.0, Fig 2.2A, B). Independence on C6 was also captured by the model: snap-
action PARP cleavage was retained even when C6 was removed completely (Fig 2.2C).
Remarkably, however, simulation shows that C6* nonetheless plays a major role in
determining overall levels of C8* in dying cells (Fig 2.2D). If the generation of C8* is
separated into its two sources, DISC and C6*, it is apparent that a dramatic acceleration
in C8* formation is induced upon C6* activation. A priori, it might be assumed that this
acceleration would constitute a key feature of snap-action switching. However, C8*
generated by C6* lags temporally behind C8* generated by DISC and is present only
after rapid cleavage of PARP has begun, making it inconsequential for the dynamics of
TRAIL-mediated cell death (Fig 2.2D). Although parameter values can be found in
which the kinetics of PARP cleavage do depend substantially on the C6* feedback loop
(either [C6]o, or the rate of C8 cleavage by C6* must be high) these conditions do not
appear to pertain to unperturbed or RNAi-treated Hela cells. However, they might occur
in cells with a different form of caspase regulation. Importantly, however, C6-mediated
positive feedback does not appear to be essential for snap-action C3 activation under our
conditions.
We therefore turned to the mitochondrial feed-forward circuit. Bcl-2 over-
expression (Fig 2.2E) or Bid depletion by RNAi (data not shown), both of which prevent
formation of Bax-containing pores in the mitochondrial membrane (Fig 2.S4), strongly
blocked PARP cleavage (f<0.04) and cell death in response to TNF or TRAIL.
However, when Bcl-2-overexpressing cells were examined by Western blotting, efficient
processing of C3 to its active form C3* was observed (Fig 2.2F). C3 processing was C8*-
dependent (as demonstrated by RNAi of C8, Fig 2.S5), even though C3* catalytic activity
and PARP cleavage were absent. The absence of C3* activity despite processing of C3
to its active form suggested that C3* must be held in check by an inhibitor. In Hela cells
this protein is most likely XIAP, which binds to and blocks C3* activity, and also acts as
a ubiquitin-targeting E3 enzyme. Bax-mediated mitochondrial permeabilization blocks
the inhibitory activity of XIAP (thereby activating C3*) by mediating the release of the
XIAP-binding protein Smac. In Bcl-2-overexpressing cells, Smac is retained in
mitochondria and cytosolic XIAP is free to inhibit C3* (Zhang et al. 2001; Deng et al.
2002; Li et al. 2002; Sun et al. 2002). The logic of these binding and translocation events
is such that the block on apoptosis imposed by Bcl-2 overexpression should be overcome
by XIAP depletion (Wilkinson et al. 2004). To confirm this prediction, Bcl-2-
overexpressing cells were treated with siRNA against XIAP and the response to TRAIL
examined. As expected, PARP cleavage was restored, but strikingly, snap-action
switching failed, with Ts increasing dramatically to -120 minutes andf falling to -0.1
(Fig 2.2F,G). Even at the 24hr time point PARP cleavage was incomplete and virtually
all cells displayed partial PARP cleavage, appearing as a single peak with median f-0.1
(Fig 2.2H). Remarkably, 45% of cells from this experimental condition were viable
when replated into fresh medium, demonstrating that they had sustained a sub-lethal level
of C3-mediated damage (Fig 2.2G). Thus, inactivation of the mitochondrial feedforward
pathway is associated with two distinct failures in the control of apoptosis: cells activate
effector caspases only slowly (long Ts) and they do not commit decisively to apoptosis
(low).
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Figure 2.2. The mitochondrial pathway is critical for snap-action PARP cleavage. A, B.
HeLa cells transfected with control or C6-targeting siRNA oligos were treated with 50
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cleavage in response to TRAIL in cells with [C6]o at wild type levels (WT), 10-fold
knockdown (KD), or completely absent (KO). D. Simulated time courses of cPARP,
total C8*, C8* produced by the DISC, and C8* produced by C6*. E. Bcl-2-
overexpressing cells transfected with control siRNA were treated with 50 ng/ml TRAIL
and cPARP was measured as in Fig. I. Simulation of PARP cleavage in Bcl-2
overexpressing cells is shown at bottom. F. Control or Bcl-2-overexpressing HeLa cells
were transfected with the indicated siRNA oligos and treated with 50 ng/ml TRAIL.
PARP and C3 processing were analyzed by immunoblot. Differential interference
contrase images of each condition were taken at 4.5 hours, and clonogenic survival was
assessed by a colony-forming assay after 4.5 hours of treatment; percentages denote the
number of colonies after TRAIL treatment relative to untreated controls. G. Bcl-2-
overexpressing cells transfected with XIAPo. 15 siRNA were treated with 50 ng/ml TRAIL
and cPARP was measured as in Fig. 1. Simulation of PARP cleavage in Bcl-2
overexpressing, XIAP-depleted cells is shown at bottom. H. Control or Bcl-2-
overexpressing HeLa cells were transfected with control or XIAPo. 15 siRNA, and treated
with 50 ng/ml TRAIL. HeLa cells were treated as indicated and cPARP levels were
analyzed by flow cytometry at 4.5 and 24 hours. Levels of cPARP are indicated by two
x-scales, one showing arbitrary units of fluorescence, and one showing the calculated
value off, which was determined by normalizing the fluorescence units to the peak
intensity of cells with complete PARP cleavage (shown in pink).
2.3.4 Mechanism of partial PARP cleavage
The failure of Bcl-2-overexpressing/ XIAP-depleted cells, to fully cleave PARP
after many hours was initially puzzling; C3* is a very potent enzyme, present at -1 04
copies/cell (Stennicke et al. 1998). Simulation confirmed our impression a priori that
activating even 1% of the C3 in a Hela cell (i.e. -1 02 C3*) should be sufficient for full
PARP cleavage over a period of several hours (data not shown). However, analysis of
Bcl-2-overexpressing/ XIAP-depleted conditions revealed a possible mechanism by
which PARP cleavage might never go to completion. C3* (but not C3) is degraded via
XIAP-dependent ubiquitination and subsequent proteasomal proteolysis (Suzuki et al.
2001; Chen et al. 2003). Under conditions in which mitochondria are not permeabilized
due to Bcl-2 overexpression and XIAP is depleted to 15% of its normal level, the rate of
C3* production by C8* is only slightly greater than its rate of degradation, and only a
small amount of active enzyme accumulates (Fig 2.3A). Eventually, precursor C3 is
exhausted, with the net effect that C3* is generated in a pulse of limited duration and
magnitude sufficient to partially, but not fully, cleave PARP. In sum, in our model, short
C3* half life and efficient inhibition of C3* by XIAP (ensured by a Kd of 109M), are
both preconditions for partial PARP cleavage (Fig 2.3A). Moreover, cell survival requires
that cPARP levels be quite low, since we estimate an LD 5s(cPARP) of 0.1 (Fig. 2F,
2.S6).
A testable prediction from modeling is thatf should be very sensitive to the rate of
C3* degradation and the consequent size of the C3* pulse in Bcl-2-overexpressing cells
(Fig 2.3B13). Cells overexpressing Bcl-2 were therefore treated with a constant level of
TRAIL and varying concentrations of the proteasome inhibitor MG-132, followed by
flow cytometric analysis of cPARP (Fig 2.3C). With increasing MG-132 (and decreasing
C3* degradation - data not shown),f was observed to increase in a dose-dependent
manner from -0.05 to -1.0. Under some conditions,f reached its limit value more
rapidly in cells than in simulation (within 6 rather than 12 hr., Fig 2.S6) probably because
details of C3* degradation were absent from the ODE model. Nonetheless, good overall
agreement between simulation and experiment supports the conclusion that partial PARP
cleavage and incomplete cell killing represents a distinctive form of failure in the
regulation of apoptosis. In Bcl-2-overexpressing/XIAP-depleted cells, incomplete death
arises because C8* alone does not generate sufficient C3* to counteract the combined
effects of C3* degradation and residual XIAP-mediated C3* inhibition.
While proteasome inhibition and gross alteration of Bcl-2 and XIAP protein
levels abolished snap-action behavior, it was unclear how sensitive switching was to
smaller changes in these parameters. We therefore simulated fin TRAIL-treated cells
across a wide range of physically reasonable values of [Bcl-2]o, [XIAP]o and the rate of
XIAP-mediated C3* degradation (Fig 2.3D,E). We found that many conditions were
compatible with efficient cell killing (f-1.0, gray areas) whereas others corresponded to
an inactive death pathway (f-O0, green areas). However, failure of snap action switching
(0<f<l.0) occurred over a fairly broad region in the [Bcl-2]o vs. [XIAP]o landscape
(denoted by yellow). At high levels of [Bcl-2]o, in particular, fincreased gradually as
XIAP levels decreased (Fig 2.3D, red arrow). To confirm this prediction, we searched
for an siRNA oligo that would deplete XIAP to <5% of its original level (XIAPo. 05 ; Fig
2.S7) as compared to the XIAP0 15 oligo used in the experiments of Fig 2.2G, which
depleted XIAP to -15% of its original level. We observed that transfection of Bcl-2-
overexpressing cells with XIAPo. 05 resulted in f-0.6, as compared tof-0. 1 with
XIAPo 15, confirming our prediction (these points are denoted by positions 4 and 3,
respectively, in Fig. 3D). A landscape divided between regions of high, low, and
intermediate values forf was also observed when [Bcl-2]o was plotted against the rate of
XIAP-mediated C3* degradation (Fig 2.3E), explaining our ability to varyf in a dose-
dependent manner with MG-132 (Figure 2.3E, red arrow). Thus, data and simulation
suggest that when the mitochondrial pathway is not efficiently activated,f is a continuous
variable of [XIAP]o and the rate of C3* degradation, leaving the apoptotic network
vulnerable to partial activation over a fairly wide range of conditions.
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Figure 2.3. Role of C3 degradation and XIAP in switching parameters. A. Simulation
of time courses for C3, C3* (divided into free/active, XIAP-bound, and degraded forms),
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at magnified scale to highlight low-abundance species (center column), and in the
absence C3 degradation (right column). B. Simulation of the time courses of cPARP and
C3*, in which the rate of XIAP-mediated C3* degradation was varied as indicated. C.
Bcl-2- overexpressing HeLa cells were co-treated with 50 ng/ml TRAIL and the indicated
concentrations of MG-132; cPARP levels were measured by flow cytometry after 6
hours, a time sufficient to reach steady state in all conditions (see Fig 2.S6). D,E.
Simulation off as a function of [Bcl-2]o and [XIAP]o (D), or off as a function of [Bcl-2]o
and the rate of C3* degradation by XIAP (E); numbered circles denote points
corresponding to the indicated experimental conditions. Red arrows denote a region of
parameter space in whichf is a continuous function of (D) [XIAP]o or (E) rate of C3*
degradation.
2.3.5 Signal transmission and ratiometric control of snap-action behavior
Because mitochondrial feedforward is essential for snap-action switching, the
proteins responsible for transmitting the signal from mitochondrial permeabilization to
C3 activation should also be important. We observed that RNAi-mediated depletion of
Smac (to -10% of initial levels) resulted inf-0. 1 in TRAIL-treated cells (Fig 2.4A).
This represents a phenocopy of Bcl-2 overexpression/XIAP-depletion (Fig 2.2E) except
that the Smac depletion was more heterogeneous in terms off values. That XIAP is
indeed the critical target for Smac was demonstrated by the observation that simultaneous
RNAi-mediated depletion of Smac and XIAP restores rapid, efficient PARP cleavage (f-
1.0; Ts -20'; Td- 60'; Fig 2.4B).
The effects of RNAi-mediated depletion of Smac alone or of Smac and XIAP
together can be understood in terms of movement along a landscape of predictedf values
from an unperturbed state in which switching was efficient (position I in Figure 4C), to a
second state at which switching was inefficient (position 2), and then to a third efficient
state with short Ts and highf but in which [Smac]o and [XIAP]o are both -10-fold lower,
(position 3). The value off is also predicted to be highly sensitive to Smac levels near
the [Smac]o=[XIAP]o threshold, providing an explanation for the heterogeneity inf
following RNAi of Smac: cell-to-cell variations in Smac concentrations are an inevitable
consequence of RNAi-mediated protein depletion. Overall, our data are consistent with
the hypothesis that states in which [Smac]o/[XIAP]o < 1.0 are associated with a disruption
of the mitochondrial feedforward signal and inefficient commitment to apoptosis.
However, it is possible that under these conditions caspase-independent cell death might
occur, as has been observed in cells in which mitochondria permeabilize but caspases are
inhibited (Chipuk and Green 2005).
The apoptosome, a complex whose assembly is triggered by cytosolic
translocation of CyC and subsequent association of Apoptosis-activating factor-1 (Apaf-
1) and C9, is known to play a role in apoptosis via C9*-mediated cleavage of C3 to C3*
(Zou et al. 1997). Depletion of Apaf-1 by RNAi appeared to phenocopy RNAi-mediated
depletion of Smac by increasing Ts and decreasingf, an effect that was reversed by
simultaneous depletion of XIAP (although results with multiple Apaf-I oligos produced
highly variable results, Fig 2.S8). Our model contains a simplified version of the
apoptosome, since much remains unknown about its stoichiometry in vivo. Simulation
suggested however, that the C3-processing activity of C9* in the apoptosome was not
critical for snap-action switching, since inactivation of this function resulted in only a
moderate decrease in Ts (Fig 2.S9). Instead the XIAP-binding activity of the apoptosome
(Bratton et al. 2002; Hill et al. 2004) was necessary for both low Ts and highf because it
sequesters XIAP away from C3* (Fig 2.S9). This is an intriguing hypothesis, but
remains speculative in the absence of an experimental analysis that separates the catalytic
activity of C9 from its XIAP-binding function. Regardless of the specifics of
apoptosome activity, whenf was plotted as a function of [Smac]o and the concentration of
the apoptosome (for simplicity, we set [C9]o, = [Apaf- ]o in this simulation),f was high
only if the sum of the two XIAP-binding species was greater than [XIAP]o (Fig 2.4D).
This explains why snap-action switching was abrogated by depletion of either Smac or
Apaf-1, since either reduced the total XIAP-sequestering activity (see Fig 2.S8 for further
discussion of this point).
The potential for coordinate action between the apoptosome and Smac is also
observed in a plot off as a function of [XIAP]o and [Smac]o (Fig 2.4C). The transition
between high and lowffalls along the line where [XIAP]o=[Smac]o, down to [Smac]o =
104 per cell, at which pointf is no longer sensitive to further reduction in Smac levels.
This discontinuity at [Smac]o = 104 represents the point at which the apoptosome
becomes the primary determinant of XIAP inactivation. Depending on where on these
surfaces the initial conditions lie, either Apaf-1, Smac, or the combination of Smac and
Apaf- could be the dominant suppressor of XIAP activity, perhaps explaining why Smac
appears critical in some cell types (Zhang et al. 2001; Deng et al. 2002; Li et al. 2002;
Sun et al. 2002; Chipuk and Green 2005), but the Apaf-1/XIAP ratio is determinative in
others (Wright et al. 2004; Potts et al. 2005).
While many regions in the plots off as a function of [XIAP]o, [Smac]o, C3*
degradation rate, etc. are flat, implying insensitivity to changes in parameter values,f
changes rapidly in other areas. Cells living in regions of rapidly changingf will be highly
sensitive to small changes in protein concentration. An oft-stated assumption about
cellular networks is that they are "robust" to changes in parameters (Stelling et al. 2004)
but our data strongly suggest that, with respect to apoptosis, Hela cells do not exhibit this
type of robustness for several key variables. Whether this proves true in general remains
to be determined, but we speculate that sensitivity rather than robustness may be
important for a process such as apoptosis that is regulated by many physiological stimuli.
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Figure 2.4. Transmission of the mitochondrial signal by Smac and apoptosome
formation. A,B. HeLa cells transfected with Smac siRNA oligo or Smac and XIAP0 05
siRNA oligos in combination, were treated with 50 ng/ml TRAIL and cPARP levels were
analyzed as in Fig. 1. C, D. Simulation off as a function of [Smac]o and [XIAP]o (C), or
off as a function of [Smac]o and [Apop]o ([Apop]o is equivalent to [C9]o and [Apaf-l]o,
which were assumed to be equal) (D). Dotted lines denote regions of parameter space in
which (C) [Smac]o equals [XIAP]o or (D) the sum of [Smac]o and [Apop]o equals
[XIAP]o. The numbered circles correspond to points sampled experimentally; see text for
details. The blue region surrounding point I in D denotes a region of uncertaintyand
"1 b" an alternate location for the wild type condition. These ambiguities arise from
uncertaininty in the extent of Apaf-1 depletion by siRNA (see Fig 2.S8).
2.3.6 Dynamic masking of XIAP depletion phenotypes
XIAP appears to play a governing role in controlling snap-action activation of
apoptosis. It is essential for preventing PARP cleavage prior to mitochondrial
1'
I
0.
I0
permeabilization, and it must be efficiently inhibited by proteins released from the
mitochondria for PARP cleavage to proceed. Given this role, it is surprising that
previous studies have observed only a mild phenotype associated with XIAP deletion
(Harlin et al. 2001). Simulation suggested that completely removing XIAP should alter
sensitivity to TRAIL (Fig 2.5A). Indeed, with [XIAP]o = 0 in our model, noise rejection
was greatly diminished and Td was short at even very low TRAIL concentrations. This is
consistent with data showing that Hct-1 16 cell lines lacking XIAP are abnormally
responsive to TRAIL (Cummins et al. 2004). Low XIAP levels are also predicted to
allow (premature) cleavage of PARP in the time preceding mitochondrial
permeabilization (Fig 2.5B). To confirm this prediction, XIAP-depleted and unperturbed
cells were treated with TRAIL and cPARP levels determined (Fig 2.5C). At early times
(1.5 hr after TRAIL addition), flow cytometry of XIAP-depleted, but not of control cells,
revealed a clear subpopulation in which PARP was partially cleaved (f-0.02 to 0.1, Fig
2.5B, shaded orange area) as well as a population in which PARP was fully cleaved (f
-1.0). feventually reached 1.0 in all cells by 3 hr (Fig 2.S10). Modeling suggested that
premature cPARP cleavage arose because low levels of C3* generated by C8* prior to
mitochondrial permeabilization were only weakly inhibited by residual XIAP, leading to
conversion of - 5% of PARP to cPARP (Fig 2.5B). Complete conversion to cPARP
eventually occurs because mitochondrial feedforward kicks in normally (Fig 2.5B, red
star). Thus, substantial differences between normal and XIAP-depleted cells early in
signaling were obscured by an overwhelming later signal. We refer to this phenomenon
as dynamic masking. While we observe in TRAIL-treated HeLa cells that the XIAP
phenotype is masked by rapid firing of the mitochondrial pathway, it is possible that,
under other conditions, delayed mitochondrial permeabilization might actually allow
states of partial PARP cleavage to persist.
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Figure 2.5. Dynamic masking of the XIAP depletion phenotype. A. Simulation of Td as
a function of TRAIL concentration for wild type conditions, or with [XIAP]o= 0 , as
indicated. B. Simulation of the time course of cPARP in wild type, XIAP-depleted, and
Bcl-2-overexpressing/XIAP-depleted conditions. Stars denote the time at which
Smac/cytochrome c release begins, and dashed lines drawn to the Y-axis indicate the
amount of PARP cleavage that preceded Smac/cytochrome c release in each condition.
C. HeLa cells transfected with control or XIAPo.o5 siRNA oligos were treated with 50
ng/ml TRAIL, and cPARP levels were analyzed by flow cytometry at 0 or 1.5 hours.
2.3.7 Mechanistic insights into snap-action, variable delay switching
Simulation makes it possible to infer the dynamics of pro-apoptotic signaling at
multiple points in a protein network in a single-cell, something that cannot be
accomplished experimentally. In figure 2.6A-K we show the time-dependent evolution of
nine biochemical species critical in C3 regulation (calculated, for simplicity, in the
absence of C6). Our use of mass-action kinetics makes it possible to interpret these plots
by inspection, but the salient features are also amenable to formal mathematical analysis,
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something we will describe elsewhere. Apoptotic signaling begins with DISC formation
(not shown) and the slow but steady accumulation of C8* (Fig. 2.6B), processing of tBid
(Fig. 2.6C), and translocation of Bax (Fig. 2.6D) from the cytosol to the mitochondrial
membrane (with 10-fold amplification in the number of molecules involved).
Multimerization of membrane-bound Bax (Bax*m, Fig. 6F) is inhibited by Bcl-2.
Simulation suggests that the relatively slow C8*---tBid--+Bax*m reaction is important for
the remarkably long duration of Td, as is the inhibition of Bax*m by relatively abundant
Bcl-2. A threshold is reached when [Bax*m] exceeds [Bcl-2] (Fig. 6E, denoted by a pink
vertical line in Fig 2.6), at which point pores suddenly form in a higher-order reaction,
followed by Smac and CyC translocation to the cytosol (Fig. 6G, which is essentially
irreversible because it involves diffusion down a steep concentration gradient (Kuwana et
al. 2002)). From the perspective of maintaining short Ts, it is necessary that pore
formation be at least second-fourth order in Bax*m so that the possibility of Bax*m-Bcl-2
binding is exhausted prior to the formation of pores. However, when pore formation
exceeds sixth order, Ts again becomes longer. These observation are consistent with
biochemical evidence that the Bax-containing pore is a 2-8 mer (Antonsson et al. 2001).
Translocation of Smac and CyC involves dramatic amplification in the number of
molecules (-500 fold) and acceleration in rates of evolution driven by high Vmax: as few
as 10-50 pores appear sufficient to transport 105 Smac and CyC molecules in -10 min. It
is noteworthy that pores continue to form hours after their transport task is complete,
probably because overshoot is an inevitable consequence of rapid and complete
activation. The amount of cytosolic Smac and newly assembled apoptosome are
considerably in excess of levels needed to neutralize XIAP (Fig. 6H). At this point de-
amplification of the cascade by 10-50 fold is observed in formation of active C3* (Fig.
61), but the amount of enzyme remains well in excess of what is needed to fully convert
PARP to cPARP (Fig. 6K).
Several general points can be deduced from this reaction scheme. First, very few
if any reactions in the pathway reach steady state before cell death occurs. Second,
signaling does not involve a chain of successively amplified steps, as observed, for
example, in glycogen breakdown triggered by protein kinase A. Instead, both
amplification (e.g. C8* -+ Bid -+ Bax*m) and deamplification (e.g. Smac -- XIAP --
C3*) of rates and number of molecules are observed, but critical steps are mediated by
processes with high catalytic capacity. Third, the relative timing of events is frequently
critical: a small amount of an active species present at an early time (DISC--+C8*) is
often more important in determining outcome than a larger quantity later (C6*--+C8*).
This point is noteworthy because quantitative analysis of cell signaling frequently focuses
on differences in protein levels or localization at steady-state and not on transient signals.
Fourth, generating a switch that allows for long Td and short Ts requires interplay
between reactions occurring on both long and short time scales (the essence of a stiff
system); a variable-delay, snap-action switch cannot occur if every process is fast.
Finally, although an analysis of cell death inevitably focuses on the mechanisms of
caspase activation, the mechanisms responsible caspase inhibition are at least as complex:
C3* is a lethal enzyme that must remain <<1% active for cell survival.
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Figure 2.6. Simulation of the levels of key proteins controlling caspase activation in
response to TNF and TRAIL. For clarity, positive feedback was omitted by setting
[C6]o=0. In (A), all species are overlaid, but three different vertical scales are used to fit
species on one graph; the axis on the left is associated with species in solid lines, except
for cPARP, which is shown at half-scale; the axis on the right, whose maximum value is
5-fold lower, is associated with species in dashed lines. In the bottom panels (B-K),
each species is shown separately, with each vertical axis scaled as indicated. The pink
vertical line denotes the time at which all free Bcl-2 is depleted, resulting in the release of
CyC/Smac. The LD50 for caspase activity (corresponding to -10% PARP cleavage) is
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denoted by a dashed line in the cPARP plot; the gray shaded region denotes time points
after this lethal dose has been reached and cells are dead.
2.4 Discussion
Here we describe the use of mathematical modeling and single-cell analysis to
derive mechanistic insight into the operation of a highly efficient, snap-action, variable
delay switch controlling extrinsic cell death. Accommodating both snap-action and
variable delay behaviors is surprisingly demanding, as is the requirement that caspases
normally be held safely in check. Our successful inclusion of these features of apoptosis
in a mathematical model distinguishes this work from previous efforts. Also valuable, in
our opinion, is the decision to restrict modeling to first-order reactions involving mass-
action kinetics, thereby avoiding phenomenological forms such as Hill functions and
other polynomial expressions. Interesting non-linear behavior in the model arises from
the interconnectivity of elementary reactions rather than from a priori assumptions.
Hitherto, it has usually been asserted that the key to control of apoptosis is
bistability (a local, steady-state phenomenon) (Eissing et al. 2004; Bagci et al. 2005).
However, our analysis shows that transient caspase activation seals the fate of a cell long
before steady-state is reached. Moreover, a quasi-steady state with very low C3* does
not necessarily correspond to sustained survival (given the potency of executioner
caspases). The extrinsic cell death pathway achieves a binary outcome through parallel
transient reactions whose relative strengths and timing determine C3* activity. The
circuit controlling receptor-mediated apoptosis is also unusual in relying on feedforward
and successive steps of negative regulation to make switching rapid and delay time long.
Variability in delay is probably involved in the dose-response of cell populations to death
ligand but we do not yet know precisely how it arises. Preliminary experiments suggest
that differences in rates of reaction upstream of mitochondrial permeabilization are
involved (data not shown).
When perturbed by RNAi or small molecules, the C3* regulatory network is
characterized by poor noise rejection, loss of snap-action behavior, and low efficiency.
The last of these failures, in whichf<l.0, is the most interesting because it has the
potential to generate indeterminate physiological states (Vaughan et al. 2002). Genomic
instability is also likely to arise through partial degradation of the genome, mediated by
the DFF40 nuclease (Samejima and Earnshaw 2005). Indeed, sub-lethal pro-apoptotic
stimuli have previously been linked to induction of chromosomal translocations typical of
leukemia (Aplan et al. 1996; Stanulla et al. 1997a; Stanulla et al. 1997b; Vaughan et al.
2005). Moreover, overexpressed Bcl-2, which we identify as a key condition forf< 1.0
failure, is a potent oncogene in lymphocytes (McDonnell and Korsmeyer 1991). Thus,
the oncogenic potential of Bcl-2 overexpression could result not only from extended cell
survival, but also accelerated accumulation of genetic lesions induced by the cell's own
apoptotic machinery.
In contrast to the focus on robustness in many contemporary efforts to model
biological pathways, our work focuses on sensitivity in the apoptosis network and modes
of failure. Apoptosis is a highly regulated process associated with a wide range of
physiological transformations (Spierings et al. 2005) and the cost of this regulability may
be higher susceptibility to failure in the face of mutation. More generally, we believe that
a rigorous application of failure analysis to biological circuits (something we have not yet
achieved) may prove valuable in understanding how quantitative changes in protein
levels or activities contribute to human disease.
2.5 Materials and Methods
Reagents and cell culture
HeLa cells stably expressing pMIG-Bcl-2 or pMIG (empty vector control) were
kind gifts of Dr. Fei Hua and Dr. Michael Cardone. Antibodies against cleaved PARP,
cleaved caspase-3, XIAP, and Apaf-l were obtained from BD Biosciences. The antibody
against caspase-6 was obtained from Cell Signaling; the antibody against Smac was
obtained from Calbiochem. Secondary antibodies for flow cytometry and western
blotting were from Molecular Probes (Invitrogen) and Rockland. SuperKiller TRAIL
was obtained from Alexis Biochemicals, and cycloheximide (CHX) and MG-132 were
from Sigma. siRNA oligos were purchased from Dharmacon.
Inclusion of cycloheximide in death assays
All treatments with TRAIL or TNF were carried out in the presence of 2.5 Rg/ml
CHX. This treatment retards protein synthesis, and is widely used in the study of TNF
and TRAIL-induced apoptosis (Wajant et al. 2000; Munshi et al. 2001). Moreover, all
published single-cell observations of all-or-none caspase FRET reporter cleavage in
response to death receptor stimulation have been performed in the presence of CHX
(Rehm et al. 2002; Luo et al. 2003; Takemoto et al. 2003; Kawai et al. 2004). Cells
treated with 2.5pg/ml CHX alone showed no evidence of PARP cleavage or cell death for
at least 24 hr.
Generation of HeLa cells expressing a caspase-3 FRET reporter.
Venus YFP was ligated into pECFP-C I downstream of a linker encoding the
sequence SGLRSSGDEVDGTSGSGST; the sequence DEVD is a consensus caspase-3
cleavage site present in PARP which has been used in other similar reporters (3,4,6). The
use of Venus as the FRET acceptor in place of EYFP is important, since EYFP displays
significant pH sensitivity (4). The resulting plasmid, pECFP-DEVD-Venus, was
transfected into HeLa cells, and stable transfectants were isolated by selection with G418
followed by flow cytometry sorting for Venus (YFP)-positive cells.
Live cell microscopy
HeLa cells stably expressing pECFP-DEVD-Venus were grown in chambered
coverglass slides (LabTek) for 24-48 hr. Immediately prior to imaging, medium was
replaced with CO2-independent medium (Gibco) containing the appropriate doses of
SuperKiller TRAIL and CHX. Cells were then imaged at 370 C on a Deltavision Spectris
AX71 equipped with a temperature control chamber using a 20X objective. CFP and
YFP images were acquired at 3-minute intervals for 12 hours. Cleavage of the reporter
by caspase-3 results in a separation of the CFP and YFP proteins, which thereby
abrogates intramolecular FRET. Reporter cleavage was monitored by the change in
CFP:YFP ratio. The change in CFP:YFP ratio over time and the Td and Ts for individual
cells were measured using ImageJ software with a custom-made plugin, which is
available from the authors. While our results are qualitatively very consistent with
previous studies (e.g. Rehm et.al. 2002), we note that relatively minor quantitative
differences are likely a result of differences in the FRET reporter and in data processing.
Flow cytometry assay.
After treatment for the appropriate length of time with SuperKiller TRAIL, HeLa
cells were trypsinized (taking care to collect both floating and adherent cells) and fixed
with 4% paraformaldehyde in PBS for 10 minutes at room temperature. Following a PBS
wash, cells were permeablized in 100% methanol. We found that fixation with
formaldehyde was essential to maintaining the specificity of the anti-cleaved PARP
antibody. Prior to staining for flow cytometry, cells were stored for up to 5 days at -20 C
in 100% methanol. Cells were stained with primary antibodies (1:250 anti-cleaved PARP
or 1:500 anti-cleaved caspase-3 in PBS-T+1%BSA) for 1 hour at room temperature,
followed by staining with secondary antibodies (1:250 in PBS-T+I%BSA) for 1 hour.
Cells were then analyzed on a Becton Dickinson FACSCalibur. Analysis was performed
using the FlowJo software package (Treestar); in each experiment the gate for partial
PARP cleavage was set to be 160 channels wide and approximately centered between the
positive and negative peaks for the control sample, and thus contained cells in which
approximately 5-20% of PARP was cleaved. Positive and negative gates were then
defined as all the remaining channels above and below the intermediate gate,
respectively. For each experiment, the same gates were used for all samples. In cases
where single-cell behavior (Td, Ts, andf) was estimated, this estimate was made by
comparing the observed frequencies of negative, intermediate, and positive cells with
simulated flow cytometry experiments generated in Matlab (see below).
Simulation of flow cytometry data
Simulated flow cytometry data were produced using the Matlab script contained
in Appendix E, where the process used to generate the simulated data is described in
detail.
siRNA transjection
siRNA transfections were performed as described (Meraldi et al. 2004), with a
final concentration of 3-5 nM for each oligo in the growth medium. Medium was
changed I day after transfection, and TRAIL treatment was performed on the second day
after transfection. Oligo sequences are shown in Table S2.
Western blotting
Western blots were carried out as described (Gaudet et al. 2005) and detected
using an Odyssey Scanner (Li-Cor Instruments, Omaha NE).
Colony-forming assays
After treatment with CHX alone or TRAIL+CHX, cells were harvested as
described for flow cytometry, collecting both floating and adherent cells. Cells were then
plated at a density of -10 2-103 in 10-cm plates. After 2 weeks of growth, colonies were
stained with crystal violet and counted. The viability percentages reported were
determined by dividing the number of colonies on the TRAIL+CHX-treated plate by the
number of colonies on a CHX-treated plate transfected with the same siRNA oligos.
Mathematical modeling
All network model simulations were carried out in Matlab (The Mathworks,
Natick, MA). Since our model is a stiff system (that is, containing processes that occur
on multiple time scales), numerical simulations were performed using Matlab's ODE1 5s
solver, which is a multistep, variable-order differential equation solver recommended for
stiff systems.. Absolute tolerances were set to 10-10, and relative tolerances were set to
10-8.Further details of model construction and simulation are discussed below.
2.6 Construction of the mathematical model
Biochemical reaction equations were derived from the canonical death receptor network
(see (Bouralexis et al. 2005) for review). For each given binary reaction, i, the
biochemical equation is represented by one of following general mass-action paradigms:
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where an enzyme or other protein, E, reacts with its substrate or binding partner, S,
forming complex, E:S, and depending on the specific reaction, i, forming product, P,
such that k,, k_,, and Kc, are the forward, backward, and catalytic rates, respectively. The
list of species that are used in the biochemical equations are in Table S3.
Mathematical Model
Assume the cytosolic and mitochondrial compartments (see below) are each well
mixed. Let [X] represent the number of molecules of species X in each compartment.
Let the rate at which the number of molecules per compartment of species x changes with
respect to time t, in seconds, be represented by x=dx/dt. Using the rates found in Table
S5, and the state variables and initial conditions in Table S7, the biochemical reactions in
Table S4 are modeled by the system of ordinary differential equations found in Table S8.
Simulation antd Visualization
Matlab stiff solver ODE15s was used to numerically solve the system of ODEs.
This is a variable order solver that employs numerical differentiation formulas (NDFs).
Graphs and visualizations were made using Matlab and Axum software packages.
Experimental over-expression and knockdown perturbations are simulated in the
model by adjusting the initial conditions appropriately in accordance with experimental
data. For example, a Bcl-2 over-expression of 30-fold would be represented by
multiplying the initial condition for Bcl-2 by 30, with all other initial conditions and
parameters unchanged.
Signaling Redundancy:
For simplicity, proteins which perform redundant or similar functions were
represented as single lumped species. Thus, "C8" represents both caspase-8 and -10, and
"C3" represents caspase-3 and -7. Mcl-I represents all Bcl-2 antiapoptotic proteins in the
cytosolic compartment that bind to Bid, and Bcl-2 represents all Bcl-2 antiapoptotic
proteins in the mitochondrial compartment that bind to Bax*m. PARP represents all
substrates of'cleaved caspase-3 (other than C6).
Cytosolic and mitochondrial compartments
Since many of the biochemical processes of the mitochondrial pathway occur on
or in the outer membrane of the mitochondria, these processes are effectively physically
separated from processes occurring in the cytosol. To reflect this segregation, the model
is comprised of two compartments, cytosolic and mitochondrial. Each compartment is a
separate, well-mixed volume; specific molecules, such as cytochrome c, may move from
one compartment to another at a defined rate. Based on measurements of the
mitochondrial and cytosolic volume of HeLa cells (Posakony et al. 1977), the volume of
the mitochondrial compartment is estimated to be 7% of the volume of the cytosolic
compartment. The rates of second-order (or higher-order) reactions, in which two (or
more) molecules must collide with each other, increase as volume decreases, due to the
increased likelihood of a collision. To reflect this, the reaction rates of intermolecular
reactions occurring in the mitochondrial compartment are divided by the ratio of the
mitochondrial compartment volume to the cytosolic compartment volume (0.07).
Rate Constants
Assume that a cell is 10- 12 liters (1 pL), and that bimolecular reaction rate
constants, k,, are diffusion limited. Therefore the forward reactions are bound by
k < lxl10 6 N M l' sec-1, for all reactions i (Berg 1985; Zhou 1993). All dissociation rates are
approximately 10-3 sec- ', resulting in dissociation constants in the range of 1-10 nM
(with one exception: activation of receptor the dissociation rate is 10-5 sec-1, since this is a
lumped parameter fit to match data). All catalytic rates are 0, 1, 0.1, or 10 sec - '. All
translocation reactions (between cytosol and mitochondrial compartments) have a rate of
10-2 sec -1
Initial protein concentrations
Relatively few references for initial concentrations of proteins are available.
However, many signaling proteins have been found to be present in the range of I nM to
I p•M (-103-106 copies/cell) (48,49). Therefore, we restricted initial protein
concentrations to fall within these bounds (with the exception of Flip, which does not
figure significantly in the model and was estimated to be present at lower levels).
Consistent with these bounds, procaspase-3 has been reported to be present at 104-1 05
copies/cell (20,50), and was therefore set conservatively as 104 copies/cell.
Protein synthesis
In all the experiments presented in this study, the cells were treated with CHX to
retard protein synthesis. To reflect this, the mathematical model contains no source
terms. Understanding and modeling the additional layers of control imposed by
transcriptional or translational regulation will be an important question for further study.
Protein Degradation
We assume that protein degradation is slow compared to signaling dynamics, so
with one exception, the model contains no sink terms. The one exception is the case of
C3* degradation by XIAP, which we have experimentally determined to occur at
significant levels on the timescale of the experiment (Fig 3). In this case, degradation is
approximated by assuming that ubiquitinated caspase-3 is catalytically inactive.
2.7 Supplemental figures and tables
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Figure 2.S1 Graded response in the accumulation of apoptotic cells. The cumulative
percentage of cells entering apoptosis (as measured by FRET reporter cleavage) was
calculated from the live-cell data shown in Fig 2.1. Apoptotic cells accumulate over the
course of hours, and the rate of accumulation is dependent on the strength of the stimulus.
Thus, at the population level, the apoptotic response is slow and can be controlled in a
graded manner, even though each individual cell exhibits an all-or-none response.
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Figure 2.S2 A data model linking live-cell and flow cytometry data. Hypothetical live-
cell data were modeled by creating families of Boltzmann equation curves for each
condition, where fand Ts were held at a constant value, while Td was chosen at random
from a normal distribution (see Methods section). In the top row, ten such curves for
each condition are shown, with the red curve representing the mean Td. For each
condition, 10,000 curves were generated and converted to the predicted flow cytometry
profile by 1) choosing values at discrete times, 2) adding simulated measurement noise,
and 3) displaying histograms of these values on a logarithmic scale. The second row of
plots shows the predicted FACS data for each condition. The predicted FACS data were
then gated into regions of low, intermediate, or high fluorescence intensity (colored
green, yellow, and gray, respectively), and the percent of cells falling into each region is
plotted on a bar graph (bottom row of plots), as was done for flow cytometry experiments
throughout the study. By using this process, live-cell and flow cytometric data can be
incomplete cleavagebaseline
directly compared. From experimental flow cytometry data, the underlying single-cell
behavior can be estimated. As discussed in the text, three major classes of deviation are
possible from the typically-observed baseline condition (a change in either Td, Ts, orf),
and each of these changes results in a distinct change in the expected flow cytometry
profile.
Figure 2.S3 Quantitation of protein depletion by immunoblot. For each siRNA oligo
used, HeLa cells were transfected as described in the Methods section. After two days,
cells were lysed in sample buffer and separated by SDS-PAGE. Blots were then probed
with an antibody against the targeted protein (top image in each panel) and an antibody
against a non-targeted protein as a loading control (bottom image in each panel). Percent
depletion for each oligo (relative to a control oligo) was quantitated using ImageJ
software. The percent knockdown in each case was then used to determine new intitial
conditions for simulation of the corresponding behavior of the mathematical model. Bcl-
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2 overexpression was found to be 30-fold relative to wild-type conditions (not shown,
K.Leitermann and P.K.S., unpublished data).
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Figure 2.S4 Bcl-2 overexpression blocks mitochondrial permeabilization under all
conditions. Control and Bcl-2-overexpressing HeLa cells were transfected with either
control or XIAP siRNA and then treated with 50 ng/ml TRAIL for 4 hours. Cells were
then fixed, and cytochrome c was detected by immunofluorescence microscopy; DNA
was co-stained with Hoechst 33342. In control HeLa cells, cytochrome c redistributes
from the mitochondria to the cytosol, resulting in a diffuse staining pattern (left). In Bcl-
2 overexpressing cells, cytochrome c remains in a punctate mitochondrial pattern even
after TRAIL treatment (center). The punctate pattern of cytochrome c staining is
maintained even in XIAP -depleted cells, where caspase activation has resulted in nuclear
condensation and cell death (right).
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Figure 2.S5 C8 is required for C3 cleavage in Bcl-2-overexpressing cells. Bcl-2
overexpressing cells were transfected with control or C8 siRNA and then treated with 50
ng/ml TRAIL. Cells were fixed at the indicated times, and C3 cleavage was assayed by
flow cytometry. While a significant increase in C3 cleavage is detected in control cells,
C8 depletion abrogates this cleavage.
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Figure 2.S6 Continuous variation off in response to proteasome inhibitor. A. Bcl-2-
overexpressing HeLa cells were co-treated with 50 ng/ml TRAIL and the indicated
concentration of MG- 132, fixed at the indicated times, and analyzed for cPARP by flow
cytometry. Representative DIC images of cells are shown for cells at 6 hours in each
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condition. B. Cells were treated and analyzed as in A, and the cPARP staining at 6 and
24 hours was compared. From this we conclude that under the TRAIL and MG-132
conditions tested here, cPARP reaches its final value (f) by 6 hours of treatment. DIC
images of the cells indicate that -50% of the cells under the TRAIL+0.75uM MG-132
treatment display apoptotic morphology, and the number of apoptotic-appearing cells
increases with MG-132 concentration. Thef value at which -50% of cells appear
apoptotic occurs is 0.11, which is similar to thefvalue in Bcl-2-overexpressing, XIAP-
depleted cells at which -50% of cells appear apoptotic and viability is reduced to -50%
(Fig 2.2F,G). Therefore, these data support the finding that, in the absence of
mitochondrial permeabilization, a pulse of C3* activity sufficient to cleave -10% of
PARP and other substrates represents the LD 50o for cumulative C3* activity.
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Figure 2.S7 Highly efficient depletion of XIAP leads to higherf Bcl-2 overexpressing
HeLa cells were transfected with the XIAP0o05 oligo, which produces >95% XIAP
depletion (Fig 2.S3), and then treated with 50 ng/ml TRAIL; cPARP levels were
analyzed by flow cytometry (A) and by western blotting (B). Under these conditions, a
higherf is reached (-0.6) relative to Bcl-2-overexpressing cells in which XIAP has been
depleted to a lesser extent (-0.15, Fig 2.2F,G). This increase inf agrees with our analysis
by simulation (C), which predicts thatf varies inversely with XIAP expression level in
Bcl-2-overexpressing cells (See also Fig 2.3D).
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Figure 2.S8 XIAP-sequestering activity of the apoptosome is essential for highf.
cPARP and C3* time courses were simulated in the baseline model and in models in
which the indicated changes were made. In the absence of either of the apoptosome
components, C9 and Apaf-l,f<l and Ts is high. Removing the ability of the apoptosome
to process C3 does not affectf and has only a moderate effect on Ts, while removing the
ability of the apoptosome to bind XIAP does affectf to the same extent as the knockouts.
Therefore, the role of the apoptosome in reachingftl is mediated by its XIAP-
sequestering activity.
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Figure 2.S9 Apaf-1 depletion phenocopies Smac depletion. HeLa cells were transfected
with siRNA oligos targeting Apaf-1, Apaf-1/XIAP, or Apaf-1/Smac, treated with 50
ng/ml TRAIL, and assayed for cPARP by flow cytometry. Apaf-1 depletion appears to
phenocopy Smac depletion, resulting in decreased f Co-depletion of XIAP and Apaf-
restores efficient PARP cleavage. Moreover, co-depletion of Smac and Apaf- I has an
additive inhibitory effect on PARP cleavage; more cPARP-negative cells persist at longer
times. These results favor a model in which both Smac and the apoptosome cooperate to
antagonize XIAP, so that depletion of either Smac or the apoptosome component Apaf-1
results in a decrease inf (points 2 and 3, respectively in Fig. 4C). The Apaf-1 oligo used
in these experiments has been previously used in other studies (Lassus et al. 2002; Burek
et al. 2006). However, other Apaf-1 oligos, which appeared to deplete Apaf-1 with
similar efficiency, did not produce a significant change inf, and did not act in an additive
manner with Smac co-depletion (not shown). This difference may be due to differences
in Apaf-1 depletion that were below the detection limit of our assay, or differences in the
depletion of other Apaf- isoforms that were not detected. The specificity of the results
seen with the oligo shown here, including rescue by XIAP and additive effect with Smac,
argues against an off-target effect, although this remains a formal possibility. However,
if it is true that Apaf-1 depletion does not significantly affectf, the implication for our
model is that wild type cells fall at a different point (position Ib) on the surface in Fig.
4C, so that Smac depletion, but not Apaf-l depletion, results in decreasedJf
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Figure 2.S10 XIAP-depleted cells achieve complete cleavage of PARP. HeLa cells
were transfected with an XIAP oligo (XIAPoo05), and then treated with 50 ng/ml TRAIL;
cPARP levels were analyzed by flow cytometry. While partial PARP cleavage is
observed in a subpopulation of cells at early times (1.5 hr, see Fig. 5C), full PARP
cleavage is reached at later times (3-4.5 hr).
Table Sl: T,,d and Ts values determined by live-cell microscopy
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target sequence
aattcatgaggtgtcaactgt
nnttgcctcaatgctaactaa
nnacattaactggcttgttca
aactaccagaaaggtatacct
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Table S3: List of Species
Description (all species are located in cellular compartment (CC) unless
otherwise stated.)
L
R
R'
flip
X.Y :=Y:X
C'S
Bar
C'3
CI6'6
C'6"
XIAP
PARP
cPARFP
Bid
fBid
Ba.r
Bar*Baor
Ba.r2
Bar4
Bcl2
,I
CyCm
CyC
SmactS marm
Apa f*
C9
Apop
C1'3#111
death ligand, such as TRAIL and TNF
inactive receptor, for example limiting factor of Death Inducing Signaling
Complex (DISC) formation
active receptor
binds to active receptor acting as an inhibitor
complex formed by species X and Y. for example. L : R is the ligand-
receptor complex
procnspase-8 and procaspase-10. inactive form of caspase-8 and caspase-10
cleaved caspase-8 and caspase-10. active form of caspase-8 and caspase-10
binds to Casp8 and acts as an inhibitor
procaspase-3 and procaspase-7, inactive form of caspase-3 and caspase-7
cleaved caspase-3 and caspase-7. active form of caspase-3 and caspase-7
procaspase-6. inactive form of caspase-6
cleaved caspase-6, active form of caspase-6
X-linked Inhibitor of Apoptosis (XIAP) in the cell
all substrates of C3'
cleaved PARP. and represents single cell death
substrate of cleaved caspase-8. inactive form
cleaved Bid, active form of Bid
represents the family of antiapoptotic Becl-2 proteins in the CC. it binds to
tBid and acts as in inhibitor
substrate of tBid. inactive form
active form of Bar
Ba.r* in the mitochondrial compartment (MC)
represents Barx : Bazn in the MC
represents Bar2 : Barz in the MC
represents all antiapoptotic Bcel-2 proteins in the MC
the number of unoccupied Baza binding sites on outer nlemblrane of the
nmitochondria. in MC
the number of pores Baza. created on the outer membrane of the mitochon-
dria, in MC
cyotochrome c inside the mitochondria. in MC
cytoclrome c released from the mitochondria, but remaining in the MC
cytochrome c in the CC
Smac/Diablo inside the mitochondria, in MC
Smac/Diablo released from the initochondria. but remaining in the MC
Smac/Diablo in the CC
Apoptosis Activating Factor (Apaf-1), substrate of CyC. inactive form
active form of Apaf-1
inactive form of procaspase-9
the apoptosome. which is the complex Apaf* : ('9
C.3* ubiquitinated and targeted for degradation. Assumed inactive
Species
Table S4: Biochemical Equations
Reaction Ref
L + R L : R R' (16
k_ 1
k2.
R" + flip k R ': flip (17)
R' + CA R' : CS 1 R' + CS' (18)
k4
TCS'' + Bar - C'8 : Bar (19)
cS. + ca A c8.: 03 M CS. + 03' (20)
k-6
C3. + C6 , CT3'- C'6 C3' + C6 (21)k-e
C6' + C8 C'' : CS C6' + CS' (22)
C3' + XIAP C T'" : XIAP ' C3- b6 + XIAP (23.24)k-a
C3' + PARP C C3' : PARP a C3' + rPARP (25)
k-o
C'8* + Bid '8* : Bid -. O CS' + f Bid (26.27)
-1o
Bid +A ell Bid: Mll (28)
k- 1 1
tBid + Barx tBid: Bar & tBid + Bar' (29)
k-12
tBa s BoxB (29)
Bar* + Be1r2 = Ba* : B-rl2 (30)
Bar
• 
+ Bcl2 BaQ : Bcl2k-le
Ba.r2 + Bazr2 hI Bara (31)
Bazr + Bel2 ý Bazr : Bcl2
k-18
Bara +A1 -4 Bar4 : Al '3 A' (32)k-10
1' + CyCM , AI: CyCm -2 31' + CyCr (33)
31' + Smacm k2l- I' : Smacm 1 A' + Snacr (34.35)k- 21
h.22CyC,. ;- CyC
CyC+ Apaf I CyC: Apaf K24 CyC +Apaf' (36)
Apaf' + CO - Apop (33)
Apop + C3 I Apop : C3 1 Apop + C'3 (33)
Smacr - Smac
k-28
Apop + XIAP - Apop: XIAP (37.38)
k2a
Smac+ XIAP S mac: XIAP (34.35)k_28
hI ble SB: Rate 
Constant Vaues
1
2
3
4
5
6
13
814
1819
10
11
12
13
14
15
1617
18
19
20
21
22
23
24
25
26
27
28
4 x 10-
10-6
10-1
10-e
10-6
3x 10-8
2 x 10-6
10-6
10-v
10-"
10-"
10-2 (sec - 1)
10-" ((#/CC)-C1sec- 1 )
10'- ((#/CC)-C.sec- 1 )
10-6 ((#/(CC)- see-i )10-r ((+ ' !CC)- -se-')1o-6 ((#/ )-"- see-' )
2 x 10-" ((,&#/CC)-I'sec- 1)
10-( (see-')
5 x 10-' "
5 x 10-s
5 x 10- 9
10-2 (see-')
2 x 10-6
7x 10-
10-3
10-3
10-3
10-3
10-3
10-3
10-3
10-3
10-3
10-3
10-3
10-3
10-2
10-3
10-3
10-3
10-3
10-3
10-3
10-3
10-3
10-2
10-3
10-3
10-3
10-2
10-3
10-3
Reaction rate constants for the ith reaction found in Table S4. CC and MC denote the cytosolic
and mitochondrial compartments, respectively.
10-S
1
1
1
1
1
11
1
1
10
10
1
1
i I k, ((#/CC)-se-' ) I L_, (see-') I K, (sec - ')
Table S6: Selected Initial Condition and Rate References
Enzymatic Reaction Km i/-,,i: kcat ,.- . kcat/Km Ref substrate
Cs'
Garcia-Calvo et.,al. 1999 4.2 x 10-  0.37 8.8 x 10-9  (39) LETD
Stennicke et.al. 1998 1.5 x 10-0 (20) C'3
Stennicke et.al. 2000 1.1 x 10o 0.69 6.4 x 10-1 (40) DEVDG
C3'
Bose et.al. 2003 1.3 x 106 0.4 3.0 x 10-v (41) DEVD
Casciola-Rosen et.al. 1996 8.6 x 10-  (42) PARP
Casciola-Rosen et.al. 1996 1.2 x 10-  (42) DNA-PK
Casciola-Rosen et.aL. 1996 3.8 x 10- 6 (42) U1-70K
Garcia-Calvo et.al. 1999 6.0 x 106 14 2.3 x 10- 0 (39) DEVD
Margolin et.al. 1997 6.0 x 106 23 3.8 x 10-  (43) PARP
Stennicke et.al. 2000 7.8 x 106 2.5 3.2 x 10- ' (40) DEVDG
alanilan et.al. 1997 6.6 x 106 2.4 3.6 x 10-  (44) DEVD
C6.
Garcia-Calvo et.al. 1999 1.0 x 10 (39) VEHD
Casp9
Garcia-Calvo et.al 1999 4.7 x 10 0.1 2.6 x 10-10 (39) LEHD
Talanian et.al 1997 1.8 x 10' 5 2.7 x 10- ' (44) VEID
Binding Reaction ko koff K Ref protein fragments
( ife/pl)'r -. c-1. 1 1
XIAP: 034/7
Humag et.al 2003 3.5 x 10-1 0.0021 600 (45) cas-pase-7/linkerBIR2
Riedl et.al 2001 4.2 x 10-0  0.0024 570 (46) caspase-3/BIR2
Riedl et.al 2001 2.3 x 10- ' 0.0014 61 (46) caspase-7/BIR2
XIAP : Ca.sp9
Sun et al 2000 6700 (47) BIR2-RF(aa 241-497) of
XIAPSmac: XIAP
Huaag ef.al 2003 1.2 x 10- s 0.0022 180 (45) Smac/linkerBIR..BIR2_BIR3
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Table S7: Variables
variable state
_rl [L]
_r. [R]
-.r [L: R]
.r [R*']
_-. [fli p)
-r,- [flip : R']
-,- [ -CS]
-•s [C' : R`j$
-rt [C'S* ]
-rio [CBar]
- [C'S' : Bar]
X3 [C'S C']3]
-r13 [CS" : '3]
-rl4 [C'3']
-rls [C'6]
r18 [C'34 : C'6]
.rt3 [cA6']
r18 [C'8* : 08]
.ri, [XIAP]
-120 [XIAP: C3
£r33 [PARP]
-r22 [C'3* : PARI
.r23 [cPARP]
r34 [Bid]
£25 [C'S : Bid]
-r2- [tBid]
Xr2 [AIlcll]
28 [IBid : Mlcll]
and Initial Conditions
model IC (,#,"CC)
103
10,
0
0
0102
0l)
0104
010"
00
105
0
0
10
S 10
· ] 0
0
4 x 104
0
0
5x 103
0
101
Table S7 (Cont): Variables and Initial Conditions
variable state model IC (#/CC)
X29
z30
S31
i33
i3 5
2:3,
-
2:38
2:39
2:41.-
2:41
:42
2:44
2:45
1:46
2:48
2:49
s51
X52
2:53
: 5 4
is 5s
is 6
i:5s
58
(Bail
[tBid : Bax]
[Bax']
[Bax4]
[Bd2]
[Barm : Bd2][Bar2]
[Barz : Bcl2]
[Bar 4]
[Baza : Bel2]
[Bazr : I]]
[CyCm][M''][Af* : CyCm]
[CyCr][Smacm,]
[A'* : Snzac,]
[Snzacr]
[CyC']
[Apaf]
[Apaf : CyC]
[Apaf']
[C9][Apop]
[Apop : C3]
[Snmoa]
[Apop : XIAP]
[Smac : XIAP]
[C3;,b]
All initial conditions are in number per cytosolic compartment (#/CC) unless otherwise noted as number
per mitochondrial compartment (#/MC).
102
0
0
o ( #/MC)
10 ( #/MC)
0 (#/MC)
0 (#/MC)
0 (#/MC)
0 (+/MC)
0 (#/MC)
5 x 105 (#/MC)
0 (#/MC)
0 (#1MC)
5 x 10o (#1MC)
0 (#/MC)
0 (#/MC)
10* (#1MC)
0 (#1MC)
0
10s
0
0
10,
0
0
0
0
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Appendix D).
113
Chapter 3: The mitochondrial pathway sets a threshold for apoptosis initiation by
variable upstream signals
Table of contents
3.1 A bstract .................................................................................................................... 115
3.2 Introduction ............................................................................................................. 116
3.3 R esu lts ...................................................................................................................... 119
3.3.1 Modeling upstream events in receptor-induced apoptosis........................... 119
3.3.2 Simultaneous imaging of multiple apoptotic events ..................................... 123
3.3.3 Control of the timing of mitochondrial permeabilization ............................. 127
3.3.4 Input-output relationship of initiator and effector caspase activity ............... 131
3.3.5 Measuring caspase input-output by flow cytometry.................. 134
3.3.6 Diagnosis of network behavior by flow cytometry............................ 140
3.4 D iscussion ................................................................................................................. 143
3.5 Materials and Methods.................................. 147
3.6 Acknowledgements ........................................ 149
3.7 R eferences ................................................................................................................ 150
114
3.1 Abstract
Release of cytochrome c and other pro-apoptotic proteins from the mitochondria is a
central event in apoptosis and is regulated by the Bcl-2 family of proteins. While it is
known that death receptor-induced caspase-8 activation induces the rapid release of
cytochrome c through the Bcl-2 family proteins Bid and Bax, little is known about
kinetics of this process. Using live-cell imaging to detect caspase-8 activity and
mitochondrial permeabilization in single cells, we show that cleavage of caspase-8
substrates upstream of the mitochondria is a gradual process with variable rate, which
suddenly induces the rapid release of mitochondrial proteins when a certain threshold is
reached. We measure the level of this threshold under various conditions, and find that
the time at which cells commit to apoptosis can be controlled in two ways, depending on
the stimulus: 1) changes in the level of caspase-8 activity, or 2) changes in the level of the
threshold. Furthermore, we show that similar measurements can be made with a high-
throughput flow cytometry assay, which enables rapid diagnosis of network behavior.
Our findings identify the point at which the apoptotic network converts graded stimuli
into an all-or-non response and provide important tools for the further study of how the
mitochondrial threshold determines apoptotic sensitivity.
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3.2 Introduction
The mitochondrial apoptotic pathway plays a essential role in the induction of apoptosis
by many stimuli (Spierings et al. 2005). This pathway is required for death receptor-
mediated apoptosis in HeLa cells and is required for the all-or-none regulation of effector
caspase substrate cleavage ((Yang et al. 1997), Ch. 2). Permeabilization of the
mitochondrial outer membrane results in the release of pro-apoptotic proteins such as
Smac and cytochrome c from the mitochondrial intermembrane space to the cytosol. The
permeabilization process is tightly controlled by the Bcl-2 family of proteins, which
include both pro- and anti- apoptotic members. The interactions between Bcl-2 family
proteins are elaborate (see section 1.3.4), but the central regulatory concept is believed to
be a stoichiometric titration process analogous to a rheostat (Korsmeyer et al. 1993):
certain pro-apoptotic family members stimulate pore formation in the outer mitochondrial
membrane (Kuwana et al. 2002), while anti-apoptotic Bcl-2 proteins bind to these pro-
apoptotic proteins and prevent them from doing so (Oltvai et al. 1993; Cheng et al. 2001).
Therefore, the level of anti-apoptotic Bcl-2 proteins present in the cell determines the
number of pro-apoptotic proteins that must be generated by a death stimulus to enable
permeabilization, effectively setting the position of the rheostat. If the number of
available anti-apoptotic Bcl-2 proteins is high, then many pro-apoptotic proteins are
needed to overwhelm the pool of anti-apoptotic proteins, and thus only prolonged or
intense pro-apoptotic stimuli will result in cell death. Conversely, if few anti-apoptotic
proteins are present, then relatively low numbers of pro-apoptotic proteins are needed to
reach the threshold set by the anti-apoptotic proteins, and thus weaker stimuli are
sufficient to induce apoptosis. Therefore, in the rheostat model, the levels of various Bcl-
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2 members in the cell are critical determinants of a cell's sensitivity to apoptosis, and the
interactions of these proteins create a threshold for apoptotic signaling.
While the Bcl-2 family is clearly an important factor in determining whether a
given stimulus results in cell death, an equally significant factor is the signal upstream of
the mitochondrial pathway. (Here, we define the mitochondrial pathway as the steps
beginning with modification of the levels or activities of the Bcl-2 family proteins and
ending in he release of Smac and cytochrome c from the mitochondria). The Bcl-2
family proteins may set the threshold for apoptosis, but the strength of the signal that
induces the activation of the pro-apoptotic Bcl-2 proteins determines whether or not this
threshold is reached. However, much remains unknown about these upstream signals.
This is partly because much less is known about the molecules involved, and partly
because these signals are subtle and difficult to observe experimentally. The best-
characterized upstream signal for the mitochondrial pathway is the cleavage of Bid by
caspase-8 in the death receptor pathway (Li et al. 1998; Luo et al. 1998). Activation of
the death receptor by ligand induces DISC formation and activation of caspase-8.
Caspase-8 then cleaves Bid, which in turn activates Bax, an effector pro-apoptotic Bcl-2
protein that translocates to the mitochondria to induce permeabilization (Eskes et al.
2000). Therefore, this chain of events - from receptor to caspase-8 to Bid - regulates the
amount and rate at which active Bax is produced, and modulation of this pathway in part
determines whether enough Bax is activated to induce mitochondrial permeabilization.
Measuring the signals upstream of the mitochondria is the key to understanding many
things that have remained obscure about the process leading from the initial pro-apoptotic
stimulus to mitochondrial permeabilization:
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* Does the mitochondrial pathway create a threshold for apoptotic signaling, as
suggested in the rheostat model? An alternative possibility is that the threshold
lies upstream (for example at the level of receptor activation), and that the
mitochondrial pathway simply amplifies once the upstream threshold has been
reached.
* If the mitochondrial pathway does set a threshold for mitochondrial
permeabilization, how much caspase-8 activity is required to reach the threshold?
* What is the kinetic behavior of the caspase-8 signal, and what is its dynamic
range in response to different strengths of stimuli?
* How do survival signals block mitochondrial permeabilization - by changing the
threshold for permeabilization, or by affecting the upstream signal?
* Where does cell-to-cell variability in response to apoptotic stimuli originate -
from cell-to-cell differences in the threshold for permeabilization or from
differences in the strength or kinetics of the upstream signal?
To answer these questions we need methods for accurately assaying both the caspase-
8 signal and mitochondrial permeabilization, so that the temporal relationship of these
two processes can be directly observed. There are a number of methods available for
assaying the activity of caspase-8, but the majority of these are based on biochemical
techniques that produce population-average data. The work already described in this
thesis (see Chapter 2) shows that population-average data can obscure essential features
of the behavior of apoptotic systems. This is due in part to the highly asynchronous
nature of apoptotic responses (Tyas et al. 2000), and in part to the fact that the myriad
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biochemical events and positive feedback loops set in motion downstream of
mitochondrial permeabilzation can overshadow the more subtle events that occur
upstream (Green 2005). Thus, a single-cell approach is essential to answer these
questions.
In this chapter, we examine the relationship of death receptor-induced caspase-8
activity and mitochondrial permeabilization in single living cells. Using fluorescent
protein reporters for caspase-8 activity and mitochondrial permeabilization, we
simultaneously observe these two events under a range of treatments. We find that
caspase-8 cleavage of its substrates is initially a slow process that is detectable shortly
after stimulation with TNF or TRAIL. The sudden onset of mitochondrial
permeabilization occurs later, once the level of caspase-8 substrate cleavage has reached
a certain threshold. Moreover, we find that the time of cell death can be modulated either
by altering the level of caspase-8 activity or by adjusting the permeabilization threshold.
We also develop a flow cytometry-based assay that enables high-throughput observation
of the relative dynamics of caspase-8 activity and mitochondrial permeabilization and use
this assay to observe network behavior in response to a number of genetic perturbations.
Together, our findings provide a clearer picture of how graded upstream signals are
converted into a discrete all-or-none cell decision.
3.3 Results
3.3.1 Modeling upstream events in receptor-induced apoptosis
In the current understanding of death receptor-induced apoptosis, caspase-8 and
Bid are both required for induction of mitochondrial permeabilization in the death
119
receptor pathway (Li et al. 2002). However, some reports have suggested that this is not
always the case (Deng et al. 2003). To verify that caspase-8 and Bid are indeed required
in our experimental system, we depleted these proteins 10-fold by siRNA (Fig 3.1A).
After treatment with TNF and cycloheximide (CHX), cytochrome c localization was
determined by immunofluorescence (Fig 3.1 B). In cells not treated with siRNA,
TNF/CHX treatment stimulated the translocation of cytochrome c from the mitochondria
to the cytosol, a hallmark event of mitochondrial permeabilization. However, in caspase-
8 or Bid-depleted cells, cytochrome c translocation did not occur under TNF/CHX
treatment. Cleavage of PARP, which requires mitochondrial permeabilization in HeLa
cells, was also blocked by caspase-8 or Bid depletion (data not shown). Therefore,
caspase-8 and Bid are essential for the induction of mitochondrial permeabilization in
HeLa cells, making these cells an appropriate model system in which to examine the
relationship of caspase-8 activity and the mitochondrial pathway.
A. B.
Bid control Casp8 siRNA Bid siRNA
control siRNA
Bid -
Casp8
control siRNA
Procaspase-8
Figure 3.1 Caspase-8 and Bid are required for TNF-induced mitochondrial
permeabilization in HeLa cells. A. Immunoblot analysis of Bid and caspase-8 depletion
by siRNA. B. HeLa cells were transfected with the indicated siRNA oligos and then
120
treated with 50 ng/ml TNF + 2.5 ug/ml CHX for 4 hours. Cytochrome c (green) was
detected by immunofluorescence, and DNA (blue) was stained with Hoechst 33342.
Cells displaying redistribution of cytochrome c from mitochondria to the cytosol are
indicated with stars.
As an aid to understanding the quantititative behavior of caspase-8 signaling and
mitochondrial permebilization, we examined our mathematical model of receptor-
induced apoptosis in HeLa cells (Fig 3.2 A). In the mathematical model, the ratio of
activated Bax (Bax*) to Bcl-2 played a central role in controlling mitochondrial
permeabilization (J.M.Burke., unpublished results). In simulations, when this ratio
exceeded I (Fig 3.2 B, green line and star), indicating an excess of Bax* relative to Bcl-2,
and Smac/cytochrome c were suddenly released (Fig 3.2 B, red curves). The release of
Smac and cytochrome c was then quickly followed by PARP cleavage (Fig 3.2.B, yellow
curves). Thus, the mathematical model is consistent with the rheostat analogy discussed
above, since the Bax*/Bcl-2 ratio sets a sharp threshold for the onset of permeabilization.
In simulation, the buildup of Bax* was directly dependent on the production of tBid by
caspase-8 (Fig 3.2.B, blue curve), which was gradual up until the point of mitochondrial
permeabilization. However, the kinetics of Bid cleavage in the model were poorly
constrained, since there are few data on the behavior of caspase-8 activity or Bid
cleavage in single cells, and further model validation necessitates experimental
examination of Bid cleavage.
~-~i~
- Md-I
Casp3
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Smac release
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Figure 3.2 Mathematical model of mitochondrial permeabilization. A. Schematic
diagram of the mathematical model. Colored ovals indicate reactions that are catalyzed
by the same upstream regulator, which are assumed to have similar kinetics. Note that
caspases are abbreviated: C3=Proaspase-3, C3*=active Caspase-3, etc. B. Model
simulation of the response to TRAIL. Line colors correspond to the colored sections in
A. The green star indicates the time at which the Bax*/Bcl-2 ratio reaches 1; the blue star
indicates the level of Bid cleavage at the time that the Bax*/Bcl-2 ratio reaches 1.
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3.3.2 Simultaneous imaging of multiple apoptotic events
To simultaneously observe the relative kinetics of caspase activity and
mitochondrial permeabilzation, we used a combination of live-cell reporters. First,
caspase activity was observed using GFP-based FRET reporters, a widely used technique
(Fig 2.1, (Luo et al. 2001; Rehm et al. 2002; Luo et al. 2003; Takemoto et al. 2003;
Kawai et al. 2004)). For this study, we employed newly-constructed, and more specific,
caspase-3 and -8 reporters (see Appendix D). The kinetics of cleavage of the caspase-8
reporter should closely follow that of Bid cleavage because they are both substrates of the
same protease (Fig 3.2 A, blue oval). Second, to monitor mitochondrial
permeabilization, we used IMS-RFP, a novel reporter that accurately indicates the onset
of mitochondrial permeabilization. Unlike Smac or cytochrome c, IMS-RFP can be
overexpressed without altering mitochondrial signaling (Fig 3.2 A, red oval and App. D).
To verify our ability to accurately measure the relative kinetics of caspase activity
and mitochondrial permeabilization, we examined the temporal relationship between
caspase-3 activity and mitochondrial permeablization. In HeLa cells treated with TRAIL,
caspase-3 is not activated until after mitochondrial permeabilization (see Fig 2.2). When
HeLa cells expressing both the caspase-3 FRET reporter and IMS-RFP were treated with
TRAIL/CHX, individual cells displayed both a sudden redistribution of IMS-RFP,
indicating mitochondrial permeabilization, and a rapid increase in CFP:YFP ratio,
indicating caspase-3 activity (Fig 3.3 A). In all cells imaged, the rapid increase of
CFP:YFP ratio did not begin until after the first frame of IMS-RFP release. Therefore,
caspase-3 was activated only after mitochondrial permeabilization, consistent with our
previous findings, and demonstrating that our live-cell techniques can accurately detect
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the relative timing of caspase activity and mitochondrial permeabilization. Moreover, as
we had observed previously (Fig 2.1), individual cells displayed high variability in the
time at which rapid FRET reporter cleavage occurred. However, when responses of the
caspase-3 FRET reporter for multiple single cells were aligned by the time at which IMS-
RFP redistribution began, a striking overlap between all cells was observed (Fig 3.3.C).
This overlap confirms that, in HeLa cells, the events following mitochondrial
permeabilization and leading to caspase-3 activation are highly stereotypical and nearly
invariable from cell to cell. Therefore, cell-to-cell variability in the response to TRAIL
likely occurs upstream of mitochondrial permeabilization.
We next examined the temporal relationship between mitochondrial
permeabilization and upstream caspase-8 activity. For this, we performed time-lapse
imaging of TRAIL-stimulated cells expressing both IMS-RFP and the caspase-8 FRET
reporter. In contrast to the caspase-3 FRET reporter, we observed a significant change in
caspase-8 FRET reporter cleavage prior to the first frame of IMS-RFP release (Fig
3.3.B). In each cell, a slow rise in cleavage occurred in the 1-4 hours preceding IMS-
RFP release, reaching 20-30% of maximum cleavage at the onset of release (Fig 3.3 B).
After IMS-RFP release, cleavage accelerated, so that the remaining -70% of cleavage
occurred in only -30 minutes. The slow initial rise in cleavage indicates that a significant
amount of caspase-8 activity occurs before IMS-RFP release; this component of the
signal is likely produced by direct activation of caspase-8 by the DISC. After IMS-RFP
release, the accelerated rate of caspase-8 reporter cleavage is likely due to the increase in
caspase-8 activity that results from the caspase-6-mediated positive feedback loop, but it
may also reflect cleavage of the reporter by related caspases such as caspase-9, which
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become active during the post-release phase. This biphasic behavior was a general
characteristic of all cells examined, as becomes clear by the overlap of trajectories when
multiple cells are aligned by the time at which IMS-RFP release began (Fig 3.3.D). This
experimentally observed behavior supports the hypothesis that the mitochondrial pathway
sets a signaling threshold, because we observed that caspase-8 activity is a gradual signal
that triggers mitochondrial permeabilization suddenly when it reaches a certain level.
Moreover, the rise in FRET reporter cleavage prior to permeabilization is essentially
linear, consistent with a first-order cleavage reaction by caspase-8, as was assumed by
our model. Together, these results suggest that the kinetics of Bid cleavage and
permeabilization triggering in the mathematical model are a good approximation of
cellular behavior.
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Figure 3.3 Simultaneous live-cell imaging of caspase-activity and mitochondrial
permeabilization. A, B HeLa cells were transfected with IMS-RFP and the caspase-3
FRET reporter (A) or the caspase-8 FRET reporter (B) and then monitored by live-cell
microscopy during treatment with 50 ng/ml TRAIL + 2.5 ug/ml CHX. The responses of
three individual cells are shown for each. Green points indicate frames occurring before
the first frame of IMS-RFP release; red points indicate frames occurring at or after the
first frame of IMS-RFP release. C, D. Individual cell responses from A and B,
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respectively,were synchronized by the first frame of IMS-RFP release (which is set to
time 0 and indicated by the red vertical line) and overlaid.
3.3.3 Control of the timing of mitochondrial permeabilization
To further characterize the mitochondrial threshold, we examined multiple
individual HeLa cells in populations treated with different concentrations of TRAIL and
CHX. Using live-cell microscopy, we determined the percentage of caspase-8 FRET
reporter cleavage at the time of IMS-RFP release; for conciseness we hereafter refer to
this measurement as the "threshold value". When different concentrations of TRAIL
were applied in the presence of CHX, the average time at which IMS-RFP was released
increased substantially as the TRAIL concentration was decreased (Fig 3.4 A). This was
also observed for PARP cleavage under similar conditions (see Fig 2.1). However the
average threshold value did not vary substantially, remaining at 23-25%, with similar
standard deviations, across a 25-fold range of TRAIL concentration. This indicates that
the differences in the delay preceding IMS-RFP release result from changes in the rate at
which cells reach the threshold value, and not from changes in the threshold value itself.
In contrast, when cells were treated with TRAIL in the absence of CHX, a significant
increase in the average threshold value (to 44%) was observed, along with an increase in
the average delay preceding IMS-RFP, relative to cells treated with the same
concentration of TRAIL in the presence of CHX (Fig 3.4 A). Together, these results
suggest that the timing of mitochondrial permeabilization can be adjusted in two ways.
First, changes in the rate of Bid cleavage (from different amounts of active caspase-8, for
example) can affect how long it takes to reach the threshold for mitochondrial
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permeabilization (Fig 3.4.B, red star). Second, the threshold itself can be adjusted (such
as by changes in Bcl-2 family protein levels, Fig 3.4.B, blue star).
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Figure 3.4 Variation in the upstream signal and in the threshold level. A. HeLa cells
were transfected with caspase-8 FRET reporter and IMS-RFP and then treated with the
indicated doses of TRAIL and CHX. The fraction of reporter cleavage at the first frame
of IMS-RFP release (threshold value) and the time of release were measured for 9-10
cells in each condition. For each treatment, the threshold value is plotted against the time
of release. B. Schematic diagram of how the timing of mitochondrial permeabilization
can be delayed. Relative to a baseline condition (green line and star), a lower slope of
Bid cleavage (such as would result from lower caspase-8 activity, red line) would result
in reaching the threshold at a later time (red star). Raising the threshold value (such as
would result from an increase in Bcl-2 levels, blue line) would also delay
permeabilization (blue star), even if the slope of Bid cleavage was not altered.
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We next examined whether the observed changes in delay time were consistent
with our mathematical model. When ligand concentration was reduced in model
simulations, fewer caspase-8 molecules were activated, and Bid cleavage was slower,
Consequently, it took longer to reach the Bax*/Bcl-2=1 threshold, and a delay in
permeabilization resulted (Fig 3.5 A). However, Bid cleavage at the time of
permeabilization remained approximately the same, consistent with our experimental
observations. A delay in permeabilziation time was also observed when Bcl-2 family
proteins were increased, such as Mcl-1, which in the model bound to tBid and prevented
it from activating Bax (Fig 3.5.B). In this case, caspase-8 activity was unaffected, and
thus Bid cleavage reached a significantly higher level by the time permeabilization is
initiated (Fig 3.5.B blue stars). Therefore, model and experiment agree that either
changes in the threshold or the upstream signal can produce substantial changes in the
timing of permeabilization. The model also indicated that only the threshold, and not the
upstream signal, can be changed such that permeabilization never occurs. For example if
Bcl-2 levels are higher than the pool of Bax that is available to be activated, the threshold
is unreachable and even complete activation of Bax will never result in permeabilization
(J.M. Burke, unpublished data). Conversely, if the threshold is reachable, then even a
very small upstream signal will, in theory, eventually allow the threshold to be reached.
The only way to adjust the upstream signal to entirely prevent permeabilization would be
to remove it completely.
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Figure 3.5 Modeling delay in mitochondrial permeabilization. A, B. Simulations of the
response to decreasing concentrations of death ligand (A, gray bar) or increasing
concentrations of Mcl-1 (B, gray bar). Green star indicates the time at which the
Bax*/Bcl-2 ratio reaches 1; blue star indicates the level of Bid cleavage at the time the
Bax*/Bcl-2 ratio reaches 1.
It is clear from the mathematical model that changes in threshold value, such as
the difference observed between cells treated with TRAIL/CHX or TRAIL alone, likely
result from changes in the abundance of Bcl-2 family members. Therefore, we examined
the levels of Mcl-1, a key anti-apoptotic Bcl-2 family protein, in HeLa cells treated with
TRAIL+CHX or TRAIL alone. While Mcl-i protein levels remained constant
throughout 6 hours of treatment with TRAIL, a >2-fold decrease in Mcl-i levels occurred
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within 2 hours of TRAIL+CHX co-treatment (Fig 3.6). A likely explanation for this drop
in levels in the presence of CHX is that Mcl-I has a half-life of -40 minutes (Nijhawan et
al. 2003), and inactivating protein synthesis by using CHX allows this degradation to
occur without replenishment of the protein. Thus, at least one key Bcl-2 family member
changes in a manner consistent with the shift in permeabilization threshold between
TRAIL and TRAIL+CHX-treated HeLa cells.
TRAIL TRAIL
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Time (hr) 0 2 4 6 2 4 6
McI-1
Figure 3.6 Mcl-2 levels are reduced during cotreatment with CHX. HeLa cells were
treated with 50 ng/ml TRAIL in the presence or absence of 2.5 ug/ml CHX. Mcl-1 levels
were determined by immunoblot at the indicated times.
3.3.4 Input-output relationship of initiator and effector caspase activity
Because both caspase-8 and caspase-3 activities were determined in relation to
IMS-RFP release, the relationship of these two signals could also be determined. We
averaged the IMS-RFP-aligned signals for each FRET reporter and plotted them on a
common timescale, with t=0 set at the time of IMS-RFP release (Fig 3.7 A). From this
plot, it is clear that mitochondrial permeabilization divides apoptosis into two phases: an
initial phase (for t<0) in which only initiator caspases are active, and a later phase (t>0)
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characterized by high activity of both initiator and effector caspases. These data can also
be plotted as the level of caspase-8 reporter cleavage vs. the level of caspase-3 reporter
cleavage, to form an input-output plot (Fig 3.7 B). Again, we can observe two phases:
initially, cleavage of the initiator caspase substrate increases while effector caspase
substrate is mostly unchanged (green circles), corresponding to a rightward shift with
little change in the vertical direction. Then, when a certain level of input (caspase-8
signal) is reached, mitochondrial permeabilization occurs (red squares), and both caspase-
8 and caspase-3 increase in activity, indicated by a shift upward and to the right.
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Figure 3.7 Input-output relationship of caspase-8 and caspase-3 activity. A. For each
FRET reporter, 9-12 individual cell responses were synchronized by the first frame of
IMS-RFP release (indicated by the red vertical line) and averaged at each time point;
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error bars represent +/- 1 standard deviation. B. The average values for caspase-3 and
caspase-8 reporter cleavage are plotted against each other on logarithmic axes.
3.3.5 Measuring caspase input-output by flow cytometry
Live cell microscopy provides detailed time course data, but is relatively low-
throughput and relies on exogenous fluorescent reporter proteins. Conversely,
immunofluorescence measurements by flow cytometry sacrifice temporal resolution, but
are higher-throughput and can reveal the behavior of endogenous proteins. Therefore, we
aimed to develop a flow cytometry assay for simultaneously detecting multiple apoptotic
events. The antibody against cleaved PARP used in Chapter 2 provides a highly specific
measurement of the level of effector caspase substrate cleavage, a measurement
analogous to the caspase-3 reporter (Fig 3.2 A, yellow oval). Another commercially
available antibody, directed against the caspase-3 epitope that is exposed when caspase-3
is cleaved by caspase-8 or -9 at Aspl75, could provides a means for quantifying the
cleavage of initiator caspase substrates (Li et al. 1997; Stennicke et al. 1998). In
principle, the signal from this antibody is analogous to the caspase-8 FRET reporter,
since the FRET reporter contains a cleavage site that is identical to the caspase-8/9
cleavage site in caspase-3 (IETD). We had previously observed that in Bcl-2-
overexpressing cells, staining with this antibody increases upon TRAIL treatment, and
that this increase is prevented by caspase-8 depletion (Fig 2.S5). However, because it is
known that cleaved caspase-3 is degraded after several hours, it was somewhat puzzling
that the signal from this antibody remained high after several hours (Fig 2.S5). A likely
explanation is that this antibody may also recognize similar epitopes on other caspase-8
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substrates. Since caspase-8 cleaves multiple proteins at sites with similar sequences,
caspase-8 activity would lead to the production of several different proteins with similar
cleaveage-dependent epitopes. Thus, the specificity of the cleaved caspase-3 antibody is
likely somewhat broader than is generally assumed, and staining with this antibody
probably reflects the aggregate levels of multiple caspase-8 cleaved proteins.
Nonetheless., this antibody provides a useful indication of the activity of caspase-8, and
thus we refer to it henceforth as "cleaved Casp8 substrate" antibody.
We combined the cPARP and Casp8 substrate antibodies in a two-color flow
cytometry experiment. To validate the two-color assay, we compared staining in the
presence and absence of mitochondrial permeabilization, using Hct- 116 Bax +/- and Bax-
/- cells. Deletion of Bax in these cells effectively blocks mitochondrial permeabilization
in response to TRAIL (Deng et al. 2002). We did not use Bcl-2-overexpressing HeLa
cells because they also express GFP, which complicates flow cytometric analysis. When
Hct- 116 Bax -/- cells were treated with TRAIL, the plot of cleaved Casp8 substrate vs.
cPARP indicated that over time the majority of cells increased in cleaved Casp8 substrate
signal but not in Casp3 substrate signal (Fig 3.8). This behavior, consistent with the live
cell data, indicates that in the period preceding mitochondrial permeabilization, caspase-8
is active while caspase-3 is not. In Hct-116 Bax +/- cells treated with TRAIL, a
subpopulation of cells showed a similar increase in cleaved Casp8 substrates with no
increase in cPARP signal. Another subpopulation displayed a larger increase in cleaved
Casp8 substrate signal as well as an increase in cPARP signal. Over time, the cleaved
Casp8 substrate-positive, cPARP-negative population disappeared, while the double-
positive population increased. This progression indicates that, in response to TRAIL
135
treatment, Hct-l 16 cells first enter a phase in which only caspase-8 is active, and later
enter a phase in which both caspase-8 and caspase-3 are active. The transition to the
second phase is dependent on mitochondrial permeabilization, since it does not occur
frequently in Bax-/- cells. Overall, this behavior is very similar to that observed by live-
cell microscopy (compare Fig 3.7.B and Fig 3.8). Thus, it is also possible from these
data to obtain an estimate of the threshold value for cleaved Casp8 substrate at which
mitochondrial permeabilization occurs, by determining the highest level of cleaved Casp8
substrate signal that occurs in cPARP-negative cells. In Hct-1 16 Bax +/- cells, this value
was 25% of the maximum signal (Fig 3.8). Thus, the cleaved Casp8 substrate/cPARP
two-color cytometry assay provides a high throughput method for measuring input-output
behavior in the caspase network.
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Figure 3.8 Flow cytometric observation of the input-output relationship of caspase-8 and
caspase-3. Bax+/- and Bax-/- Hct- 116 colon carcinoma cells were treated with 20 ng/ml
TRAIL + 2.5 ug/ml CHX for the indicated times. Cells were fixed and analyzed by flow
cytometry for cPARP and cleaved caspase-8 substrates. For Bax +/- cells, colored lines
indicate the basal (green), threshold (red), and maximum (blue) values of cleaved
caspase-8 substrate signal, respectively. The magnitude of the threshold signal, as a
fraction of the maximum signal, is indicated under the left-most plot. Lines are not
shown for Bax -/- cells because there is no clearly defined threshold value.
We then used the cleaved Casp8 substrate/cPARP assay to examine the threshold
value in HeLa cells. We first examined HeLa cells treated with different concentrations
of TRAIL or TNF in the presence of CHX (Fig 3.9.A). In each case, the cleaved Casp8
substrate/cPARP pattern observed was similar to that in Hct- 116 cells; cells first
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increased in cleaved Casp8 substrate signal alone until a threshold point was reached, and
then became positive for both antibodies. The threshold value of cleaved Casp8 substrate
was calculated for each condition and was found to range from 10-14% in each case. In
cells treated with TRAIL in the absence CHX, the threshold value rose to 25% (Fig
3.9.B). Thus, the general behavior of the threshold value measured by cytometry is in
good agreement with that measured by live-cell microscopy. However, the absolute
values measured by flow cytometery were consistently lower than the values observed by
live-cell microscopy (-12% vs. -24% with CHX and -25% vs. -44% without). One
possible reason for this discrepancy is that caspase-8 cleaves the FRET reporter and the
pool of substrates detected by the Casp8 substrates antibody at different rates. Another
possibility is errors in calibration; in both methods, the threshold values are determined as
a percentage of the maximum value, and therefore measurements are highly sensitive to
errors in the estimation of the maximum value. Nonetheless, the two methods provide a
narrow range of estimates for the level of cleavage of Bid that is necessary to cross the
mitochondrial pathway threshold. In the future, more accurate calibration and knowledge
of the extent to which each method over- or under-estimates the actual rate of Bid
cleavage should yield a better estimate.
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Figure 3.9 Flow cytometric determination of threshold value in HeLa cells. A,B. HeLa
cells were treated as indicated and analyzed by flow cytometry for cPARP and cleaved
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caspase-8 substrates as in Fig. 3.7. Colored lines indicate the basal (green), threshold
(red), and maximum (blue) values of cleaved caspase-8 substrate signal, respectively.
3.3.6 Diagnosis of network behavior by flow cytometry
Next, we examined the effects of perturbation of the network by siRNA depletion
on the mitochondrial pathway threshold (Fig 3.10). We first examined the depletion of
Bid, the link between Casp8 activity and mitochondrial permeabilization. When Bid was
depleted by 10-fold, the pattern of Casp8 substrate/cPARP staining observed by flow
cytometry shifted so that the threshold for mitochondrial permeabilization increased to
-50% of the maximum cleaved Casp8 substrate signal. This shift is consistent with our
model results; when fewer Bid proteins are present, Bax activation is slower and thus it
will take longer to reach the point at which free Bcl-2 is exhausted. Consequently,
mitochondrial permeabilization is delayed, and more caspase-8 substrates are cleaved
before permeabilization occurs.
Conversely, when caspase-8 was depleted by siRNA (by 10-fold), the initial
phase of caspase-8 substrate cleavage was strongly attenuated, and cells were unable to
reach the threshold for mitochondrial permeabilization (Fig 3.10). Even more strikingly,
when Bid and XIAP were depleted simultaneously, the apparent threshold was destroyed;
under these conditions, cPARP signal always increased in proportion to cleaved Casp8
substrate. This pattern is consistent with the mechanism of snap-action switching
described in Chapter 2, since both XIAP and the mitochondrial pathway are required for
effective switching. Furthermore, Smac depletion, another perturbation that resulted in a
loss of snap-action switching (Ch. 2), produced a similar pattern with no apparent
threshold (Fig 3.10). Therefore, at least 3 different cases can be distinguished by the two-
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color cPARP/cleaved Casp8 substrate assay: 1) regulation of the upstream signal (e.g.
caspase-8 depletion), 2) alteration of the threshold for mitochondrial permeabilization
(e.g. Bid depletion), and 3) breakdown of switching behavior (e.g. Smac depletion).
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Figure 3.10 Observation of network behavior by flow cytometry. HeLa cells were
transfected with the indicated with the indicated siRNA oligos, and then treated with 50
ng/ml TRAIL + 2.5 ug/ml CHX. cPARP and cleaved caspase-8 substrates were
measured by flow cytometry.
Next, we studied the effect of TNF, in the absence of CHX, on caspase-8 and
caspase-3 activity in HeLa cells. In the absence of CHX, TNF treatment did not produce
a significant increase in either cPARP or cleaved Casp8 substrate (3.11), similar to the
effect of caspase-8 depletion in TNF+CHX-treated cells (Fig 3.10). Therefore, in the
case of TNF stimulation, the pro-survival pathway inhibited by CHX must act at or
upstream of the level of caspase-8. This is consistent with the general hypothesis that
TNF strongly stimulates the NF-kB pathway, which upregulates the DISC regulator Flip
(Micheau et al. 2001); treatment with CHX blocks this upregulation. Interestingly, our
results suggest that the pro-survival mechanisms inhibited by CHX in the cases of TRAIL
and TNF stimulation are different. Under TRAIL stimulation, CHX blocks a pathway
that regulates the threshold for the mitochondrial pathway, while under TNF stimulation,
CHX blocks a pathway that inhibits caspase-8 activation at the DISC. Thus, within the
same cell type, different ligands induce different survival pathways, which intervene in
apoptotic signaling in distinct ways.
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Figure 3.11 Suppression of Caspase-8 activity in cells treated with TNF in the absence of
CHX. HeLa cells were treated for 4 hours with 100 ng/ml TNF in the presence or
absence of 2.5 ug/ml CHX. cPARP and cleaved caspase-8 substrates were analyzed by
flow cytometry.
3.4 Discussion
In this chapter, we studied the junction between upstream death receptor-induced
signaling and mitochondrial permeabilization. Using live-cell microscopy, we showed
that upstream of the mitochondrial pathway, cleaved caspase-8 substrates accumulate
gradually, and upon reaching a certain threshold level, they trigger the sudden and rapid
release of proteins from the mitochondrial intermembrane space. This supports the
hypothesis put forward in Chapter 2 that permeabilization of the mitochondria is the
critical threshold event in death receptor-induced apoptosis.
Importantly, our data support a quantitative model for how different
concentrations and types of death ligand induce apoptosis with very different timing. The
number of death receptors engaged by ligand determines the number of caspase-8
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molecules that are activated; this in turn determines the rate at which tBid is cleaved and
the rate at which Bax* reaches the threshold level set by anti-apoptotic Bcl-2 proteins.
Under the conditions we examined, the cleavage of caspase-8 substrates increased with
monotonic and approximately linear kinetics until the threshold was reached. However,
after permeabilization, the rate of caspase-8 substrate cleavage increased markedly. This
second phase of cleavage, likely a result of positive feedback, may explain the
discrepancies in previous studies of caspase-8 activation in response to death receptor
stimulation (Luo et al. 2003; Kawai et al. 2004). In the absence of information about
mitochondrial permeabilization, interpreting the kinetics of capase-8 activity would be
difficult. However, by simultaneously imaging caspase-8 activity and mitochondrial
permeabilization, we were able to clearly distinguish these two phases.
It should be emphasized that the apparent threshold that we observe
experimentally is likely an indirect measurement of the true threshold for mitochondrial
permeabilization. In the current model, the true threshold is set by the ratio of Bax* to
Bcl-2. However, we made surrogate measurements of the level of tBid, which is one step
upstream of Bax*. The relationship of our measurements to the true threshold will
therefore depend on the amount of signal amplification in the tBid to Bax* step. In future
work, it may be possible to directly measure Bax* levels in relation to both tBid
production and mitochondrial permeabilization; this will enable an even more accurate
quantitative model of signal transduction in this pathway. Nonetheless. the
measurements reported here have significant value, because they clearly distinguish
events that affect the signal upstream of Bid from events that affect Bid and Bax directly.
In interpreting our data, it must be remembered that the apparent (or experimentally
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observed) threshold can be affected both by molecules that interact directly with Bax*
and molecules that interact only with tBid, whereas the true threshold would only be
affected by the former. Interestingly, because some Bcl-2 anti-apoptotic proteins may
interact with tBid and not with Bax*, the apparent threshold we observe may actually be
a more informative measure of the total activity level of anti-apoptotic Bcl-2 proteins
than direct measures the threshold for Bax*.
The sensitivity of cells to a given apoptotic stimuli is widely thought to depend on
the threshold set by the ratio of Bcl-2 family proteins. This threshold is believed to play a
critical role in the resistance of cancer cells to apoptosis (Lowe et al. 2004). By
measuring the input and the output to the mitochondrial pathway, we report the first
single-cell measurements of where on the continuum of input values the threshold lies in
a widely-used cancer cell line. Although the measurements reported here are relative
values, calculated as a percentage of the maximum signal, it should be possible, using
quantitative calibration methods, to determine the absolute number of tBid (and
eventually, Bax*) molecules needed to cross the threshold. Moreover, it will be
interesting to make similar measurements in other cell types, and to determine how their
threshold values relate to their sensitivity to various apoptotic stimuli. Our flow
cytometry results with HeLa and Hct-1 16 cells indicate a 2-fold difference in threshold
value between these cell lines, confirming that substantial variation among cell lines
exists. We also demonstrate that changes in this threshold value result from anti-
apoptotic signaling. Detecting such changes will be useful in evaluating the effects of
pro-survival pathways; the relative effectiveness of multiple survival pathways may be
quantitatively compared by examining the extent to which they alter the threshold.
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We find that similar measurements of the mitochondrial threshold, and of general
network dynamics, can made either by live-cell microscopy or by flow cytometry. While
live-cell microscopy provides better temporal resolution and is likely more accurate, the
flow cytometry assay is much higher throughput. Flow cytometry measurements of at
least 11 parameters are now possible (Irish et al. 2004), but we find that even a 2-
parameter experiment provides a highly information-rich assay of network behavior,
when it is interpreted in the context of a quantitative mechanistic model. This would
suggest that flow cytometry experiments with more than two parameters could yield a
remarkable amount of mechanistic information from a single sample, when experimental
analysis is coupled with an appropriate modeling approach. Yet, even in its current stage,
the 2-parameter experiment described here will provide an excellent means for high-
content, high-throughput measurement of death receptor-induced responses in multiple
cell lines. Moreover, it can be used to screen libraries of drugs or genetic reagents for
molecules that specifically affect the death receptor-induced signal, the mitochondrial
threshold, or snap-action switching.
Our results highlight the interesting relationship between the timing of cell death
and apoptotic sensitivity. It could be argued that setting the threshold of input signal
required for cell death is equivalent to setting the delay time in response to a given
stimulus. This may be true in many cases, but our model suggests that the threshold can
be changed in two ways. First, it is possible to set the threshold so high that it can never
be reached by pro-apoptotic signals of any strength; this requires a high level of
overexpression of Bcl-2 family proteins. Second, the threshold can be raised to a high,
but still attainable level, resulting in a delayed mitochondrial pemeabilization in response
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to any given stimulus. This could also ultimately reduce the senstitivity of the cell,
because it could enable the cell to "wait out" transient pro-apoptotic stimuli without
committing to apoptosis. The existence of these two distinct forms of resistance to
apoptosis raises the question of whether it is necessary for cancer cells to set the
threshold so high that it is unattainable, or whether they can survive effectively simply by
delaying death. In many studies, when sensitivity to apoptosis is measured, the
distinction between delaying death and preventing it indefinitely is not made. Our model
suggests that closer attention to this detail will be important in understanding tumor cell
behavior.
3.5 Materials and Methods
Reagents and cell culture
HeLa cell lines were maintained in DMEM supplemented with 10% fetal bovine
serum and glutamine. Hct-1 16 cell lines, a kind gift of Dr. Bert Vogelstein, were
maintained in McCoy's 5A medium supplemented with 10% fetal bovine serum. siRNA
oligos were obtained from Dharmacon. Construction of the plasmids pExchange I-IMS-
RFP, pECFP-DEVDR-Venus, and pECFP-IETD2X-Venus are described in Appendix D.
SuperKiller TRAIL was obtained from Alexis, and TNF was from Peprotech. Anti-
cytochrome c, anti-cPARP, and anti-cleaved caspase-3 were from BD Biosciences.
Secondary antibodies were obtained from Molecular Probes. Oligofectamine was
obtained from Invitrogen, and Fugene 6 was from Roche.
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Transfection
siRNA transfections were performed as previously described using
Oligofectamine. The concentrations of siRNA oligos in complex were between 4 and 16
nM. Plasmid DNA transfections were performed with Fugene 6 according to the
manufacturer's instructions.
Immunofluorescence microscopy
HeLa cells were cultured on chambered slides (LabTek), transfected with siRNA
oligos for 48 hours, and treated as indicated. Fixation was the performed using 4%
formaldehyde in PBS at room temperature for 10 minutes. Cells were blocked and
permeabilzed in Perm/Wash solution. Primary antibody (anti-cytochrome c) was diluted
1:250 or 1:500 in Perm/Wash and incubated on the samples for 1 hour at room
temperature or 4' C overnight. Secondary antibody and Hoechst 33342 were diluted in
Perm/Wash buffer and incubated with the samples for 1 hour at room temperature. Slides
were mounted with coverslips and imaged using a Deltavision Spectris AX71
fluorescence microscope.
Live cell microscopy
HeLa cells transfected with fluorescent reporters were seeded in chamberered
cover glass slides (LabTek). Immediately prior to imaging, medium was replaced with
C0 2-independent medium (Gibco) containing the appropriate doses of SuperKiller
TRAIL and CHX. Cells were then imaged at 370 C on a Deltavision Spectris AX71
equipped with a temperature control chamber using a 20X objective. CFP, YFP, and
RFP images were acquired at 3-minute intervals for 12 hours. Image analysis was
performed in ImageJ.
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Flow cytometry
After treatment for the appropriate length of time with SuperKiller TRAIL, HeLa
cells were trypsinized (taking care to collect both floating and adherent cells) and fixed
with 4% paraformaldehyde in PBS for 10 minutes at room temperature. Following a PBS
wash, cells were permeablized in 100% methanol. Prior to staining for flow cytometry,
cells were stored for up to 5 days at -20 C in 100% methanol. Cells were stained with
primary antibodies (1:250 anti-cleaved PARP and 1:500 anti-cleaved caspase-3 in PBS-
T+1%BSA) for 1 hour at room temperature, followed by staining with secondary
antibodies (1:250 in PBS-T+I%BSA) for I hour. Cells were then analyzed on a Becton
Dickinson FACSCalibur. Analysis was performed using the FlowJo software package.
Measurements of the mitochondrial threshold value for the cleaved Casp8 substrate
antibody were made by first estimating the average maximum fluorescence level across
all time points for that experiment and the approximate position of the threshold
fluorescence intensity for the time point that was closest to the average cPARP Td for
that condition. Threshold values were then calculated by dividing the fluorescence
intensity of at the threshold by the maximum fluorescence intensity.
Mathematical modeling
Model simulations were performed in Matlab using the model and the procedures
described in Chapter 2.
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4.1 Abstract
Signal transduction pathways control cellular responses to stimuli, but it is unclear
how molecular information is processed as a network. We constructed a systems model
of 7980 intracellular signaling events that directly links measurements to 1440 response
outputs associated with apoptosis. The model accurately predicted multiple time-
dependent apoptotic responses induced by a combination of the death-inducing cytokine
tumor necrosis factor (TNF) with the pro-survival factors epidermal growth factor (EGF)
and insulin. By capturing the role of unsuspected autocrine circuits activated by TGF-a
and IL-la, the model revealed new molecular mechanisms connecting signaling to
apoptosis. The model derived two groupings of intracellular signals that constitute
fundamental dimensions (molecular "basis axes") within the apoptotic signaling network.
Projection along these axes captures the entire measured apoptotic network, suggesting
that cell survival is determined by signaling through this canonical basis set.
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4.2 Introduction
Despite extensive molecular-level information on how external stimuli affect cell
fate, there is minimal understanding of how such intracellular processing occurs at a
system-wide level. Most extracellular "inputs" initiate complex signaling patterns that
propagate through an intracellular network to change the response "outputs" that
determine a cell's phenotype (Downward 2001). Molecular signaling through this
network is branched (fig. 4.S1) and dynamically interconnected to the molecular history
of the prior inputs, signals, and outputs (Dumont et al. 2002). Thus, we sought to
develop a mathematical formalism to connect signals and outputs in such a way that
cellular responses could be predicted from molecular signaling patterns alone.
To reduce the biological complexity of cellular signal processing, experimental
systems usually monitor changes in one defined extracellular stimulus (for example, a
soluble cytokine) and one output response (such as apoptosis). However, physiological
input stimuli are not processed in isolation, because signaling networks constantly receive
additional inputs from changing environmental conditions, such as nutrient availability,
cell density, and exposure to the extracellular matrix (Bissell and Radisky 2001). To
investigate multi-input signal processing, large-scale "systems biology" approaches have
been proposed. However, most of the analyses to date have concentrated on
characterizing signals downstream of individual inputs (Bouwmeester et al. 2004; Zhu et
al. 2004).
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4.3 Results
Studying multiple input stimuli requires information about the network as a
whole; otherwise, intracellular changes in signal transduction molecules (called
"molecular signals" hereafter) can appear paradoxical. For example, c-jun N-terminal
kinase (JNK) is a protein that has been reported to be proapoptotic (Lei and Davis 2003),
antiapoptotic (Lamb et al. 2003), or uninvolved in apoptosis (Abreu-Martin et al. 1999)in
different cell systems. To investigate this JNK-apoptosis link further, we added multiple
combinations of tumor necrosis factor (TNF) and epidermal growth factor (EGF) to HT-
29 human colon adenocarcinoma cells and then measured the amounts of phosphorylated
JNK (P-JNK) and apoptosis (Fig. 4.1A). A plot of the TNF and EGF input stimuli and
corresponding P-JNK signal and apoptosis outputs established a four-dimensional signal-
response "surface" (Fig. 4.1 B). "Slices" through this surface mimicking single TNF or
EGF inputs could recapitulate any of the previously reported correlations between P-JNK
and apoptosis (Fig. 4.1, C-E) (Abreu-Martin et al. 1999; Lamb et al. 2003; Lei and Davis
2003). This indicated that individual molecular signals like P-JNK cannot uniquely
determine a cell's commitment to apoptosis, a complex output response. Quantitative
experiments that dynamically sample many critical signals would be needed (Janes et al.
2003).
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4.3.1 Dense experimental sampling of 7980 molecular signals and 1440 response
outputs for cytokine-induced apoptosis.
To investigate how signaling networks coordinate cellular output responses, we
used an established multi-input system where HT-29 cells are stimulated with three
biologically relevant cytokines: TNF, EGF, and insulin (Gaudet et al. 2005a; Janes et al.
2006). The intracellular protein network downstream of these cytokine inputs is
understood in reasonable detail (fig. 4.S 1). Within well-recognized network branches, 19
intracellular measurements of key receptor, kinase, caspase, and adaptor proteins were
collected (Table 4.1 and fig. 4.S1) (Janes et al. 2006). Using nine distinct pairwise
combinations of TNF, EGF, and insulin (Fig. 4.1F), we sampled each molecular signal in
triplicate at 13 time points between 0 and 24 hr to compile 7980 distinct molecular
signals from the shared intracellular network (Janes et al. 2006). TNF and EGF or insulin
are opposing cytokine inputs that promote or inhibit apoptosis, respectively (Abreu-
Martin et al. 1995; Remacle-Bonnet et al. 2000), and the intracellular measurements thus
identified which molecular signals were activated en route to the cellular decision to die
or to survive. However, it remained unclear how EGF- and insulin-induced molecular
signals antagonized TNF-induced apoptosis.
To test whether apoptosis could be connected to the measured signaling network
(Janes et al. 2006), we measured the cell-death phenotype for each combinatorial
cytokine stimulus (Fig. 4.1 F). The apoptotic response itself involves various cellular
changes (outputs) that can be regulated independently (Del Bino et al. 1999). Individual
parameters used to characterize cell death (such as loss of membrane asymmetry) only
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partially reflect the overall cellular response. Therefore, we selected four distinct
apoptotic outputs (phosphatidylserine exposure, membrane permeability, nuclear
fragmentation, and caspase substrate cleavage) and measured each output response by
flow cytometry 12, 24, and 48 hr after stimulation (Fig. 4.1, G-O). Together, these
output measurements constituted an apoptotic "signature" that characterized early
(phosphatidylserine exposure), middle (caspase substrate cleavage and membrane
permeability), and late (nuclear fragmentation) responses of apoptosis (the biological
outputs in our system).
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Table 4.1. Signaling network measurements
Protein name Function* Molecular signalt Assayl
Inhibitor of nuclear factor-kappaB Ser kinase Kinase activity Kinase assay
kinase (IKK)
c-jun N-terminal kinase 1 (JNK 1)
Mitogen-activated protein kinase-
associated protein kinase 2 (MK2)
Epidermal growth factor receptor
(EGFR)
Mitogen-activated protein kinase and
extracellular regulated kinase
kinase (MEK)
Extracellular regulated kinase (ERK)
Insulin receptor substrate 1 (IRS 1)
Akt
Ser-Thr kinase
Ser-Thr kinase
Receptor Tyr
kinase
Dual-specificity
kinase
Ser-Thr kinase
Adaptor-scaffold
Ser-Thr kinase
Kinase activity
Kinase activity
Phosphorylation
(Tyr1068)
Total amount
Phospho/total ratio
Phosphorylation
(Ser217/Ser221)
Kinase activity
Phosphorylation
(Ser636)
Phosphorylation
(Tyr896)
Phosphorylation
(Ser473)
Total amount
Kinase activity
Kinase assay
Kinase assay
Ab microarray
Ab microarray
Ab microarray
Western blot
Kinase assay
Western blot
Western blot
Ab microarray
Ab microarray
Kinase assay
Phosphorylation (Ser Western blot
473)
Phospho/total ratio Ab microarray
Forkhead (FKHR) Transcription Phosphorylation Western blot
factor (Ser256)
Caspase-8 Cys protease Zymogen amount Western blot
Cleaved amount Western blot
Caspase-3 Cys protease Zymogen amount Western blot
*Biological functions were assigned based upon the most recognized property of the protein.
tSignals indicate the biochemical property of the protein that was measured.
+Assay indicates whether the protein was measured by high-throughput kinase activity assay (10), antibody
microarray (33), or quantitative Western blotting (12).
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Apoptotic signatures were measured for the nine cytokine input combinations
(Fig. 4.1F), revealing temporal and cytokine dose-dependent features that would have
been missed by examining single apoptotic outputs alone. Membrane permeability (red)
and caspase substrate cleavage (purple) measured dead cells cumulatively
(Darzynkiewicz et al. 1997). Therefore, these outputs increased monotonically with time
and TNF dose (Fig. 4.1, G, J, and M). In contrast, phosphatidylserine exposure (loss of
membrane asymmetry before membrane permeability) and nuclear fragmentation
(digestion of DNA before complete cellular fragmentation) were transient cell states
(Darzynkiewicz et al. 1997) that could increase and decrease with time and input dose
(Fig. 4.1, G-O).
High concentrations of EGF and insulin antagonized TNF-induced cell death in a
similar manner, particularly reducing apoptotic responses at early times (Fig. 4. 1, M-O;
Fig. 4.S2). Low concentrations of EGF and insulin elicited different output responses.
EGF reduced TNF-induced membrane permeability at 48 h but increased transient
phosphatidylserine exposure at 12 h (Fig. 4.1, J and L; p < 0.05, Student's t-test with
Bonferroni correction). In contrast, insulin reduced TNF-induced membrane
permeability at 12 and 48 h, and phosphatidylserine exposure was decreased at 12 h but
higher at 48 h (Fig. 4. 1, J and K; p < 0.05). These measured apoptotic signatures provide
evidence that different apoptotic outputs can be controlled separately, depending upon the
input stimulus. For example, membrane permeability is most commonly associated with
secondary production of reactive oxygen species (Vanden Berghe et al. 2004), whereas
phosphatidylserine exposure is thought to involve caspase- and Ca2+-dependent processes
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(Fadok et al. 1998). The JNK family protein kinases (Fig. 4.1A) have been implicated in
reactive oxygen signaling (Ventura et al. 2004; Kamata et al. 2005) but are thought to be
largely independent of Ca2 + signaling (Cruzalegui et al. 1999). Thus, relating the
intracellular network dynamics to the complete apoptotic signature requires more
information than can be provided by individual molecular signals, like JNK1.
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Figure 4.1. JNK phosphorylation after multi-input cytokine stimulation fails to correlate
with apoptotic responses. (A) JNK phosphorylation and apoptosis in HT-29 cells treated
with TNF, EGF, or both. Phospho-JNK (P-JNK) was analyzed at 15 min by quantitative
Western blotting with tubulin as a loading control, and apoptosis was measured at 24 hr
by cleaved caspase-cytokeratin staining and flow cytometry. (B) Response surface for P-
JNK (z-axis) and apoptosis (color bar) induced by the input described in (A). (C-E)
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Lack of a correlation between JNK phosphorylation and apoptosis. P-JNK appeared to
be (C) proapoptotic, (D) antiapoptotic, or (E) uninvolved in apoptosis depending upon the
experimental "slice" through the TNF-EGF signaling space. (F) Experimental design for
TNF, EGF, and insulin stimulation. Letters correspond to the experimental treatment,
used in the respective figure panels, for which 19 molecular signals (Table 4. 1) (Janes et
al. 2006) and apoptotic outputs were measured. In addition, signals and apoptotic outputs
were measured in cells stimulated with 0.2 ng/ml TNF and 1 ng/ml insulin. The carrier
was always 0.02% DMSO. (G-O) Apoptotic outputs by flow cytometry. In (G), (N),
and (0), the insets depict representative density plots of the cleaved caspase+-cleaved
cytokeratin ÷ population. All flow cytometry measurements were normalized to the
maximum observed apoptosis for phosphatidylserine exposure (25%), membrane
permeability (67%), nuclear fragmentation (21%), and cleaved caspase-cytokeratin
(77%). Data are presented as the mean ± S.E.M. of triplicate biological samples.
4.3.2 A partial least squares model predicts the 12 cytokine-induced apoptotic
outputs from a 660-element signaling vector.
We sought to determine whether multiple molecular signals in combination could
quantitatively capture the entire apoptotic signature as a response and predict apoptosis
more globally. We designed a mathematical formalism that could identify the
information content within each molecular signal that most closely mapped onto the
output responses. The resulting mapping of lumped signals to corresponding responses
might then allow us to identify the most relevant "information variables" for apoptosis
and use these variables to predict apoptotic responses to stimuli outside the training set.
It was unclear what aspect of a dynamically sampled molecular signal should fill
the role of an information variable for apoptosis. For example, in addition to
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measurements of kinase activity at various time points, it was not known if other data
such as the maximum activity, the rate of rise of activity, or the time when peak activity
occurred also contained useful information. Therefore, we defined a panel of time-
dependent signaling "metrics" that could be derived empirically from any dynamic signal
(Fig. 4.2A). Each of the metrics [for example, activity of the mitogen-associated protein
kinase (MAPK) ERK at 5 min, ERK activity at 15 min, peak ERK activity, and the
abundance of phosphorylated (active) the MAPK kinase MEK (P-MEK) at 5 min] can
then be represented by an "axis" along which particular multi-input stimuli project (Fig.
4.2C).
In total, we extracted 30 to 40 metrics (Table 4. S ) from each time course of a
molecular signal to form a composite "metric set" (Fig. 4.2A). Metric sets were defined
for all 19 molecular signals, forming a group of individual axes that together define a
660-dimensional signaling space. The projection of a multi-input stimulus along these
axes creates a "signaling vector" of 660 column elements corresponding to the 30-40
metrics from each of the 19 measured molecular signals (Fig. 4.2B). The apoptotic
outputs were similarly concatenated to form an apoptosis vector, where the 12 column
elements are the four apoptotic outputs at three time points each (Fig. 4.2A). Each input
stimulus has its own particular signaling and apoptosis vectors, so these were calculated
separately for each of the nine treatment combinations (Fig. 4.1 F).
We sought to identify the best mapping of the 660-dimensional signaling metric
space onto the 12-dimensional output response space. A simple linear mapping would
require the 7920-element coefficient matrix (12 rows x 660 columns) that best
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transformed the signaling space into the response space (Fig. 4.2B), a calculation that
would be impossible to solve uniquely given only nine multi-input conditions. To
simplify the signal to response mapping and retain biological meaning, we first assumed
that some of the signaling metric dimensions were either redundant or irrelevant. For
instance, the peak activity of ERK contains the same information as the ERK activity at 5
min, when the ERK peak often occurred (Fig. 4.2C). Likewise, other axes (e.g., metrics
at 0 min, prior to stimulus) merely scrambled the projections since they pointed in
directions unrelated to apoptosis (Fig. 4.2C). These redundant and uninformative axes
could be deemphasized or eliminated without any loss of information about the apoptotic
outputs. Second, we assumed that the remaining informative axes could be compressed
by linear combination into a small number of dimensions that retained the critical
apoptotic information and thus constituted a biologically relevant basis set for the signal
to response mapping. For instance, proteins like MEK and ERK are part of the same
signaling pathway and were thus activated similarly. Although not identical, the
information in many MEK and ERK metrics pointed in collinear directions that could be
combined into a MEK-ERK "super axis" that retained the projection with fewer
dimensions (Fig. 4.2C).
To reduce unnecessary axes and condense important axes mathematically, we
used partial least squares (PLS) regression, which simplifies dimensions based upon their
covariance with a specified dependent variable (P.Geladi and Kowalski 1986; Janes et al.
2004). The original 660-dimensional signaling space was reduced to a series of super
axes that together best orient the measured apoptotic-output elements within the
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apoptosis vector (Fig. 4.2, A and C). PLS modeling, like singular value decomposition
(Alter et al. 2000), calculates super axes as an orthogonal set of "principal components",
which contain linear combinations of the original 660 metric dimensions weighted by
their contribution to the apoptotic outputs (Fig. 4.2C). Principal components are
calculated iteratively so that successive PLS dimensions are regressed against the
apoptotic-output information not captured by the preceding component. After several
iterations, including more dimensions becomes undesirable, because the residual
information is so small that new principal components capture spurious fluctuations in
the outputs, like measurement error and noise, rather than meaningful data (Janes et al.
2004).
To optimize the number of model dimensions, we examined the root mean-
squared error (RMSE) between the measured apoptosis vector and the values from
models with increasing numbers of principal components. All of the input treatments
were included in the initial model training to assess the RMSE of data fitting
(calibration). Each treatment was then individually withheld from the training set to
construct a cross-validation model, in which an RMSE of prediction could be assessed by
predicting the withheld sample. The calibrated RMSE decreased monotonically, but the
predicted RMSE was minimized with just three principal components (Fig. 4.2D). Using
the resulting three-component apoptosis model, we examined the correlation between the
measured apoptotic outputs and the cross-validated predictions for each treatment (Janes
et al. 2004). If the correct signaling information was retained by the principal
components in the model, then the apoptotic outputs for TNF, EGF, and insulin stimuli
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not included during the model training should also be predicted. Indeed, we found a high
correlation for all 12 apoptotic outputs, with predictions that were accurate to within 94%
of the measured values overall (Fig. 4.2, E-J). Although the 12 individual apoptotic
outputs differed quantitatively from one another (Fig. 4.1, G-O), their stimulus-
dependent changes were almost entirely captured by a single PLS model of the
intracellular network (Fig. 4.2, E-J). The 660 dimensions of the original signaling space
(Fig. 4.2C) had thus been condensed to three dimensions, which were enriched in the
molecular signals most useful for predicting the apoptotic outputs. Furthermore,
specifying the dynamic state of the intracellular signaling network was absolutely
essential-an equivalent PLS model given only cytokine-input concentrations (Fig. 4.1 F)
rather than intracellular signaling metrics could not correctly predict the apoptotic outputs
(45% accuracy) (K.A.J., unpublished data).
The original measurements (Janes et al. 2006) of the signaling network contained
several direct effectors of apoptosis, such as caspases (Table 4. 1) (Nicholson and
Thornberry 1997). The model would obviously be less valuable if these late-effector
signals were providing all of the predictive power to the model. To test whether caspase
metrics were required for accurate predictions, we removed all of the caspase signals
from the model and rederived the principal component axes. The resulting predictions
were essentially identical (Fig. 4.2, E-J). Thus, non-caspase signals in the network
contained more than enough information to predict the apoptotic outputs quantitatively.
Furthermore, molecular signals activated before the initial onset of apoptosis were
themselves sufficient for predicting the apoptotic signature. We found that a separate
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PLS apoptosis model derived exclusively from signaling measurements made at 0 to 4
hours after cytokine addition was accurate to within 81% (Fig. 4.S3).
To examine the relationship between other molecular signals and late effector
caspases directly, we next removed the apoptotic outputs altogether and defined the
procaspase-8, cleaved caspase-8, and procaspase-3 time-point measurements as a new set
of cellular outputs (Fig. 4.2K). Using the remaining network measurements, the PLS
model predicted the caspase response dynamics within 81% accuracy (Fig. 4.2K).
Together, this suggested that both the caspase effector signals and the final cellular output
responses were encoded by the upstream signaling network.
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Figure 4.2. A data-driven principal components-based model correctly predicts
apoptosis and caspase activation from molecular signals activated by multi-input TNF,
EGF, and insulin stimulation. (A) Extraction of signaling and response metrics. Upper
panel: time course measurements () of the signaling network were used to group
individual time points (t), instantaneous derivatives (d/dt), area under the curve (AUC),
and the maximum, mean, and steady-state (S-S) values and form a signaling metric set, in
this example for ERK. The activation slope and decay rates for signaling peaks were also
incorporated. Bottom panel: individual apoptotic output time points were concatenated
for each treatment into an apoptosis vector. (B) Construction of the partial least squares
apoptosis model. Individual signaling metric sets were concatenated into a single
signaling vector for each treatment condition and these vectors then regressed against the
corresponding apoptotic response vectors (Janes et al. 2004). wA is the coefficient matrix
of the apoptosis regression model. (C) PLS-based supervised decomposition of signaling
vector space into principal components. Upper panel: a simplified example of
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dimensionality reduction by principal components analysis. In this example, collinear
axes like peak ERK activity, ERK activity at 5 min, and P-MEK levels at 5 min could be
reduced into a single principal component axis (pi). Lower panel: principal component
axes were captured in a supervised manner to maximize prediction of apoptotic
responses. In the full PLS model, the four apoptotic outputs (red, green, blue, and purple
quandrants of each data point) at three time points (12, 24, and 48 hr slices within
quadrants) were oriented along three principal component axes (pl, P2, and p3)
determined to contain the essential signaling information for predicting apoptosis. Each
point corresponds to one multi-input stimulus, such as TNF + EGF, and the shading of
the point corresponds qualitatively to the extent of measured apoptosis. The numbered
axes (left) indicate separate metrics extracted from different molecular signals, shown in
(A). (D) RMSE of calibration and prediction of apoptotic outputs by the PLS model as a
function of increasing number of principal components. An optimum model with three
components was selected. (E-G) Correlation plots between measured phosphatidylserine
exposure (y-axis) and cross-validated predictions of phosphatidylserine exposure (x-axis)
by the PLS model with (red) and without (yellow) caspase signals included. The merged
overlay is shown in green. Marker size ( * * ) corresponds to the response time point
at 12, 24, and 48 hr. Data are presented as the mean ± S.E.M., and model uncertainties
were estimated by jack-knifing (Janes et al. 2004). (H-J) Correlation plots between
measured and cross-validated predictions of membrane permeability, nuclear
fragmentation, and caspase substrate cleavage. Data are presented as in (E-G). (K)
Comparisons between measured caspase levels and cross-validated predictions from a
specific PLS model of caspase activation. Signaling metric vectors from non-caspase
molecular signals were regressed against the 0-24 hr time-point measurements of
procaspase-8, cleaved caspase-8, and procaspase-3. wc is the coefficient matrix of the
caspase regression model. The nine rows in the measured and predicted color coding
correspond to the nine treatment combinations shown in Fig. 4.1F. Each region of the
heat map was normalized separately for comparison.
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4.3.3 Model-driven discovery of apoptosis regulation via autocrine circuits.
In HT-29 cells, two regulated autocrine stimuli-transforming growth factor-a
(TGF-c) and interleukin- I a (IL-la)-cooperate with TNF to activate molecular signals
in the network (Fig. 4.3A) (Janes et al. 2006). Whether these autocrine circuits contribute
significantly to TNF-induced apoptosis is not known. We therefore used the PLS model
to predict what the apoptotic signature would be when autocrine TGF-a and IL-la
circuits were disrupted with either an antibody to the EGFR (C225) or an IL-1 receptor
antagonist (IL-Ira) and the cells were then treated with TNF. All 19 molecular signals
were measured from 0-24 hr (Janes et al. 2006) and provided as input data to the PLS
model. We then measured the actual TNF + C225- and TNF + IL-Ira-induced apoptotic
signatures experimentally (9) and compared these with the model predictions. This
experiment was a particularly stringent test of the model, because neither TGF-a nor IL-
Ia had been part of the original training set (Fig. 4.1F).
Strikingly, we observed a 90% correlation between the measured apoptotic
outputs and the model predictions when the two autocrine loops were disrupted
individually (Fig. 4.3B), indicating that the model could predict the contributions of
cytokines other than TNF, EGF, and insulin. Furthermore, upstream molecular signals
alone were highly predictive of downstream effector caspase activation after TNF + C225
and TNF + IL-Ira stimuli (prediction within 91% of measured values; Fig. 4.3C).
Therefore, the contributions of autocrine TGF-a and IL-la to TNF-induced apoptosis
had been implicitly and correctly incorporated throughout models of apoptotic outputs as
well as caspase activation.
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Interestingly, disruption of the IL- l autocrine loop decreased most apoptotic
outputs in cells responding to TNF (Fig. 4.3D), suggesting that autocrine IL-la was an
extracellular positive-feedback circuit for TNF-induced apoptosis. In contrast, disruption
of TGF-ca signaling by C225 led to large changes in TNF-induced activation of the
network but did not lead to any clear overall changes in apoptosis (Fig. 4.3D). Some
outputs, like phosphatidylserine exposure, were increased in cells treated with C225 (p <
10 5, two-way analysis of variance). Others, like caspase substrate cleavage, were
decreased (p < 0.05), whereas six of the 12 individual apoptotic outputs did not change in
a statistically significant manner.
TGF-a is a member of the EGF family (Rouse et al. 1994), and treatment of cells
with EGF was shown to reduce apoptosis (Fig. 4.1, M and 0). Why then did blocking
autocrine TGF-ca with C225 not increase apoptosis overall? First, in HT-29 cells,
autocrine TGF-ca activates a pro-death signal by inducing late (12 to 24 hr) release of
autocrine IL-la (Fig. 4.3A and Fig. 4.S4) (Janes et al. 2006). Second, we reasoned that
the late, pro-death IL-la signal must be offset by some unknown late, pro-survival
signal. Concurrent pro-death and pro-survival signals at late times could then neutralize
one another and explain the net lack of an effect of autocrine TGF-a on apoptosis. To
help identify this late, pro-survival signal, we examined the coefficients within the PLS
model that quantified the contribution of each signal to apoptosis (Fig. 4.2B), since the
model correctly predicted the mixed apoptotic response resulting from autocrine TGF-a
perturbation (Fig. 4.3B). Early MAPK-Activated Protein Kinase 2 (MK2) kinase activity
in the model correlates with apoptosis; by contrast, the model revealed that MK2
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signaling at times after 12 hr was strongly anticorrelated with apoptosis, implicating
MK2 as a pro-survival kinase at later times. In agreement with this, when autocrine
TGF-a was blocked by C225, MK2 activity at late times was inhibited (Fig. 4.3E) (Janes
et al. 2006). Thus, both model and experiment suggested that late MK2 activity was a
pro-survival signal activated by autocrine TGF-cc.
If effectively pro-survival, then MK2 activity at late times should be present
primarily in viable cells. MK2 signaling was therefore analyzed separately in live and
apoptotic cells by measuring the floating and adherent subpopulations of TNF-treated
cells. All MK2 activity was detectable only in the adherent (viable) cells (Fig. 4.3F). If
we permitted the early phase of MK2 activity to occur in response to TNF but rapidly
inhibited the late phase with SB202190, a small-molecule inhibitor of the MK2-activating
kinase p38 (Lee et al. 1994; Yadav and Sarvetnick 2003), we observed a significant
increase in cell death at 24 hr (Fig. 4.3G). Taken together, these experiments
demonstrate that the signal to response linkages implicated by the PLS model can reveal
new biological mechanisms that would not be easily recognized without a mathematical
formalism.
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Figure 4.3. The principal components-based model captures hidden autocrine feedback
in the signaling network and identifies late MK2 activity as a TGF-a-induced pro-
survival signal (A) Diagram of TNF-induced autocrine circuits in HT-29 cells (Janes et.
al 2006). Orange arrows indicate fast pathways (before four hours) and purple arrows
indicate slow pathways (after four hours). C225 and IL-Ira were used as
pharmacological inhibitors of autocrine TGF-a and IL-i la, respectively. (B) The model
correctly predicts TNF-induced apoptosis when the autocrine feedback circuits are
disrupted by C225 and IL-1ra. Apoptotic outputs were measured as in Fig. 4.1, G-O for
cells treated with 5 ng/ml TNF and 10 ýtg/ml C225 (circle) and 100 ng/ml TNF plus 10
Lg/ml IL-I ra (square). Marker color corresponds to the apoptotic index (c.f. Fig. 4.1, G-
0) and size corresponds to the time point (c.f. Fig. 4.2, E-J). (C) The model correctly
predicts caspase cleavage in response to TNF stimulation when the autocrine feedback
circuits are disrupted. Comparisons between measured caspase levels and model
predictions for the autocrine circuit perturbations. Each panel was normalized separately,
and the unperturbed caspase dynamics were included for comparison. (D) The TNF--IL-
1 a autocrine circuit is proapoptotic, while the TNF-*TGF-ca circuit sends both pro- and
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antiapoptotic signals. Comparison of TNF-induced apoptotic outputs with and without
autocrine IL-la and autocrine TGF-c. Data are shown as percent change in apoptosis in
C225- and IL-Ira-treated cells compared with unperturbed TNF-stimulated cells (Janes et
al. 2006). (E) TNF-induced late MK2 activity is TGF-a-dependent. Cells were
stimulated with 5 ng/ml TNF in the presence or absence of 10 pLg/ml C225 to block
autocrine TGF-a, and MK2 activity was measured by in vitro kinase assay (Janes et al.
2003). (F) Late MK2 activity is restricted to surviving cells. Left panel: cells were
treated with TNF for 20 hr, separated into floating and adherent subpopulations, and
MK2 activity was assayed as in (E). Data were normalized to basal MK2 activity as
described (Gaudet et al. 2005). Right panel: floating and adherent cells correspond to
apoptotic and viable cells respectively, as indicated by caspase-8 cleavage and DAPI
staining. (H) Late MK2 activity is a pro-survival signal. Cells were treated for 24 hr
with 100 ng/ml TNF in the presence or absence of the inhibitor SB202190 during the
indicated times and assayed for apoptosis by the presence of caspase substrate cleavage.
For (E), (G), and (H), data are presented as the mean ± S.E.M. of triplicate biological
experiments (Janes et al. 2006).
4.3.4 Redundant encoding of signaling components and critical roles of MAP
kinases in PLS predictions of apoptosis.
In the full model, 660 metrics derived from 7980 signaling measurements were
used to predict apoptosis (Fig. 4.2, E-J; 3B). In retrospect, it was not clear whether
apoptotic outputs could be predicted equally well by a reduced number of metrics derived
from smaller, more tractable experiments. We found that a model containing only the 20
most informative metrics, as determined by the relative magnitude of their coefficients in
the model (Table 4. S2), was nearly as predictive of apoptosis as one that used all 660
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metrics (Fig. 4.4A). A noteworthy feature of the top 20 metrics was that they were not
the obvious metrics we would have chosen on the basis of our basic understanding of the
regulation of apoptosis. Activation slopes of Akt and IRS I phosphorylation and
integrated peaks of JNKI and IKK signaling were included, but caspase metrics were
missing entirely (Table 4. S2). Use of fewer than these top 20 metrics, in isolation, gave
significantly less effective predictions (data not shown), supporting our original
hypothesis that individual signaling measurements would not broadly predict cell
responses (Fig. 4.1, C-E).
High predictive ability of the top 20 metrics (Fig. 4.4A) suggested redundancy in
the signaling information contained within the original 660-metric model. To investigate
this, we sequentially removed various portions of the most informative metrics and then
recalculated the prediction of apoptosis by cross-validation. Up to the top 350 metrics
could be eliminated from the full list of 660 metrics before the apoptosis model lost all
significant predictive ability (Fig. 4.4A). This implied that the full set of 660 biological
metrics was redundantly encoded with the stimulus-specific information required to
mediate all of the apoptotic outputs (Ozaki and Leonard 2002; Wiley et al. 2003). We
also analyzed the contributions of individual proteins (that is, the 19 molecular signals)
based on the average information contained in their derived metrics. The top three
molecular signals, JNKI, MK2, and ERK, belonged to MAPK cascades (data not shown).
A model given only metrics from these three signals performed nearly as well as the full
PLS model in predicting the effects of autocrine perturbations (Fig. 4.4B). A model
derived from the seven least informative molecular signals was also predictive (Fig.
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4.41). Together, these findings suggest that measurements of 3 to 7 relevant intracellular
molecular signals are sufficient to predict network-dependent output responses.
Prediction efficiency (defined as the relative predictive ability divided by the number of
molecular signals included in the model) was maximal with 4 to 5 molecular signals (Fig.
4.4B, inset).
4.3.5 The PLS model identifies stress-apoptosis and survival signaling axes.
We examined the relationship between all of the signaling network measurements
and the input treatments as signals propagated through the model's first two principal
components (Janes et al. 2004), which predicted the apoptotic output within 92%. These
components are the two main lumped contributions of the signaling metrics, which form
a pair of orthogonal axes defining the optimal two-dimensional slice through the
signaling dataset (Janes et al. 2004). We found that certain signals and treatments were
clearly overrepresented in these dimensions. The first principal component, Axis #1, was
oriented toward stress and apoptotic pathways and included early JNKI activity, early
MK2 activity, and late cleaved caspase-8 metrics (Table 4. S3). In contrast, the second
principal component, Axis #2, appeared to constitute a global survival signal that
included phosphorylated Akt (P-Akt), phosphorylated insulin receptor substrate I (P-
IRS 1), phosphorylated Forkhead transcription factor (P-FKHR), and procaspase-3
metrics (Table 4. S4). The specific molecular signals emphasized in these components
were entirely consistent with the known molecular mechanisms that link these signaling
proteins to apoptosis (Fig. 4.Sl).
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Using the principal component axes, we could now reanalyze the signaling
contributions to apoptosis from cells exposed to single or combined cytokines. Certain
signals, such as IKK, contributed differently to the stress-apoptosis and survival axes
depending upon the time point when the molecular signal was measured. Early IKK
activity induced directly by the TNF receptor (TNFR) was weighted predominantly along
pro-survival Axis #2 (Fig. 4.4C). However, IKK activity after 12 hr, which occurs
indirectly in response to an autocrine signal from IL-la (Fig. 4.3A) (Janes et al. 2006),
contributed more to the stress-apoptosis axis (Fig. 4.4C). Thus, the PLS model had
revealed that the same molecule, such as IKK, can convey either pro- or anti-apoptotic
messages depending on the timing and mechanism of activation.
For individual cytokines, we found that TNF treatment alone projected strongly
along pro-death Axis #1, whereas isolated EGF and insulin treatments mapped
exclusively on pro-survival Axis #2 (Fig. 4.4E). This reinforced our original intuition
that TNF and EGF-insulin stimuli act upon orthogonal and antagonistic signaling axes for
apoptosis. In contrast, the multi-input projections were remarkably different from what
would be predicted by a summation of the single-input treatments (Fig. 4.4F, gray).
TNF, EGF, and insulin each lost a fraction of their original projections along the two
axes, indicating that the input stimuli were antagonized when added in combination (Fig.
4.4F). The TNF + EGF and TNF + insulin treatments were distinctly separated from one
another: EGF appeared to antagonize TNF-induced apoptosis by specifically reducing
the projection along the stress-apoptosis Axis #1 without any change along Axis #2 (Fig.
4.4F); in contrast, insulin actively promoted pro-survival signaling along Axis #2 while
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also inhibiting stress-apoptosis signaling along Axis #1. Therefore, analyzing the multi-
input stimuli through these model-derived biological "basis axes" (Fig. 4.4E) helped to
reveal the different network strategies used by EGF and insulin to antagonize TNF-
induced apoptosis.
Finally, to determine the contributions of TNF-induced autocrine circuits in the
model, we mapped the TNF + C225 and TNF + IL-Ira treatments (Fig. 4.4G). The
projection of TNF along the stress-apoptosis axis (Fig. 4.4G) was enforced by the
autocrine circuits, which increased the contribution along Axis #1 and decreased the
contribution along Axis #2. This is consistent with the notion that regulated autocrine
circuits provide microenvironment-dependent feedback to cells during phenotypic
decision processes, such as death-survival (Janes et al. 2004; Janes et al. 2006).
Furthermore, it illustrated directly that effects of complex environmental stimuli were
entirely contained within the two canoncial basis axes distilled from the original 660-
dimensional signaling metric space by the PLS model (Fig. 4.4E).
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Figure 4.4. Two orthogonal stress and survival axes link complex stimuli to apoptosis.
(A and B) The principal component-based model is redundantly encoded. (A) Decreased
accuracy of prediction of apoptotic responses to TNF, EGF, and insulin with decreasing
number of signaling metrics. (B) Decrease in accuracy of prediction of apoptotic
responses to autocrine signals with decreasing number of molecular signals. Both
metrics and molecular signals were eliminated sequentially from best to worst on the
basis of their variable importance in the principal component projection (9). (inset)
Predictive efficiency as a function of number of molecular signals included. To calculate
efficiency, the TNF-EGF-insulin apoptotic predictions in (B) were divided by the number
of molecular signals in the submodel. For (A) and (B), data are presented as the central
prediction ± 90% Fisher Z-transformed confidence intervals. (C) The two principal
components can correspond to distinct time-resolved mechanisms of molecular-signal
activation. Contribution of IKK activity time-point metrics to Axis #1 and #2. Early and
late IKK time points are shaded in light and dark gray, respectively. A reciprocal time-
dependent change in projection along Axis #1 and #2 was observed for MK2 (data not
shown). (D-F) The intracellular signaling network is defined by two orthogonal stress
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and survival axes that link complex stimuli to apoptosis. (D) Cytokine inputs project
along orthogonal stress and survival axes (Axis #1 and #2) of the PLS model. (E)
Cytokine combinations project differently from linear superposition of isolated cytokine
stimuli. EGF in combination with TNF directly antagonizes stress pathway signaling,
while insulin in combination with TNF both antagonizes stress signaling and induces
separate pro-survival signaling pathways. The linear superposition of single-input TNF,
EGF, and insulin projections from Fig. 4.4E is shown in gray. (F) Autocrine feedback
circuits rotate the TNF-induced signaling network to reinforce stress responses and
suppress any signaling down the survival axis. For (E-G), samples were projected using
the model scores as described (Janes et. al 2004).
4.4 Conclusion
In summary, by using a systems approach that combines quantitative experiments
with data-driven modeling, we have identified two canonical axes-a stress-apoptosis
axis and a survival axis-that together constitute a molecular basis set for the signaling
network that controls apoptosis. These axes capture the dynamic intracellular signal
processing of diverse stimuli, including autocrine-feedback circuits. Our work illustrates
how a complex signaling network can be reduced empirically to a much simpler
computational model that is directly tied to biological mechanism.
4.5 Materials and methods
P-JNK immunoblotting
HT-29 cells (ATCC) were plated and sensitized as described (Janes et al. 2005),
then stimulated with combinations of 0, 1, 5, or 100 ng/ml TNF and EGF for 15 min and
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lysed by standard techniques (Janes et al. 2003). 100 ptg of each lysate was run on a 10%
SDS-PAGE gel and transferred to PVDF (Millipore). The membranes were blocked with
5% nonfat skim milk in 20 mM Tris-HCI (pH 7.5), 137 mM NaCI, 0.1% Tween-20 and
probed overnight with anti-phospho-SAPK/JNK (Cell Signaling) at 1:1000 dilution. The
membranes were then probed with horseradish peroxidase conjugated anti-rabbit
secondary antibody (Amersham) at 1:10,000 dilution and visualized by enhanced
chemiluminescence (Amersham) on a Kodak Image Station (Perkin Elmer). Bands were
selected and quantified according to the manufacturer's recommendations. To improve
quantitation, each membrane was normalized to an internal positive control (100 ng/ml
TNF, 15 min). The membranes were stripped and reprobed with anti-tubulin
(Calbiochem) to confirm equal protein loading.
Large-scale apoptotic marker measurements
HT-29 cells were plated in 24-well plates and were sensitized and treated
identically to the cells used in the corresponding signaling measurements on the same day
(Janes et al. 2005). After 12, 24, or 48 hours of cytokine treatment, the cells were
trypsinized until all cells were detached from the plate. The growth medium was
combined with the trypsinized cells to ensure capture of both floating and adherent cells
in each well. The combined pool of cells from each well was split into thirds; one third
was analyzed for phosphatidylserine exposure and membrane permeability, one third was
fixed with methanol and analyzed for cleaved caspase-cytokeratin, and one third was
fixed with methanol (MeOH) and analyzed for nuclear fragmentation. For the
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phosphatidylserine-membrane permeability analysis, the cells were washed once with
Annexin Binding Buffer (ABB, 10 mM HEPES, 140 mM NaCI, 2.5 mM CaCl2) and
stained with Alexa Fluor 488-conjugated Annexin-V (Molecular Probes) and I ug/ml
propidium iodide (PI) for 10 minutes at room temperature. Excess ABB was added and
the cells were analyzed by a Becton Dickinson FACScan or FACSCalibur flow
cytometer. For the cleaved caspase-cytokeratin assay, MeOH-fixed cells were stored at -
20 C for up to I week. After centrifugation to remove the MeOH, cells were washed in
PBS + 0.1% Tween-20 (PBS-T), and were then stained with anti-cleaved caspase-3 (Cell
Signaling, Becton Dickinson) and anti-cleaved cytokeratin (Roche) antibodies in PBS-T
+ 1% bovine serum albumin (PBS-TB) for I hour at room temperature. The cells were
washed and stained with secondary antibodies, Alexa Fluor 488-conjugated donkey anti-
mouse IgG and Alexa Fluor 647-conjugated donkey anti-rabbit IgG (Molecular Probes)
in PBS-TB for 1 hour at room temperature. The cells were then washed and analyzed on
a Becton Dickinson FACSCalibur flow cytometer. For the nuclear fragmentation assay,
MeOH cells were stored at -20 C for up to one week. After centrifugation to remove the
MeOH, cells were washed once with PBS-T, and then incubated with I mg/ml RNAse A
in PBS-T for 2.5 hours. PI was then added at a final concentration of 50 ug/ml, and the
cells were analyzed on a FACSCalibur flow cytometer to quantify nuclear fragmentation.
For all flow cytometry assays, data was analyzed using FlowJo software (TreeStar).
To fuse quantitative measurements on different days, 100 ng/ml TNF and mock
treatments were always included as fixed positive and negative controls. Experimental
samples were then scaled by the TNF (membrane permeability and cleaved caspase-
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cytokeratin) or mock (phosphatidylserine exposure and nuclear fragmentation) index for
that day. By cross-validation we verified that the magnitude and dynamics of these
normalized apoptotic indices were highly reproducible, with R2 = 0.79-0.98 (Gaudet et
al. 2005b). The entire dataset of 1440 flow cytometry runs is available in the Supporting
Online Material.
Signaling network measurements
Details of the signaling network measurements are described elsewhere (Gaudet
et al. 2005b; Janes et al. 2005). Briefly, 19 quantitative signaling network
measurements-IKK activity, JNKI activity, MK2 activity, P-EGFR (Y1068), total
EGFR, P/total EGFR, P-MEK (S217/221), ERK activity, P-IRS1 (S636), P-IRSI (Y896),
P-Akt (S473) by Western blot, total Akt, Akt activity, P-Akt (S473) by antibody
microarray, total Akt, P/total Akt, P-FKHR (S256), procaspase-8, cleaved caspase-8, and
procaspase-3-were compiled from triplicate biological samples treated with 0, 0.2, 5,
100 ng/ml TNF and 0, 1, 100 ng/ml EGF or 0, 1, 5, 500 ng/ml insulin for 5, 15, 30, 60, 90
min or 2, 4, 8, 12, 16, 20, 24 hr. With each treatment, sextuplicate 0-min samples were
also prepared to measure the level of baseline signaling. Exact treatment combinations
are shown in Fig. 4.1F and described in the legend. The total number of individual
protein measurements in the initial compendium was 7980: 19 molecular signals x 3
replicate measures x 10 treatment combinations x the equivalent of 14 time points (i.e.,
zero in sextuplicate) = 7980 individual signals.
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For autocrine perturbations, cells were pretreated with 10 tg/ml C225 for one hr
or cotreated with 10 ýtg/ml IL-Ira, then stimulated with 5 or 100 ng/ml TNF (Janes et al.
2005). These data provided an additional 1596 protein measurements (19 molecular
signals x 3 replicate measures x 2 treatment combinations x the equivalent of 14 time
points) to test model predictions.
Signaling metric extraction
For each signaling time course, the following signaling metrics were derived:
a. Thirteen time-point metrics, defined as the mean signal at each point in the time
course.
b. Thirteen instantaneous-derivative metrics, defined as the forward slope between the
current time point and the subsequent time point. For the final time point (24 hr), the
instantaneous derivative was set to zero.
c. Four summary metrics, which included the area under the curve for the entire time
course, the maximum signal, the mean signal, and the steady-state signal (defined as
the mean of the final four time points).
d. A variable number of peak metrics. For each signal a tolerance value (defined as a
percentage of the dynamic range of the signal) was set for the algorithm to classify an
upward fluctuation as a peak. Tolerances were set at: 50% for Akt activity, IKK
activity, and all antibody microarray measurements; 5% for JNKI activity and MK2
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activity; and 20% for all other signaling network measurements. For each peak
identified, three metrics were extracted: area under the curve, activation slope
(defined as the best linear fit between the preceding local minimum and the peak
maximum), and decay rate (defined as the best exponential fit between the peak
maximum and the proceeding local minimum).
These signaling metrics are summarized in Table 4. S2. Metric extraction algorithms
were coded in MATLAB and are available upon request.
PLS model construction and validation
Prior to all analyses, the signaling and apoptosis matrices were variance scaled to
nondimensionalize the different measurements. The PLS model was constructed in the
SIMCA-P 10.0 (Umetrics) software suite according to the following iterative formulas:
El = X - tipiT; E2 = F- t2E2T , t2  EIw 1; Ei = Ei-I - tipiT, ti = Ei- wi
Fi = Y - bitlqiT; F2= F - b2t2q2T; Fi = Fi-I - bitiqiT
where Ei represents the residual of the ith principal component, with score vector ti,
weight vector wi, and loading vector pi, and T represents transpose. Fi represents the
residuals of the ith dependent principal component, with score vector ti and loading vector
qi, and bi represents the coefficient characterizing the inner relation between the
independent and dependent principal components. Model predictions were made by
leave-one-out crossvalidation for the TNF-EGF-insulin treatments and by unbiased
prediction for the autocrine perturbations (Gaudet et al. 2005b). Model uncertainties
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were calculated by jack-knifing (Efron and Tibshirani). Signaling axes and treatment
mappings (Fig. 4.4, E-G) were plotted using wl, w2 and ti, t2 respectively after a 600
subspace rotation (Alter et al.). Centered and scaled coefficients were used as the
regression weights.
PLS model perturbations - Reduced metric submodels
For the reduced metric submodels, the information content of each signaling
metric was assessed by its variable importance in the projection (VIP):
VIP, =
where k is the number of signaling metrics, wak is the weight of the kth metric for
principal component a, A is the total number of principal components, and SSa is the sum
of squares explained by principal component a (Wold 1994). For the reduced signal
submodels, the mean VIP score for each signal calculated across all metrics was used as
the central estimate of the pure-signal information content.
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4.6 Supplementary Figures and Tables
TNF EGF (TGF-' ) Insulin
Out
In
I
) Kinase assay * Western blot * Ab microarray
Figure 4.S1. Schematic of the shared TNF-EGF-insulin signaling network. Nineteen
molecular signals (numbers) from protein nodes highlighted in black were measured by
high-throughput kinase activity assays, quantitative Western blotting, or antibody
microarrays as described (Janes et al. 2005).
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Figure 4.S2. Insulin and EGF antagonize TNF-induced apoptosis. (A-D) Insulin
significantly reduces all four apoptotic outputs at 12 and 24 hr and reduces membrane
permeability and phosphatidylserine exposure from 12 to 48 hr (p < 0.05, two-way
analysis of variance). (E-H) EGF significantly reduces caspase substrate cleavage from
12 to 48 hr and membrane permeability at 12 and 24 hr (p < 0.05). Nuclear
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fragmentation was also reduced but did not reach statistical significance (p = 0.07). Data
are replotted from Fig. 4.1, M-O.
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Figure 4.S3. The partial least squares model does not require late time points to make
predictions of apoptosis. Correlation plots between measured apoptotic indices and
cross-validated predictions of (A) phosphatidylserine exposure, (B) membrane
permeability, (C) nuclear fragmentation, and (D) cleaved caspase-cytokeratin. The full
PLS model (red) was compared with a truncated PLS model (yellow) that omitted
signaling measurements after four hours. The merged overlay is shown in green, and
marker size corresponds to the response time point. Data are presented as the mean +
S.E.M., and model uncertainties were estimated by jack-knifing.
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Figure 4.S4. TNF-induced autocrine TGF-c causes the release of autocrine IL-(la.
Autocrine TGF-a was blocked with 10 tg/ml C225 antibody and HT-29 cells then
stimulated with 0, 5, or 100 ng/ml TNF for 24 hr and analyzed for IL-la release (Janes et
al. 2004).
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Table 4.S1. Signaling metrics extracted from dynamic network measurements
Metric class*
Time point
Instantaneous derivative
Summary metrics
Peak metrics
*See for a complete description and definition of the signaling metrics.
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Metrics extracted
0 min
5 min
15 min
30 min
60 min
90 min
2 hr
4 hr
8 hr
12 hr
16 hr
20 hr
24 hr
0 min
5 min
15 min
30 min
60 min
90 min
2 hr
4 hr
8 hr
12 hr
16 hr
20 hr
24 hr
Area under the curve
Maximum signal
Mean signal
Steady-state signal
Area under the curve
Activation slope
Decay rate
Table 4.S2. Top 20 most informative signaling metrics of the PLS model
VIP*
1.57
1.43
1.39
1.35
1.35
1.30
1.30
1.29
1.29
1.29
1.29
1.28
1.28
1.28
1.28
1.28
1.28
1.27
1.27
1.27
Proteint
IRS-I
Akt
IRS-I
JNKI
IKK
MK2
MK2
JNKI
IKK
JNK1
MK2
MK2
MK2
JNK1
MK2
IKK
IKK
IKK
IKK
MK2
Signalt
P-Ser636
P-Ser473
P-Ser636
Activity
Activity
Activity
Activity
Activity
Activity
Activity
Activity
Activity
Activity
Activity
Activity
Activity
Activity
Activity
Activity
Activity
*Variable importance in the projection.
tSee Table 4. 1 and (Janes et al. 2005) for a complete description of the network
measurements.
JSee Table 4. SI and for a complete description of the signaling metrics.
§The top caspase metric, mean cleaved caspase-8, was only 34th overall .
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Metrics
Decay rate, peak #2
Activation slope, peak #3
Activation slope, peak #2
Area under the curve, peak #2
Area under the curve, peak #2
4 hr time point
8 hr time point
8 hr time point
Steady-state
Decay rate, peak #2
Mean
30 min time point
Area under the curve
Mean
Maximum
20 hr time point
Area under the curve
12 hr time point
16 hr time point
90 min time point§
Table 4.S3. Top 20 loadings in the first principal component of the PLS model
Wici * Proteint Signalt Metricl
Cleavage
P-Tyrl068/total
Activity
Activity
Activity
P-Ser473
Activity
Activity
Activity
Activity
Cleavage
Activity
Activity
Activity
Cleavage
Activity
Cleavage
Cleavage
Total
Activity
Cleavage
2 hr derivative
16 hr derivative
5 min derivative
5 min derivative
15 min time point
Activation slope, peak #3
Activation slope, peak #1
Area under the curve, peak #1
15 min time point
Maximum
4 hr derivative
30 min time point
90 min time point
60 min time point
12 hr time point
30 min time point
16 hr time point
8 hr derivative
20 hr derivative
Maximum
Steady-state
*Loading weights of the first principal component.
tSee Table 4. 1 and for a complete description of the network measurements.
ISee table Si and for a complete description of the signaling metrics.
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0.097
0.095
0.095
0.093
0.092
0.092
0.092
0.091
0.091
0.090
0.090
0.089
0.089
0.088
0.088
0.087
0.087
0.087
0.086
0.086
0.085
Caspase-8
EGFR
MK2
JNKI
MK2
Akt
JNK1
MK2
JNKI
JNKI
Caspase-8
JNKI
MK2
MK2
Caspase-8
MK2
Caspase-8
Caspase-8
Akt
MK2
Caspase-8
Table 4.S4. Top 20 loadings in the second principal component of the PLS model
W2C2 *
-0.0695
-0.0691
-0.0622
-0.0615
-0.0613
-0.0608
-0.0605
-0.0605
-0.0603
-0.0600
-0.0599
-0.0599
-0.0596
-0.0595
-0.0593
-0.0590
-0.0587
-0.0586
-0.0583
-0.0581
Proteint
IKK
EGFR
Akt
MK2
Akt
FKHR
Akt
EGFR
Akt
Procaspase-3
Procaspase-3
Procaspase-3
Procaspase-3
Procaspase-3
Caspase-8
FKHR
Akt
FKHR
Akt
IRS1
MetricsSignalt
Activity
Total
P-Ser473
Activity
P-Ser473
P-Ser256
P-Ser473
Total
P-Ser473
Zymogen
Zymogen
Zymogen
Zymogen
Zymogen
Cleavage
P-Ser256
P-Ser473
P-Ser256
P-Ser473
P-Tyr896
*Loading weights of the second principal component.
tSee Table 4. 1 and (Janes et al. 2005) for a complete description of the network
measurements.
:See Table 4. S1 and for a complete description of the signaling metrics.
§Five P-IRS I (Ser636) metrics were identified within the top 30 loadings of the second
principal component.
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Activation slope, peak #2
60 min derivative
24 hr time point
Decay rate, peak #2
8 hr derivative
16 hr time point
16 hr time point
Area under the curve, peak #3
Steady-state
12 hr time point
Steady-state
20 hr time point
24 hr time point
16 hr time point
90 min time point
12 hr time point
20 hr time point
Steady-state
12 hr time point
24 hr time point§
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5.1 Introduction
The study of apoptosis is important both from a basic biology and a clinical
perspective. A thorough understanding of how, when, and to what extent cells commit to
apoptosis will enable a better understanding of how multicellular organisms develop and,
ideally make it possible to adjust the rate and extent of cell death so as to intervene in
pathological processes. Part of this understanding will come from the continued
discovery of additional components and interactions in the apoptotic pathways and a
corresponding increase in the accuracy of the qualitative/descriptive models currently
used to summarize our knowledge. However, it is increasingly apparent that a critical
component of this understanding will be the integration of our knowledge in quantitative
and mechanistic models. When I began this work, the prospect of developing such
models seemed remote. Today the term "systems biology" and its goal of building
formal quantitative models are widely recognized, although the approach is still viewed
with skepticism by many traditional biologists. Critics note, quite rightly, that such
modeling approaches will be of little use unless they are closely coupled to
experimentation. Others remain unsure of how modeling approaches represent an
advantage over more traditional experimental and analytical approaches. Thus, the
crucial challenge, as systems biology comes of age, will be to effectively integrate data
with models, not simply for the sake of building models but to answer questions that have
remained inaccessible by experimental analysis alone. The work presented in this thesis
aims to be such an integration, with the goal of gaining insight into a number of open
questions in the fields of signal transduction and apoptosis. In this chapter, I summarize
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the progress that my collaborators and I have made toward answering these questions, as
well as the areas that remain in need of further exploration.
5.2 A quantitative mechanistic model of caspase substrate cleavage.
The model developed in Chapter 2 has served as an important tool throughout our
single-cell studies. Our model served as a means for integrating data from various
sources, including live-cell imaging, flow cytometry, and immunoblotting. Data from
each of these sources were used as constraints on the model behavior, and thus the model
effectively contains most of the information collected throughout our studies of TRAIL-
induced apoptosis in HeLa cells. While numerous differential equation models of
caspase networks have been developed, ours represents a significant advance in several
ways. First, our model contains only mass-action equations; unlike several other models,
there are no fitted forms or exponential equations that could enforce switch-like behavior
(Bentele et al. 2004; Bagci et al. 2005). Thus, untested assumptions about the behavior
of the biochemical network have not been hard-wired into the model. Second, our model
has been extensively validated using single-cell data. While other models have been
regressed against experimental data, population-average methods have been the main
data source for these studies (Bentele et al. 2004). Mass-action biochemical models are
based on the assumption that all reactions are occurring within the same physical
compartment (or its sub-compartments). Therefore, comparing model behavior to
population-average data rests on the assumption that the population-average behavior
approaximates single-cell behavior. However, our live-cell experiments demonstrate that
this assumption is not valid, and thus fitting the model to population average data
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introduces a significant source of error into the model. Third, our model explicitly
includes the cleavage of an effector caspase substrate (i.e. PARP). Most previous models
have considered the network only up to caspase-3, and have assumed that the steady-state
level of this enzyme can be equated to cell death. However, since there is a finite pool of
effector caspase substrates in the cell, this simplification can be a significant problem.
Under this simplification, the cleavage of caspase substrates induced by transient
caspase-3 activation is not accurately accounted for. Moreover, we have observed in our
model that participation of caspase-3 in enzyme-substrate complexes with its substrates
can play a significant role in the extent to which it is accessible to its inhibitor XIAP.
Thus, including caspase substrates such as PARP in the model, as we have done,
substantially improves model accuracy.
Despite the progress that has been made in modeling caspase activation, there are
clearly many aspects that have yet to be explored. Several known features of the
signaling networks have been omitted from the current model; these could now be added
to the model to explore whether they significantly alter the model behavior. For example,
the formation of the DISC is a complex process involving the recruitment of multiple
adaptor proteins. Additional complexities include a requirement for the interaction of
adjacent receptor trimers (Holler et al. 2003), secondary complex formation (in the case
of TNF, Micheau and Tschopp 2003), and signaling modulation by internalization
(Schneider-Brachert et al. 2004). The cell-to-cell variability observed in caspase-8
activity (Chapter 3) could potentially arise from such a complex process, and numerous
other forms of regulation are likely to modify the cellular response at this point.
Secondly, additional details of proteasome-mediated protein degradation could be added,
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which might improve the model's ability to predict the kinetics of PARP cleavage when a
proteaseome inhibitor is added (Chapter 2). Thirdly, caspases considered redundant, such
as caspase-7 and caspase- 10, could be added to the model; caspase-7 could potentially act
as a further amplifying step in effector caspase activation, since it has been reported to be
activated downstream of caspase-3.
Other additions, which will require a substantial amount of experimental
validation, are the inclusion of other pathways in the model. To fully model the response
to TNF, for example, both the caspase pathway and the NF-KB survival pathway must be
accounted for. The NF-rB pathway feeds back into the caspase pathway by
transcriptionally regulating anti-apoptotic proteins such as FLIP, Bcl-XL, and XIAP
(Stehlik et al. 1998; Tsukahara et al. 1999; Micheau et al. 2001). Since each of these
species is already present in the model, and models of TNF-induced NF-KB activation
have also been developed (Hoffmann et al. 2002; Nelson et al. 2004), it would be
relatively straightforward to integrate models of the two pathways. However,
quantitative experimental data for the amount and timing of the transcriptional
upregulation of each gene will be necessary to create an accurate link between the two
pathways. The integration of other pathways, such as the Akt and ERK pathways, is also
feasible, with similar requirements for data to calibrate the strength of crosstalk.
One final area into which the model could be extended is non-redundant parallel
pathways. Several reports have suggested the existence of pathways that run in parallel
to the canonical pathway included in the model, which are reported to be essential for
TNF- or TRAIL-induced apoptosis (Deng et al. 2003; Chau et al. 2004; Baksh et al.
2005). For example, one study found that the tumor suppressor protein RASSF IA
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activates the BH-3 protein MAP-1 at the DISC to stimulate mitochondrial
permeabilization (Baksh et al. 2005). Blocking this pathway by gene knockout or siRNA
greatly reduced death receptor-induced apoptosis, suggesting that this pathway may be
equally as important as the well-known caspase-8/Bid pathway. However, this pathway
is based only on one isolated report, and thus extensive experimental validation would be
necessary before it could be included in the model with a high level of confidence.
Nonetheless, this effort could be essential to fully capture the entire network.
5.3 Mechanism of all-or-none caspase activity
All-or-none caspase activity appears to be an important feature of apoptotic
regulation. While several hypotheses have been put forward for this phenomenon, none
have previously been tested experimentally (Eissing et al. 2004; Bagci et al. 2005). In
our work, we identify the underlying mechanism of this regulation and demonstrate its
breakdown under various conditions. This behavior has two essential components: first,
XIAP acts to ensure that caspase-3 remains inactive despite being cleaved; second, the
mitochondrial pathway produces a sudden, overwhelming signal that relieves XIAP
inhibition and quickly leads to a sharp increase caspase-3 activity (Fig 2.6A). An
important point to note is that caspase-3 activation is not literally all-or-none; even in the
"all" case, our model indicates that only -40% of the caspase-3 molecules in the cell are
active at any one time. Rather, "all-or-none" most accurately describes the cleavage of
the substrates downstream of caspase-3. When the switch functions properly, the amount
of caspase-3 activity induced is far in excess of the amount needed to exhaustively cleave
the cellular pool of substrates. Conversely, in the "none" case, the total cumulative
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caspase-3 activity is low enough that less than 5% of cellular substrates are cleaved. An
interesting consequence of the regulation of caspase-3 by XIAP is that, under some
conditions, caspase-3 can be first activated and then degraded, creating a pulse of
caspase-3 activity that is sufficient to cleave some, but not all, of the pool of caspase-3
substrates (Fig 2.3A). In some cases, this pulse causes damage (partial cleavage), but not
death (Fig 2.2 G). We speculate that this could lead to genomic damage in the surviving
cells, due to the activation of caspase-activated DNAses. However, we have yet to
confirm the existence or the extent of such DNA damage; demonstrating this will be an
essential test for the hypothesis that partial caspase substrate cleavage may lead to
oncogenesis. Moreover, it will be important to examine the in vivo effects of partial
caspase substrate cleavage. While it would be difficult to control caspase substrate
cleavage precisely in vivo, perhaps one possibility would be a xenograft-type approach, in
which cells are stimulated in vitro under conditions that result in partial caspase substrate
cleavage, and then replaced into an animal to assess their tumorigenic potential.
It will also be interesting to explore situations in which partial caspase activation
occurs for physiological reasons. There are numerous reports of caspases acting in non-
apoptotic processes, such as differentiation and T-cell proliferation (Algeciras-Schimnich
et al. 2002; Chun et al. 2002). Further work will be needed to determine whether the
regulation of caspases under these circumstances is similar to the conditions we have
described for partial caspase activation. The existence of situations in which the cell does
not require full caspase activation may also suggest a reason why the all-or-none caspase
activation is not more "robust". If the caspase network is required to fill multiple roles,
some of which require full caspase activation and some which require partial activation,
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these constraints could prevent the evolution of a system that can only operate in an all-
or-none manner. While switching mechanisms could be envisioned in which it is much
harder to cause partial caspase activation, these may not be practical because of the
additional roles that the caspase network is required to fill.
5.4 Relationship of caspase-3 activity to cell fate.
Caspases kill the cell, but how lethal are these enzymes in quantitative terms? An
interesting outcome of studying all-or-none caspase substrate cleavage is that it enabled
us to create situations in which caspase activation does not result in exhaustive cleavage
of cellular substrates. The final extent of effector caspase substrate cleavage can be
adjusted by simultaneously inactivating the mitochondrial pathway by Bcl-2
overexpression and varying the XIAP level or the rate of proteasomal degradation (Fig
2.3). One advantage of this arrangement is that, by preventing mitochondrial
permeabilization, a potential complicating source of cytotoxicity is removed, since it has
been reported that mitochondrial permeabilization may result in cell death even in the
absence of caspase activity (Ekert et al. 2004; Chipuk and Green 2005). Thus, the
conditions of Bcl-2 overexpression and XIAP depletion allow the death-inducing power
of the effector caspases to be examined in isolation of other cell death pathways. Based
on these experiments we estimated that a pulse of caspase-3 activity sufficient to cleave
-10-20% of the cellular pool of substrates is lethal to -50% of cells (Fig 2.2F,G and
2.S6). However, as noted in Chapter 1, there may be a number of redundant, or
"backup", pathways leading to cell death (Golstein and Kroemer 2005). In the case of
many cell deaths, caspase activation is only part of the lethal mix; substantial cell killing
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results even if the caspases are inhibited. Much further study and quantitative modeling
will be needed to understand these alternate death pathways. Nonetheless, a quantitative
understanding of caspase-induced lethality is an important part of the overall cell death
equation. The ultimate goal of understanding cell death in all its physiological forms will
come when the independent contributions and synergistic behavior of multiple death
mechanisms can be quantitatively modeled.
5.5 Single-cell apoptotic assays
The results presented here provide several good examples of why single-cell
assays are important in studying many cell biological processes. Even within an isogenic
population, individual cell responses can be highly variable (Tyas et al. 2000; Geva-
Zatorsky et al. 2006). Furthermore, single-cell assays allow the distinction of different
types of responses; e.g. a complete response in a subset of cells vs. a partial response in
all cells. However, our findings also provide a good example of why it is also critical to
integrate single-cell measurements with population-average methods. When using the
DEVD-based FRET reporter in Chapter 2, its behavior accurately reflected the kinetics of
endogenous caspase-3 substrates under the conditions examined. However, we later
observed that this reporter was also cleaved at a much slower, but significant, rate in Bcl-
2-overexpressing cells, a condition where the specificity of western blotting indicated
unequivocally that endogenous substrates such as PARP are not cleaved (see Fig 2.2F
and Appendix D). This enabled us to switch to a redesigned reporter with improved
specificity for further studies (Chapter 3, Appendix D). Nonetheless, single-cell
reporters, when carefully integrated with other data types, are an invaluable tool and an
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exciting area for future development. Perhaps the most interesting area for exploration is
the combination of multiple reporters within the same cell. As shown in chapter 3,
multiple reporters can allow both an upstream and a downstream signal in the same
pathway can be simultaneously assayed. This arrangement makes it possible to observe
the input-output behavior of a portion of the pathway and, if a threshold exists, allows the
quantification of the position of the threshold in individual cells. The cell-to-cell
variability in input-output behavior and threshold position can then be assessed,
providing insight into the molecular mechanisms of population heterogeneity. Another
arrangement, which has not yet been explored in detail, is the use of reporters in parallel
pathways; this arrangement would allow measurements of pathway correlation and cross-
talk in single cells. This method could be very useful in developing integrated models of
multiple pathways. For example, the pro-survival (NF-KB) and pro-apoptotic (caspase)
pathways triggered by TNF could be simultaneously assayed by existing reporters; this
would provide valuable quantitative information for the integrated TNF model discussed
above (section 5.2).
5.6 Position of the threshold in the death receptor pathway
The ability of the mitochondrial pathway to act as an adjustable threshold and the
point of no return in apoptosis has long been hypothesized. However, these hypotheses
were based solely on observations of the behavior of cytochrome c/Smac release and the
downstream events. A formally possible alternative to these hypotheses was that the final
commitment to apoptosis was made by signals upstream of the mitochondria, and that
cytochrome c/Smac release simply transmitted and amplified this binary decision. We
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provide the first single-cell data confirming that the mitochondrial pathway is indeed the
location of the threshold (Fig 3.3 B). Caspase-8 signaling upstream of the mitochondria
appears to vary continuously with the amount of death ligand stimulation; the higher the
concentration of ligand, the faster the cleavage of caspase-8 substrates. The
mitochondrial pathway appears to play the role of an analog-to-digital converter,
providing a uniformly rapid output (cytochrome c/Smac release) for all values of input
(rate of caspase-8 activity). Moreover, the mitochondrial pathway effectively translates
stimulus strength into the delay time of cell death, since the time at which
permeabilization occurs depends on the rate of caspase-8 activity (Fig 3.4). Thus, the
mitochondrial pathway appears to have the characteristics of a very sharp threshold. As
noted in Chapter 1, such a threshold is not likely to result from a simple first order
protein-protein interaction. Therefore, although the ability of Bcl-2 to bind and inhibit
Bax prompted the original threshold model and is a necessary component of the
threshold, the full mechanism is necessarily more complex. Our model will serve as a
useful tool for understanding this mechanism, since it recapitulates the experimentally
observed behavior. Preliminary analysis suggests that the threshold results from a
combination of the rate at which Bax translocates to the mitochondrial compartment, the
concentrating effect of the smaller mitochondrial volume (relative to the cytosol), the
required oligomerization of Bax, and the high Vmax of pore mediated cytochrome c/Smac
release. A more formal mathematical analysis is underway, which will enable a clear
definition of the feature of this pathway required for effective threshold behavior.
One significant advantage of the single-cell methods developed is that they enable
sensitive discrimination of where pro-survival effects affect pro-apoptotic signaling -
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upstream of, downstream of, or directly at the mitochondrial pathway. Since many
survival factors, such as Akt, have been shown to intervene at multiple points in the
apoptotic pathway (Datta et al. 1997; Cardone et al. 1998; Brunet et al. 1999), these
methods will make it possible to identify which of the anti-apoptotic functions is most
important in a given context. Thus, these methods will be important in the effort to
understand how information from pro-survival signals is translated into changes in the
signaling kinetics of the central death pathways.
5.7 Quantitative integration of information from multiple pro-survival pathways
In the work described in Chapter 4, we took a data-driven modeling approach to
examine the integration of multiple pro- and anti- apoptotic signals in response to
simultaneous stimulation by multiple ligands. While in Chapters 2 and 3 our approach
was to use mechanistic modeling to understand the behavior of a more limited
biochemical pathway, the sheer number of pathways and unknowns in the network under
study in Chapter 4 make the mechanistic approach currently intractable. Therefore, this
question required a modeling technique appropriate to the scale of the problem, and much
information was gained from the principal component-based model that we developed.
From the information encoded in a system-wide signaling data set, which was sufficient
to predict the measured apoptotic signatures, we were able to identify the temporal
molecular signals that were most important in determining the apoptotic response. While
the model was correlative and not mechanistic, we were able to confirm a number of
mechanistic hypotheses that were suggested by examining the key components of the
model. Thus, in a situation where numerous pathways were active, many of which have
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been shown to regulate apoptosis, this data-driven approach made it possible to quickly
identify the subset of signals that were the most quantitatively important in controlling
the cellular response. It is interesting to ask whether this model is specific to this
particular cell context. In other words, would the same model successfully predict the
apoptotic response, given the appropriate signaling data, in other cell types with other
stimulation conditions? If the same principal-component model were broadly applicable,
it would suggest that many different cell types have a similar processing mechanism for
intracellular signals. The alternative hypothesis is that signal processing is highly
context-dependent, meaning that the same Akt time course in two different cell types
would influence the cellular response differently. These hypotheses are currently under
investigation (K.A. Janes and K.E. Miller, unpublished data).
Another interesting direction will be to further link the highly significant signals
in the principal component model to our mechanistic model. To harness the power of the
data set already collected, further experiments could be performed in the HT-29 system,
using the highly informative single-cell techniques developed in chapter 3. Then, a
principal component model could be developed to connect the signaling data to specific
molecular steps in the apoptotic pathway. It might be possible, for example, to connect
the early peak in Akt signaling to a change in the mitochondrial threshold and the later
peak to decreased signaling downstream of the mitochondria. Thus, by combining the
mechanistic and data-driven approaches, it could be possible to develop a view of
apoptotic signal integration that is both broad in signal diversity and deep in molecular
mechanism.
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Yet another interesting question is whether similar signaling processing occurs at
the single cell level as occurs at the population level. To test this, multiple single-cell
reporters corresponding to the highly significant signals in the model could be
simultaneously monitored (for example, NF-rB GFP and FKHR-RFP). It would then be
possible to determine whether the time points and signal strengths that were predictive in
the population model were similarly predictive of the fate of each individual cell.
Although it might seem that this should be the case, the presence of complex autocrine
feedback loops would make it possible for population-level signal processing to differ
significantly from the mechanism by which each individual cell chooses its fate.
5.8 Summary
Overall, my work presented here has contributed to the field of apoptosis by
revealing the dynamic mechanisms by which the rate, completeness, and timing of
caspase activation are controlled by the central apoptotic pathway and by survival signals
that interface with the central pathway. This work has also contributed to the field of
systems biology through the development of new mathematical models that are closely
tied to experimental data. There are a number of interesting directions in which the
integrated experimental and computational work begun here may continue.
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Appendix A
Reprinted from:
Gaudet, S., Janes, K. A., Albeck, J. G., Pace, E. A.,
Lauffenburger, D. A., and Sorger, P. K. (2005).
A compendium of signals and responses triggered by
prodeath and prosurvival cytokines.
Mol Cell Proteomics 4, 1569-1590.
©2005 by the American Society for Biochemistry and Molecular Biology
Used with permission.
In this study, I performed the cell death measurements shown in Figures 4B and 6B,
which became an essential part of the compendium analysis. All other experiments and
modeling were performed by Suzanne Gaudet, Kevin Janes, and Emily Pace.
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A Compendium of Signals and
Responses Triggered by Prodeath and
Prosurvival Cytokines*
Suzanne Gaudett, Kevin A. Janes§, John G. AlbeckI, Emily A. Pacefl,
Douglas A. Lauffenburgert§, and Peter K. Sorgert§|
Cell-signaling networks consist of proteins with a variety
of functions (receptors, adaptor proteins, GTPases, ki-
nases, proteases, and transcription factors) working to-
gether to control cell fate. Although much is known about
the identities and biochemical activities of these signaling
proteins, the ways in which they are combined into net-
works to process and transduce signals are poorly under-
stood. Network-level understanding of signaling requires
data on a wide variety of biochemical processes such as
posttranslational modification, assembly of macromolec-
ular complexes, enzymatic activity, and localization. No
single method can gather such heterogeneous data in
high throughput, and most studies of signal transduction
therefore rely on series of small, discrete experiments.
Inspired by the power of systematic datasets in genomics,
we set out to build a systematic signaling dataset that
would enable the construction of predictive models of
cell-signaling networks. Here we describe the compilation
and fusion of -10,000 signal and response measurements
acquired from HT-29 cells treated with tumor necrosis
factor-a, a proapoptotic cytokine, in combination with
epidermal growth factor or insulin, two prosurvival growth
factors. Nineteen protein signals were measured over a
24-h period using kinase activity assays, quantitative im-
munoblotting, and antibody microarrays. Four different
measurements of apoptotic response were also collected
by flow cytometry for each time course. Partial least
squares regression models that relate signaling data to
apoptotic response data reveal which aspects of compen-
dium construction and analysis were important for the
reproducibility, internal consistency, and accuracy of the
fused set of signaling measurements. We conclude that it
is possible to build self-consistent compendia of cell-
signaling data that can be mined computationally to yield
important insights into the control of mammalian cell re-
sponses. Molecular & Cellular Proteomics 4:1569-1590,
2005.
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The development of numerical models of complex biologi-
cal processes such as signal transduction depends on the
availability of accurate, self-consistent, and quantitative ex-
perimental data. Large scale collection and systematization of
such data is likely to have as great an impact on cell biology
as complete genome sequencing has had on genetics (1, 2).
A few high throughput signaling datasets describing lympho-
kine-induced protein networks (3) and phosphotyrosine net-
works (4) have recently become available, and the Alliance for
Cellular Signaling continues its efforts to collect data on large
numbers of signaling proteins (5). However, the assembly of
cell-signaling datasets is in its infancy and faces challenges
not encountered in genomics. First, unlike gene sequences,
signaling data are necessarily heterogeneous (6). Activation of
intracellular signal transduction networks involves biochemi-
cal processes as distinct as receptor-ligand binding, protein
modification, assembly of multicomponent complexes, trans-
location among cellular compartments, and protein synthesis
and destruction (hereafter referred to as "signals"). Whereas
the sequence of an entire genome can be determined using a
single mature technology and genome-wide transcriptional
profiling can be accomplished with microarray methods
alone, monitoring cell signaling requires a wide variety of
experimental techniques including enzymatic assays (7), im-
munoblotting (8), flow cytometry (3), immunofluorescence (9),
and mass spectrometry (10). Only a subset of these ap-
proaches are currently used in large scale data collection
(phosphoprotein mass spectrometry for example) in part be-
cause techniques that are mainstays of standard cell biology,
such as immunoblotting and immunofluorescence, are not
well adapted to high throughput analysis.
A second complication in systematizing cell-signaling
measurements is the lack of inherent structure in the data.
Structured data, such as DNA sequence, can be referenced to
a single data model and systematized via relational data-
bases. Manipulating unstructured data, such as microscopy
and immunoblot images, is a significant informatic challenge
to which current databases are not well suited (11). Third,
unlike gene sequences, the meaning of data on kinase acti-
vation, receptor-ligand interaction, signalosome assembly,
and phospholipid modification depends heavily on context (6,
11). Critical aspects of biological context include cell type,
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nature and concentration of a cytokine stimulus, and cell
cycle or growth phase. Experimental methods also contribute
to context because quantitative measurements vary with re-
agent source and protocol. Finally signaling data are neces-
sarily incomplete: whereas a genomic sequence has a well
defined start and finish, the characterization of a complex
signaling network is an open-ended process.
This study examined signaling networks that control the
apoptosis-survival decision in HT-29 human colon adenocar-
cinoma cells treated with combinations of the prodeath cyto-
kine tumor necrosis factor-a (TNF)1 and the prosurvival
growth factors epidermal growth factor (EGF) and insulin. TNF
activates intracellular signals by binding to trimeric death
receptors and promoting assembly of intracellular death-in-
ducing signaling complexes (12, 13). Death-inducing signaling
complexes then activate several parallel signaling pathways,
including apoptotic caspases (14), stress-activated c-jun N-
terminal kinase 1 (JNK1) and p38 pathways (15), and the
proinflammatory IKB kinase (IKK)-nuclear factor-KB pathway
(16).
Activation of the EGF receptor (EGFR) tyrosine kinase oc-
curs through receptor dimerization, conformational change,
and autophosphorylation (17, 18). Phosphorylated receptors
recruit adaptor proteins, and these then activate multiple sig-
naling proteins including extracellular signal-regulated kinase
(ERK) via Ras and the Akt kinase via phosphatidylinositol
3-kinase (19). The binding of insulin to the insulin receptor also
activates ERK and Akt, but in contrast to EGFR, the insulin
receptor is constitutively dimerized, and most insulin-induced
signaling involves modification of insulin receptor substrate 1
(IRS1), a multidomain adaptor protein (20). Antagonism be-
tween TNF and EGF or TNF and insulin is well documented
and relevant to many diseases, including cancer, inflamma-
tory bowel disease, and diabetes.2 However, there exists only
limited molecular level understanding of the strategies cells
use to process conflicting cytokine stimuli and regulate re-
sponses such as apoptosis. The limitation arises in part be-
cause current practice in signal transduction research, as in
other areas of cell biology, is to interpret data only with
1 The abbreviations used are: TNF, tumor necrosis factor a; CSR,
cytokine-signal-response; EGF, epidermal growth factor; EGFR, epi-
dermal growth factor receptor; ERK, extracellular signal-regulated
kinase; FKHR, Forkhead transcription factor; pFKHR, phospho-
FKHR; FOXO3, Forkhead box 03a; IKK, IKB kinase; IL-1 a, interleukin-
la; IL-1R, IL-1 receptor; IL-lra, IL-1 receptor antagonist; IR, insulin
receptor; IRS1, insulin receptor substrate 1; plRS1, phospho-IRS1;
JNK, c-jun N-terminal kinase; MEK, mitogen-activated protein kinase
and extracellular signal-regulated kinase kinase; MK2, mitogen-acti-
vated protein kinase-activated protein kinase 2; PLSR, partial least
squares regression; ptAkt, phospho-to-total Akt; ptEGFR, phospho-
to-total EGFR; SGK, serum- and glucocorticoid-inducible kinase;
TGF-a, transforming growth factor a; VIP, variable importance in the
projection.
2 K. A. Janes, S. Gaudet, J. G. Albeck, U. B. Nielsen, D. A. Lauffen-
burger, and P. K. Sorger, submitted for publication.
respect to contemporaneous controls. Categorical conclu-
sions are drawn from direct comparison of experimental and
control samples (e.g. ERK is more, less, or equally active
between samples), and the next experiment is designed. In
studies of complex networks, however, many variables must
be measured, and the piecemeal accumulation and analysis
of data become both cumbersome and limiting.
In this study we asked whether a validated and self-consis-
tent dataset could be constructed from diverse biochemical
measurements of cell-signaling proteins in human cells ex-
posed to TNF, EGF, and insulin. Using techniques available in
the average research laboratory, we normalized and fused
into a single dataset -10,000 data points collected over an
18-month period. We have not yet tackled the informatic
challenge of building a database to hold the information,
relying instead on a series of customized spreadsheets. We
therefore refer to the assembled dataset as a compendium.
The heterogeneity, lack of intrinsic structure, context depend-
ence, and open-ended nature of the signaling data make the
construction of this cytokine-signal-response (CSR) compen-
dium nontrivial (22). However, we show that the compendium
makes it possible to compare, with high reliability, data that
were not collected contemporaneously. We also show that
data can be mined for insights that would not be obvious from
more conventional approaches. Finally because the value of a
data compendium can only be unlocked computationally, we
analyzed the full dataset by using a predictive statistical
model based on partial least squares regression (PLSR).3 We
will describe elsewhere the use of modeling to elucidate the
mechanisms by which cells process conflicting cytokine stim-
uli3 ; here we apply modeling to the more general problem of
assessing the quality and information content of a CSR com-
pendium. In contrast to many other proteomic efforts, we
incorporated modeling early in the data collection process by
linking protein signaling to relevant phenotypic responses.
The inclusion of responses is necessary to constrain statisti-
cal models sufficiently to provide useful quantitative assess-
ment of compendium design. Our key findings are that het-
erogeneous, time-resolved information is indeed critical for
predictive power as is sampling broadly across the network.
Nonetheless it appears sufficient to monitor a subset of net-
work reactions, significantly reducing the data collection bur-
den on future proteomic compendia.
EXPERIMENTAL PROCEDURES
Cell Culture and Treatments--HT-29 human colon adenocarci-
noma cells (ATCC) were maintained in McCoy's 5A supplemented
with 10% fetal bovine serum, 2 mM glutamine, 10 units/ml penicillin,
and 10 units/ml streptomycin (Invitrogen). Cells were used within
passage 10 after thaw for all experiments and passaged 2 days prior
to plating. For each experiment, HT-29 cells were plated at 50,000
cells/cm2 .After 24 h, the cells were sensitized by changing to medium
3 K. A. Janes, J. G. Albeck, S. Gaudet, P. K. Sorger, D. A.
Lauffenburger, and M. B. Yaffe, submitted for publication.
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supplemented with 200 units/ml interferon-y at a ratio of -0.13 ml of
medium/cm2. The cultures were stimulated 24 h later by adding the
stimulus diluted in 1/2o of the culture volume of serum-free medium for
final concentrations of 0, 0.2, 5, or 100 ng/ml TNF (Peprotech); 0, 1, or
100 ng/ml EGF (Peprotech); and 0, 1, 5, or 500 ng/ml insulin (Sigma).
The C225 anti-EGFR monoclonal antibody (H. S. Wiley laboratory)
and IL-1ra (Amgen) inhibitors were used at 10 Lg/ml. Triplicate plates
were lysed at 0, 5, 15, 30, 60, and 90 min and 2, 4, 8, 12, 16, 20, and
24 h or prepared for flow cytometry at 12, 24, and 48 h.
Cell Lysis-Cell lysis had to be compatible with multiple assays and
combine dead (floating) and viable cells. Floating cells were pelleted
from culture supernatant and rinsed with ice-cold PBS. Adherent cells
were lysed in ice-cold lysis buffer (as described in Ref. 7) and com-
bined with the dead cells pelleted from the culture medium. An aliquot
of the whole-cell homogenate was immediately frozen for use in
immunoblot analysis. The lysates were clarified by centrifugation
(10 min at 15,000 rpm) and aliquoted for antibody array and kinase
assay. Total protein concentration was determined using the bicin-
choninic acid assay (Pierce) for both the clarified lysates and the
whole-cell homogenates (following addition of SDS-based lysis
buffer to final concentrations of 112.5 mM Tris-CI, pH 7.5, 4% SDS,
10 mM P-glycerophosphate, 10 mM NaF, 10 mM sodium pyrophos-
phate, 1 mM Na3VO4, 1 tg/ml leupeptin, 1 g.g/ml pepstatin, and 1 Ag/ml
chymostatin).
Kinase Assays - Kinase assays were performed as described pre-
viously (7). All signaling measurements were normalized to total
protein concentration in each lysate. For kinase assays, we also
corrected for variations in ATP specific activity; all measurements
are expressed in relative units of kinase activity. Relative units were
calculated by comparing the day-specific ratio of t = 0 min (un-
treated) kinase activity/background activity to a compendium-wide
average. The data were normalized so that one relative unit corre-
sponded to the compendium-averaged t = 0 min activity for the
kinase.
Antibody Microarray--Antibody microarrays were processed as
described previously (24). For EGFR, the same antibodies were used
(24), for Akt array measurements anti-Akt (Upstate Biotechnologies)
was used as a capture antibody, and anti-phospho-Akt and anti-pan-
specific Akt (catalog numbers 4051 and 9272, Cell Signaling Tech-
nologies) were used as detection antibodies. We obtained three
measurements for EGFR and Akt, phosphoprotein levels, total protein
level, and phosphorylated to total protein ratio, from triplicate spots
for each lysate. The ratiometric measurement was used to account for
spot-to-spot variation in printing. All three measures were normalized
to total protein concentration and to the t = 0 min average for each
time course and are therefore expressed as -fold activation over the
base-line signals.
Immunoblots- For immunoblots, 75 tkg of total cell homogenates
were separated by SDS-PAGE and transferred to nitrocellulose. Ref-
erence samples of HT-29 cells treated with 200 units/ml interferon--y
for 24 h and then 500 ng/ml insulin for 30 min or 100 ng/ml TNF for
40 h were run on each gel for normalization purposes. Membranes
were cut at specific molecular weights to allow probing with several
antibodies for each gel. Immunoprobing was performed as described
previously (25). Primary antibodies used were anti-phospho-Akt-
Ser473 (catalog number 9271), anti-caspase-8 1C12 (catalog number
9746), anti-phospho-FKHR-Ser 256 (catalog number 9461), anti-phos-
pho-IRS-Ser63 6 (catalog number 2388), and anti-phospho-MEK1/2-
Ser217/221 (catalog number 9121) from Cell Signaling Technologies;
anti-phospho-IRS1-Tyr896 (catalog number GF1003) from Calbio-
chem; and anti-caspase-3 (1:250, catalog number SC-7272) from
Santa Cruz Biotechnologies. The fluorescence was assessed using a
Fluorlmager 495 scanner (Amersham Biosciences) and quantitated
using ImageQuant (Amersham Biosciences). Signal intensities were
normalized to intensities in the reference samples to correct for dif-
ferences in transfer and probing efficiencies. Signals where the t = 0
min average was consistently above background level were normal-
ized to this basal level for each time course and expressed in -fold
activation units.
Flow Cytometry-Cells were grown in 24-well plates and treated
with the indicated cytokines as described above. For each experi-
ment, triplicate reference samples (untreated, treated with 100 ng/ml
TNF, and treated with 100 ng/ml TNF + the prosurvival factor used in
that experiment) were collected for normalization purposes and to
verify the bioactivity of the cytokines. The supernatant and rinse were
saved and combined with the trypsinized cells to assay both floating
and adherent cells. Live cells were stained with Alexa 488-labeled
annexin V and 1 j.g/ml propidium iodide (Molecular Probes). Fixed
cells (4% formaldehyde for 10 min followed by 100% methanol) were
stained with 50 gg/ml propidium iodide (for sub-G, DNA content) or
with M30 monoclonal antibody against cleaved cytokeratin (Roche
Applied Science) and anti-cleaved caspase-3 (Cell Signaling Tech-
nologies, BD Biosciences) followed by Alexa 488-conjugated donkey
anti-mouse IgG and Alexa 647-conjugated donkey anti-rabbit IgG
(Molecular Probes). Samples were analyzed on a BD Biosciences
FACSCalibur or FACScan. Apoptosis measurements were normalized
to average values found in contemporaneously treated and pro-
cessed reference samples to account for variations in staining effi-
ciency: 100 ng/ml TNF-treated reference samples were used for
propidium iodide permeability and cleaved caspase-3 and cytokeratin
staining assays, and untreated reference samples were used for
annexin V binding and sub-G, DNA content assays.
Partial Least Squares Model-The descriptors of signaling dynam-
ics and partial least squares models were generated using MATLAB®
and SIMCA-P, respectively, as described elsewhere. 3 The fitness of
values predicted by the model to the measured values for cell death
was evaluated according to the equation,
R2= 1 -
,(Predictedi - Measured;) 2
E(Predicted) 2
_11
(Eq. 1)
Predicted) 2
i=n
n
where n is the number of response measurements. The non-paramet-
ric 90% confidence intervals on the fitness to measured values were
evaluated, based on the Fisher inversion, on the average R2 value for
seven models from cross-validation,
(e2 y - 1) 1 (1 + R2) ] +1.645
(e2 + 1) where y 2(1 - R2 J - 3(e Y + )  ý1_ _R 0- (Eq. 2)
The variable importance in the projection (VIP) was calculated using
A
kwakSSa
a=1VIPk= j A a
E Ss,
a 1
where k is the number of variables, wk is the weight of the kth
variable for principal component a, A is the total number of principal
components, and SS, is the sum of squares explained by principal
component a.
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To mimic measurement error, random noise was added to the
signaling measurements in the 5 ng/ml TNF + 1 ng/ml EGF treatment
from a normal distribution centered at zero with a standard deviation
of 0.1, 0.2, 0.3, 0.4, or 0.5 times the range of values for the time
course in that signal. Time course descriptors were then extracted as
described elsewhere.3
RESULTS
Data Generation
To explore systematically the relationships between cyto-
kine-receptor interaction, activation of intracellular signaling
cascades, and apoptosis-survival cell fate decisions, HT-29
human colon adenocarcinoma cells were exposed to a set of
10 cytokine treatments and monitored over a 48-h period.
Each treatment consisted of a combination of TNF and either
EGF or insulin (Fig. 1A). HT-29 cells respond to TNF, EGF, and
insulin in a dose-dependent manner (26, 27),2 and all three
cytokines were therefore examined at subsaturating concen-
trations designed to mimic physiological conditions and at
saturating concentrations at which essentially all receptors
were ligand-bound. At 13 time points after cytokine addition,
three replicate dishes of cells (six for the zero time point) were
harvested to measure kinase activities, changes in protein
phosphorylation, caspase cleavage, and changes in protein
abundance. Altogether, 19 protein distinct signals were ex-
amined (Fig. 1C and Table I). Five kinases, ERK (28), Akt (29),
JNK1 (28), IKK (16), and mitogen-activated protein kinase-
activated protein kinase 2 (MK2) (30), were assayed in vitro
using microtiter-based immunocomplex kinase activity as-
says (7). Five phosphorylation sites on four proteins and
cleavage of caspase-3 and -8 were measured by quantitative
immunoblotting. Phospho-, total, and phospho-to-total (pt)
measures of EGFR and Akt were obtained by using antibody
arrays (24). Because kinases such as Akt and ERK were
maximally active 5-15 min after cytokine addition (Fig. 1, D
and E), whereas caspase cleavage was evident only after 4 h
(Fig. 1F), time points were spaced closely from 0-2 h (0, 5, 15,
30, 60, 90, and 120 min) and then more sparsely from 4-24 h
(4, 8, 12, 16, 20, and 24 h) where t = 0 min is the time of
cytokine addition. Nonuniform sampling made it possible to
measure both early and late signals effectively (Fig. 1B).
To characterize the responses of cells to cytokine combi-
nations, four measures of apoptosis were performed on trip-
licate plates 12, 24, and 48 h after stimulation (Fig. 1B). These
four measures represent distinct stages or aspects of pro-
grammed cell death (Fig. 1C). Both adherent (viable) and
floating (dying) cells were examined in all cases. In TNF-
treated cells, procaspase-8, an initiator caspase, is activated
by cleavage and then cleaves and activates the executioner
caspase, caspase-3, leading to the degradation of a wide
variety of essential proteins. The cleavage of procaspase-3
and -8 measured by immunoblots constituted signals in our
dataset, whereas downstream events, measured by flow cy-
tometry, were considered to be responses. The cleavage of
caspase-3 and of its target, cytokeratin, was measured using
cleavage-specific antibodies (Table I, response R1). DNA di-
gestion by endonucleases and subsequent nuclear fragmen-
tation were quantified by propidium iodide staining to detect
cells with sub-G, DNA content (R2). Loss of plasma mem-
brane asymmetry was assayed by the binding of annexin V to
exposed phosphatidylserine, a phospholipid normally re-
stricted to the inner membrane leaflet (R3). Finally, the com-
plete loss of plasma membrane integrity was assayed using a
vital stain (R4). Most of the apoptotic response measures are
end points that increase steadily over time. However, phos-
phatidylserine exposure (R3) represents a transient state fairly
early in apoptosis in which membrane structure is partially but
not yet completely disrupted. The final product of the signal
and response measurements was a set of 10 time courses,
each describing the activities of 19 protein signals measured at
13 time points and four response measures at three time points,
all in triplicate biological samples. The total number of meas-
urements in this initial dataset was 8,340, collected over a
period of 18 months by four scientists working in collaboration.
FIG. 1. Design of a self-consistent compendium of TNF-, EGF-, and insulin-induced signals and responses in HT-29 cells. A,
three-dimensional representation of the 10 treatments used to generate the data compendium. TNF (7), EGF (E), and insulin (/) were used alone
or in combination. B, data collection in single treatment planes. Each plane represents one contemporaneous set of measurements for 19
signals and four death markers on cells treated with a single cytokine combination. Signals were measured at 0, 5, 15, 30, 60, and 90 min and
2, 4, 8, 12, 16, 20, and 24 h. Cell death markers were assayed at 12, 24, and 48 h. C, schematic representation of the signaling network induced
by TNF, EGF, and insulin. Arrows indicate the type of interaction: activation (green), inhibition (red), slow process (blue), or pathway cross-talk
(dashed). The measured proteins are highlighted in yellow; red circles, triangles, and rectangles indicate kinase assay, antibody array, and
immunoblot measurements, respectively. D-F, protein signals exhibit dramatically different dynamics of activation. Shown are time courses of
ERK activity (D), immunoblot-measured phospho-Akt levels (E), and cleaved caspase-8 levels (F) in cells co-treated with 100 ng/ml TNF and
500 ng/ml insulin. Values are means of biological triplicate samples, and error bars show the S.E. IB, immunoblot; KA, kinase assay; PS,
phosphatidylserine; NFkB, nuclear factor KB; CytoC, cytochrome c; FADD, Fas-associated death domain; TRADD, tumor necrosis factor
receptor-associated death domain protein; MAP3K, mitogen-activated protein kinase kinase kinase; XIAP, X-linked inhibitor of apoptosis
protein; clAP, cellular inhibitor of apoptosis protein; HSP, heat shock protein; RIP, receptor-interacting protein; P13K, phosphatidylinositol
3-kinase; P'ase, phosphatase; GAP, GTPase-activating protein; FLIP, FADD-like interleukin-1 -converting enzyme (FLICE)-inhibitory protein;
MEKK1, MEK kinase 1; mTOR, mammalian target of rapamycin; Grb2, growth factor receptor-bound 2; JNKK, JNK kinase; Ins, insulin; Ptdlns,
phosphatidylinositol; pAkt, phospho-Akt; Casp., caspase; TNFR1, tumor necrosis factor receptor 1; PDK1, 3-phosphoinositide-dependent
protein kinase 1; S6K, S6 kinase; AP-1, activator protein-i; PTEN, phosphatase and tensin homolog; TRAF2, tumor necrosis factor
receptor-associated factor 2; TSC, tuberous sclerosis complex; AFX, ALL1 fused gene from chromosome X.
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TABLE I
Measured protein signals and apoptosis markers
MAPK, mitogen-activated protein kinase; pAkt, phospho-Akt; tAkt, total Akt; ProC3, procaspase-3; ProC8, procaspase-8; CIvC8, cleaved
caspase-8; AA, antibody array; IB, immunoblot; pEGFR, phospho-EGFR; tEGFR, total EGFR; pMEK, phospho-MEK; PI, propidium iodide; Ab,
antibody; PKB, protein kinase B.
No. Assay Protein Name Function Marker Abbreviation
1 Kinase assay Akt Akt/PKB Ser-Thr kinase Activity Aktf
2 ERK Extracellular signal-regulated kinase Ser-Thr kinase Activity ERK
3 IKK Inhibitor of nuclear factor-KB kinase Ser kinase Activity IKK
4 JNK1 c-Jun N-terminal kinase 1 Ser-Thr kinase Activity JNK1
5 MK2 MAPK-associated protein kinase 2 Ser-Thr kinase Activity MK2
6 Immunoblot Akt Akt/PKB Ser-Thr kinase Phospho-Ser47 3  pAkt (IB)a
7 Casp.3 Caspase-3 Cysteine protease Zymogen level ProC3
8 Casp.8 Caspase-8 Cysteine protease Zymogen level ProC8
9 Cleaved level CIvC8
10 FKHR Forkhead Transcription factor Phospho-Ser 256  pFKHR
11 IRS1 Insulin receptor substrate 1 Adaptor-scaffold Phospho-Ser 636  plRS1-Ser636
12 Phospho-Tyr896  plRS1 -Tyr896
13 MEK1/2 MAPK and ERK kinase Dual specificity kinase Phospho-Ser217/221 pMEK
14 Ab array Akt Akt/PKB Ser-Thr kinase Phospho-Ser473  pAkt (AA)
15 Total level tAkt
16 Phospho/total ratio ptAkta
17 EGFR Epidermal growth factor receptor Receptor Tyr kinase Phospho-Tyr1068  pEGFR
18 Total level tEGFR
19 Phospho/total ratio ptEGFR
R1 Flow cytometry Cleaved caspase-3 and cytokeratin Cell rounding Cleaved levels CC3/CCK
R2 Sub-G, DNA content Nuclear fragmentation Low PI staining Sub-G,
R3 Phosphatidylserine exposure Recognition by macrophages Annexin V binding PS exposure
R4 Membrane permeabilization Secondary necrosis P1 permeability Memb. perm.
a Signals used to validate measurements across assays.
Creation of a Cytokine-Signal-Response measurements were compared with contemporaneous posi-
Data Compendium by Data Normalization, tive and negative control cell populations to yield a normalized
Fusion, and Validation cell death fraction. We found that careful normalization was
Our overall aim was to merge time course data collected at essential for data fusion: by minimizing the contributions of
different times into a single self-consistent compendium. This experimental variability on signal measurements, it was pos-
involved a variety of experimental and data analysis tech- sible to reduce the median coefficient of variation among
niques, some of which were obvious, whereas others were biological replicates to -11%.
more subtle. One obvious step was to limit day-to-day and As one means to judge how reliably data from different
sample-to-sample variation by standardizing assay protocols, assays had been fused in the CSR compendium, we exam-
limiting cells to a narrow range of passage number, and ined correlations among three measures of Akt protein kinase
ensuring uniformity in cell culture and treatment conditions activation. Immunoblots and antibody microarrays were used
through the use of lot-controlled sera, cytokines, and antibod- to monitor the levels of phospho-Ser47 3 , a modification that is
ies (supplemental material, Table Sl). Raw data were cor- associated with Akt activation (31, 32) (Table I and Fig. 2A). An
rected for other sources of variation by signal-specific nor- in vitro immunocomplex kinase assay was used to monitor
malization. As described in greater detail under "Experimental Akt-catalyzed phosphorylation of a sequence-optimized pep-
Procedures," normalization included the following: 1) correct- tide substrate (Table I and Fig. 2A). After normalization, we
ing each signaling measurement for the total amount of cel- found that all three measures of Akt were correlated across
lular protein in the sample, 2) adjusting kinase activity meas- the full panel of cytokine combinations with pairwise Pearson
urements for changes in the specific activity of [y-32P]ATP, coefficients of 0.80-0.87 (Fig. 2, B-D). Although experimental
and 3) comparing immunoblot signals to contemporaneous error may be partly responsible for the discrepancies among
positive controls to correct for variations in transfer efficiency these measures, the biochemistry of Akt was also an impor-
and antibody binding. Signals with t = 0 min normalized tant factor. Akt activation is known to involve two phospho-
averages that were consistently above background were di- rylation events: Ser473 modification by rictor-mTOR (mamma-
vided by the t - 0 min average for that treatment to yield a lian target of rapamycin) (33) and modification of Thr308 by
measure of "-fold activation." Other signals were expressed in 3-phosphoinositide-dependent protein kinase 1 (34). Al-
activity units referenced to a base line of zero. Apoptosis though fully activated only when doubly phosphorylated, Akt
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FIG. 2. Heterogeneous Akt measurements are quantitatively comparable in the fused compendium. A, schematic showing three
measures of Akt activation: kinase activity assays (KA), phospho-Ser47 3 levels by immunoblot (IB), and ratio of phospho-Ser473 to total levels
by antibody array (AA). B-D, scatter plots of pairwise comparisons of heterogeneous Akt activation measurements: immunoblot phospho-
Akt-Ser473 assay compared with kinase activity (B), ptAkt ratio from antibody arrays compared with kinase activity (C), and immunoblot
phospho-Akt-Ser 473 assay compared with ptAkt ratio from antibody array (D). Pearson correlation coefficients are indicated above each plot
(R). The ptAkt measurements by antibody microarray are the most distant because they are an aggregate measure of phospho-to-total levels
of Akt. Values in B-D are means + S.E. of biological triplicate samples normalized to the maximal value in the compendium for that signal. a.u.,
arbitrary units.
is at least partially active with only one modification (35, 36).
We might therefore expect to see situations in which Akt
activity was relatively high but Ser473 phosphorylation was
low; this is exactly what was observed in cells treated with
saturating TNF + insulin at t = 2-12 h (Fig. 4A). Other dis-
crepancies in measures of Akt activation could similarly be
explained by current understanding of its regulation. In sum-
mary, the strong correlation among three different measures
of Akt kinase activity argues that data from different biochem-
ical assays can be fused into one compendium. It is important
to note, however, that correlations among different measures
of protein function are critically dependent on understanding
the mechanisms of signal activation and inhibition.
Signals and responses were acquired as time course ex-
periments, one cytokine combination at a time over a period
of 18 months. To enable direct comparison of data collected
non-contemporaneously, it was essential that the CSR com-
pendium be self-consistent. Reproducibility over time is the
most obvious criterion for self-consistency. To address the
issue of reproducibility, we generated a validation dataset by
using an experimental scheme orthogonal to that of the pri-
mary dataset. The validation data consisted of the 19 protein
signals measured in triplicate at a single time point (t = 15
min) following exposure to eight different cytokine treatments;
this corresponds to a single-time slice through the CSR data
space (Fig. 3A). Apoptotic responses were also assayed at 12,
24, and 48 h in this experiment. We observed good correla-
tions between values in the validation dataset and the initial
CSR compendium: most signals and responses had correla-
tion coefficients of 0.9 or higher. However, a subset of signals
were poorly correlated. We noticed that these signals did not
vary substantially from one treatment to the next, and thus the
Pearson correlation coefficient was dominated by experimen-
tal noise. To distinguish high and low variance signals, we
calculated their "dynamic range" by taking the variation in a
signal (measured across treatments) and dividing by the
measurement noise (from triplicate biological samples; see
Fig. 3 legend for details). A signal such as phospho-Ser47 3 Akt
(measured by immunoblotting) had a high dynamic range (7.5)
at t = 15 min and was characterized by a high correlation
between the single treatment and single time experiments
(R = 0.98; Fig. 3B). IKK varied little among treatments (dy-
namic range, 1.5), and the correlation between compendium
and validation data was low, although the absence of observ-
able differences between the two datasets emphasizes that
the issue was primarily one of noise and not inconsistency
(Fig. 3C). Overall the great majority of signals and responses
had a dynamic range above 2.5 and were well correlated
between the compendium and the validating single time data-
set (median Pearson coefficient of 0.95 for responses and
0.91 for signals; Fig. 3D). Monte Carlo simulations indicated
that a Pearson coefficient of 0.9 corresponds to a -14%
coefficient of variation between measurements. This is only
slightly larger than the 11% median coefficient of variation
observed among biological replicates assayed at the same
time, suggesting that day-to-day variation in compendium
data was similar in magnitude to biological variation and
measurement noise. We conclude that our experimental
methods and data fusion techniques had therefore generated
a self-consistent compendium in which data collected at dif-
ferent times could be compared with confidence.
226
" "
Al~4
R = 0.81
,u,,)
I-+-r
!1
rmt U.,-ny " =.u.i
S-·~·~
Compendium of Signals and Responses to TNF, EGF, and Insulin
.I ,Val4 ARe
.---/C
Signals 4 # # -*-
Responses
TiMe course
idation experiment at t = 15 min
plicated cell death measurements
I Treatments
48h
pAkt-S473 (IB) at t z 15 mn IKK actviy at t = 1 mm
Dynic range= 7.5, R 9 1.5, R = 0.9800
4 4
3 3
l fm -- ,100 .- 5 _100 - 5 100 -- 100- 100
/ml) - - 100100 100 - - -100 1 100 --
SL- - - - m M 500m 5
12h 24h
SCompendium Sin-tire experiment I Maximal value
From compendium From single-time experiment Signal values, normalized to max
TNF,,gimi - 100 . 5 100 - 5 100- 100- 5 100 - 5 100
EF f 1(nmi - -100 1 100-- -- 100 1 100 - - -
Insulin (ng/m
Dynamic Pearson
range ffent
) 57.7 0.95
27.0 0.94
(48h) 15.2 0.98
m. (48h) 13.2 0.96
S(IB) 10.9 0.73
10.8 0.85
m. (24h) 8.6 0.96
(24h) 8.3 0.98
) 7.6 0.68
7.5 0.98
(12h) 7.4 0.97
ure (12h) 7.0 0.95
6.2 0.92
3) 5.3 0.40
4A (2411) 5.0 0.93
4.9 0.91
5 (IB) 4.9 0.98
rm. (12h) 4.8 0.79
IA (12h) 4.3 0.93
ure (24h) 3.5 0.90
4A (48h) 2.5 N.A.
4A) 2.4 N.A.
1.5 N.A.
1.5 N.A.
ure (481) 1.1 N.A.
IB) 0.7 N.A.
227
TNF (n
EGF (n
Insulin
PI
-- -------- ·- -- ·
Compendium of Signals and Responses to TNF, EGF, and Insulin
Key Features of the Signaling Compendium Identified by
Cytokine-Signal Covariates
To visualize the entire CSR compendium in a compact form,
a heat map was constructed (Fig. 4, A and B). The error
analysis described above (Fig. 3D) suggested that quantitative
differences larger than --30% between observed signals or
responses were likely to be biologically significant. Most var-
iation in the compendium was much larger than this, ranging
from 3-fold changes in ptEGFR to over 50-fold changes in
JNK and MK2 activity. Many of the patterns that could be
discerned from the heat map were expected (e.g. EGF and
insulin significantly inhibited TNF-induced caspase-8 cleav-
age at t = 8-24 h; p < 10-4; Fig. 4A), but several were
unanticipated (see supplemental material, Figs. S1-S4). In
these cases the primary value of the CSR compendium was
its ability to put each measured signal within the broader
biological context of other signals, treatments, and time
points.
In addition to visual inspection, the quality of the CSR data
enabled us to examine quantitative correlations between cy-
tokines and signals. We applied a previously described sta-
tistical mapping technique based on eigenvalue decomposi-
tion and rotation (25).2 Briefly each protein signal in the
compendium was integrated over its 24-h time course and
then projected onto a set of classifiers describing the TNF and
EGF or insulin treatment (see Ref. 25 for details). This projec-
tion generated a map in which the positions of 19 protein
signals were plotted relative to the TNF, EGF, and insulin
stimuli. The closer a protein signal is to a cytokine, the more
strongly and specifically the signal is activated by that cyto-
kine. For example, TNF strongly induces caspase-8 cleavage
and JNK1 and MK2 activation (14, 15), and these signals were
closest to TNF on the cytokine-signal map (Table II). Of par-
ticular interest were unanticipated map positions. We illus-
trate this point with two examples: one in which an unexpect-
edly close correlation was observed between EGF and plRS1-
Tyr"96 and a second in which a lack of correlation was
observed between the Akt kinase and its substrate, pFKHR.
IRS1-Tyr 96 as a Candidate EGFR Phosphorylation Site-
The signal that mapped closest to EGF was not a measure of
EGF receptor activation but IRS1 phosphorylation at Tyr896
(Table II). IRS1 is a key adaptor protein associated with insulin
signaling and is known to contain at least 12 functionally
important phosphorylation sites (37, 38). IRS1 tyrosine phos-
phorylation, on sites such as Tyr6'2 , Tyr941, and Tyr98 9, is
strongly induced by insulin and insulin-like growth factor re-
ceptor tyrosine kinases (37, 39). Whereas IRSI tyrosine phos-
phorylation stimulates downstream signaling, serine phos-
phorylation is inhibitory (40, 41). The kinase that mediates
IRS1-Tyr896 phosphorylation has not been identified, but the
modification is known to create an Src homology 2 binding
site for Grb2 (growth factor receptor-bound 2) and thus to
serve as a positive regulator of signaling (39, 42) (Fig. 1C).
In agreement with results from the cytokine-signal map,
strong IRS1-Tyr8 96 phosphorylation was observed in time
courses of EGF-treated cells, but the modification was unde-
tectable in the presence of insulin or TNF alone (Fig. 4, A and
C). EGF-induced IRS1 modification was not unique to HT-29
cells: EGFR-dependent IRS1-Tyr 896 phosphorylation was also
observed in A431 epidermoid carcinoma cells.4 EGF has pre-
viously been reported to promote tyrosine phosphorylation of
IRS1, but specific sites of phosphorylation have not been
identified (43-45). To search for candidate IRS1-Tyr896 ki-
nases, we used the Scansite motif-based searching algorithm
(46), which compares Swiss-Prot protein sequences to exper-
imentally determined consensus sites for dozens of protein
kinases. Strikingly the amino acid sequence surrounding
IRS1-Tyr896 (EPKSPGEYVNIEFGS) conformed well to the
EY(FN/VI) consensus site for the EGFR tyrosine kinase (47, 48)
and ranked in the top 0.113% of potential EGFR substrates
overall (Table Ill). This score is considerably better than the
0.2% cutoff recommended to avoid false positives with Scan-
site (49). Moreover only one known EGFR autophosphoryla-
tion site scored better than IRS1-Tyr896 (EGFR-Tyr 1197 at
0.041%); conversely other well characterized EGFR sites had
poorer scores than IRS1 -Tyr896 (Table Ill). Several sequences
within IRS1 were correctly identified as substrates for the
insulin receptor (IR), but IRS1-Tyr896 scored only within the
4 S. Gaudet and P. K. Sorger, unpublished observations.
FIG. 3. An orthogonal single-time, multitreatment experiment validates that the compendium is fused properly. A, schematic of the
orthogonal validation experiment. Signals were measured contemporaneously in a series of eight representative treatments. All signaling
measurements were made at a single time point 15 min after cytokine addition (red vertical plane). Cell death marker measurements were
repeated in these eight conditions at 12, 24, and 48 h. B and C, bar graphs comparing immunoblot phospho-Ser 473 Akt levels (B) or IKK activity
(C) from the compendium (gray) with those obtained in the single time validation experiment (red) and with the maximal value in the full
compendium (blue, treatment and time as indicated). Measurements are plotted as the mean of three biological replicates ± S.E. The dynamic
range and Pearson correlation coefficient (R) are shown. The dynamic range was calculated as the ratio of the square root of the variance in
the mean values across all treatments by the average standard deviation of replicate measures. D, heat map comparison of the average values
from the compendium (left) and the single-time validation experiment (right). The average values from biological triplicates were normalized to
the maximal value in the compendium for that assay (0, green; 0.5, black; 1, red). Protein signals were measured 15 min after cytokine addition,
and the responses were measured at 12, 24, or 48 h as indicated. The signals and responses were ranked by dynamic range, and when
applicable, the Pearson correlation coefficient between two datasets is listed. KA, kinase assay; IB, immunoblot; AA, antibody array; Memb.
perm., membrane permeability; pMEK, phospho-MEK; PS, phosphatidylserine; CIvC8, cleaved caspase-8; pAkt, phospho-Akt; CC3/CCK,
cleaved caspase-3/cleaved cytokeratin; ProC3, procaspase-3; a.u., arbitrary units.
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FIG. 4. Compendium of signaling and cell death measurements in TNF-, EGF-, and insulin-treated HT-29 cells. A, heat map of
time-dependent signals in cells treated with 10 cytokine combinations. For each treatment, the average signal intensities were normalized to
the maximal value obtained for that signal (0, green; 0.5, black; 1, red) and are plotted for the 13 time points. The signals were measured by
kinase assay (KA), immunoblot (IB), or antibody microarray (AA). B, heat map of cell death responses for the 10 treatments. The average values
from triplicate samples were normalized to the maximal value for that assay and are plotted for 12, 24, and 48 h of treatment (0, green; 0.5,
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TABLE II
Top cytokine-signal covariates
Cytokine Protein signala  Map Pearsondistanceb correlationc
TNF CIvC8 0.18 0.83
JNK1 0.24 0.75
MK2 0.37 0.88
EGF pIRS1 -Tyr896  0.20 0.69
ptEGFR 0.39 0.63
plRS1-Ser 636  0.41 0.59
Insulin Akt 0.21 0.95
Akt (1 B) 0.31 0.83
ptAkt 0.44 0.88
pFKHR 0.68 -0.39
a Proteins are abbreviated as described in Table I and ranked
according to map distance.b Euclidean cytokine-signal distances on the mapping described in
Footnote 2. Distances were normalized to the farthest protein signal
for each cytokine.
c Calculated between a scaled cytokine classifier (Footnote 2) and
the integrated signal for each treatment.
TABLE III
EGFR and IRSI phosphorylation sites for EGFR and insulin receptor
tyrosine kinases
Tyrosine kinase scorebProteina Site Substrate sequence Tyrosine kinase r
EGFR Insulin receptor
IRS1 Tyr896  EPKSPGEYVNIEFGS 0.113 2.820
Tyr612  TLHTDDGYMPMSPGV N.S.C 0.056
Tyr632  GRKGSGDYMPMSPKS 2.574 0.002
Tyr662  QRVDPNGYMMMSPSG 2.507 0.021
Tyr94' EETGTEEYMKMDLGP 2.820 0.001
Tyr989 VPSSRGDYMTMQMSC N.S. 0.050
EGFR Tyr 0 16 DVVDADEYLIPQQGF 1.543 N.S.
Tyr'092 TFLPVPEYINQSVPK 0.691 N.S.
Tyr 111o GSVQNPVYHNQPLNP 0.975 N.S.
Tyr1172 ISLDNPDYQQDFFPK 0.206 N.S.
Tyr1197 STAENAEYLRVAPQS 0.041 N.S.
a Proteins are abbreviated as described in Table I.b Ranked percentile as EGFR and insulin receptor tyrosine kinase
substrate motifs as scored by Scansite (46).
C N.S., not scored (too poor a substrate).
top 2.82% of sequences for IR tyrosine kinase (Table III and
Ref. 39). IRS1-Tyr8 96 lacks a methionine in the +1 position
that is important for IR-dependent modification (48) and is
therefore less likely to be an in vivo IR kinase substrate.
Intriguingly, IRS1-Tyr8 96 also scored highly as a potential
substrate for the fibroblast growth factor receptor and plate-
let-derived growth factor receptor tyrosine kinases (data not
shown). This raises the possibility that IRS1 functions down-
stream of EGFR and other growth factor receptors. Directed
experiments in vivo and in vitro will be required to test this
hypothesis and unravel the role played by IRS1 in cross-talk
between EGFR, fibroblast growth factor receptor, platelet-
derived growth factor receptor, and insulin receptors.
FKHR Phosphorylation Does Not Correlate with Akt Activa-
tion-The closest signals to insulin on the cytokine-signal
map were the three measures of Akt activation (Table 11) (50).
One might expect that Akt substrates, like FKHR (51, 52)
would also map closely to insulin. However, pFKHR-Ser 2 5 6
was closer to TNF and EGF (map distances of 0.50 for TNF
and 0.58 for EGF versus 0.68 for insulin), and there was no
positive correlation with insulin treatment (Table II). When the
dynamics of Akt activation and FKHR-Ser 256 phosphorylation
were examined, we found that EGF induced a sharp, transient
Akt signal at t = 5 min, consistent with previous studies in
myocytes (53), and an overlapping peak in pFKHR-Ser 256
levels (Fig. 4, A, D, and E). TNF treatment also caused tran-
sient (but weaker and delayed) Akt activation, probably as a
result of a TNF-inducible TGF-a autocrine loop,2 and a tran-
sient pFKHR-Ser25 6 peak (Fig. 4, A, D, and E). In contrast, Akt
was strongly induced in a sustained fashion by insulin, but no
significant increase in pFKHR-Ser 2 5 6 was observed (Fig. 4, A,
D, and E). Thus, within the CSR compendium, Akt activation
and FKHR-Ser256 phosphorylation are not always correlated
(-0.01 < R < 0.02 overall with each of the three measures of
Akt activation). The absence of a correlation between signals
thought to be biochemically coupled is potentially as valuable
as a strong correlation because it implies that mechanistic
models are incomplete.
One simple explanation for the discordance between Akt
activation and pFKHR-Ser 2 56 modification is that, in TNF- and
EGF-treated cells, FKHR is phosphorylated by a basophilic
kinase other than Akt. Indeed two other FKHR phosphoryla-
tion sites (Thr 24 and Thr316), originally identified as Akt phos-
phoacceptor sites (52, 54), have recently been reported to be
Akt-independent in hepatocytes (55). Furthermore the equiv-
alent sites on a closely related transcription factor, FOXO3
(Thr32 and Ser315 ), are not phosphorylated by Akt but rather
by serum- and glucocorticoid-inducible kinase (SGK) (56). We
therefore hypothesize that TNF- and EGF-induced FKHR-
Ser256 phosphorylation is mediated by SGK or a similar ki-
nase. It is noteworthy that FOXO3-Thr32 , targeted by SGK,
ranks even higher than FKHR-Ser 256 as a substrate motif for
Akt (top 0.001% for FOXO3-Thr32 versus 0.049% for FKHR-
Ser2 56 of all Akt substrate motif matches by Scansite) (46),
illustrating the overlap between Akt and SGK substrate spec-
ificities. Distinguishing the roles of Akt and SGK has been
difficult because both lie downstream of phosphatidylinositol
black; 1, red). The fractions of cells doubly positive for cleaved caspase-3 and cleaved cytokeratin (CC3/CCK) or with phosphatidylserine (PS)
exposure, membrane permeability (Memb. Perm.), or sub-G, DNA content were measured by flow cytometry. C-E, time courses of
pIRS1 -Tyr"96 (C), Akt activity (D), and pFKHR-Ser25 6 (E) in untreated cells (gray) or cells treated with 100 ng/ml TNF (red), 100 ng/ml EGF (blue),
or 500 ng/ml insulin (black). Values in C-E are means -+ S.E. of biological triplicate samples normalized to the maximal value in the compendium
for that signal. ClvC8, cleaved caspase-8; pAkt, phospho-Akt; pMEK, phospho-MEK; ProC3, procaspase-3.
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3-kinase and 3-phosphoinositide-dependent protein kinase 1
(34), but the compendium data may have determined condi-
tions under which Akt is uncoupled from FKHR-Ser 256 mod-
ification. Follow-up experiments can now be designed to test
the idea that the critical FKHR kinase in TNF- and EGF-treated
cells is SGK. Moreover novel mechanistic hypotheses can be
derived by examining even well known signaling events within
a broad biological context of compendium data.
A Linear Model of TNF-induced Cell Death
To evaluate rigorously our design strategy for the CSR
compendium (e.g. selection of which signals to measure and
time points to sample, assembly of multiple data types,
choice of cytokine treatments, and approaches to data proc-
essing), we used a data-driven PLSR model. This model,
designed to generate predictions of apoptotic responses
based on measured intracellular signaling profiles, will be
described in detail elsewhere." Briefly, signal measurements
were cast as independent (predictor) variables, and apoptotic
responses were cast as dependent (predicted) variables. To
maximize the information extracted from compendium data,
the set of independent variables was expanded to include not
only the actual measurements of each of the 19 signals at 13
time points (247 independent variables) but also 22-25 met-
rics describing the time-dependent dynamics of that signal.
These derived metrics included "local descriptors" such as
the instantaneous derivative of the signal at each time point,
the area under the curve, and the activation and down-regu-
lation rates for each peak in the time course. "Global descrip-
tors" included the total area under the curve over a 24-h
period and the global maximum, mean, and steady-state val-
ues of the signal. Together the time point measurements and
the derived metrics for each signal constituted a set of 660
independent variables.3 Changes in the independent vari-
ables were related to changes in the dependent variables
(apoptosis measures) through regression coefficients that the
PLSR algorithm calculates for the full range of cytokine treat-
ments in the compendium. Cross-validation showed that the
PLSR model could predict the apoptotic responses for any
single treatment withheld from the training set with a squared
Pearson correlation (R2) of 0.94. Furthermore this model could
predict data not in the training set with R2 = 0.91.3
Maximizing Information Content in Models by
Unit-Variance Scaling
PLSR models weigh independent and dependent variables
with large covariance most heavily (57); this biases the models
toward variables with the largest dynamic range. In the com-
pendium, JNK1 activity at t = 15 min varied more than 200-
fold across all treatments, whereas Akt activity never varied
more than 5-fold at any time point. A priori it is not obvious
that large changes in JNK1 activity are more important than
more modest but sustained changes in Akt activity, yet re-
gression-based models emphasize the former. To give all
variables an equal likelihood of contributing to the PLSR
model, we applied unit-variance scaling, a common prepro-
cessing technique in regression analysis (57). Each variable
(JNK1 activity at t = 15 min, for example) was divided by the
square root of its variance calculated across all cytokine
treatments. This maintained the relative variation in the CSR
compendium (e.g. JNK1 activity at t = 15 min was still higher
for TNF treatment when compared with insulin treatment), but
the dataset was scaled so that all variables had the same
"spread" of values. Some time courses were altered quite
dramatically by unit-variance scaling. For example, high vari-
ance in JNK1 activity at t = 5, 15, and 30 min and lower (but
potentially informative) variance across treatments at later
time points led to a scaled TNF-induced time course in which
the second wave of activation was emphasized (Fig. 5A). For
caspase-8 activation, easily overlooked differences in the ex-
tent of cleavage at early times were amplified relative to
cleavage at later times (Fig. 5B). As a general rule, we found
that scaling enhanced the importance of signals at late time
points relative to those at early times (Fig. 5D). However, a few
signals with relatively uniform variance were minimally af-
fected by scaling; raw and scaled phospho-Akt time courses
were very similar for example (Fig. 5C).
Does unit-variance scaling increase the amount of informa-
tion extracted from the compendium as measured by the
number of independent variables incorporated into the
model? To answer this, we constructed PLSR models from
either scaled or unscaled data and then evaluated the contri-
bution of each variable (i.e. measurements and derived met-
rics such as maximum, area under the curve, etc.) to the two
models by examining the VIP. The VIP is a normalized expres-
sion for the magnitude of the regression coefficients for each
variable (see Ref. 58 and "Experimental Procedures"). Vari-
ables with a high VIP value (VIP > 1) play an important role in
the PLSR model, whereas variables with a low VIP value (VIP
<< 1) do not. For a model with unscaled variables (the "un-
scaled" model), only a small number of independent variables
had a high VIP with most of the signals contributing negligibly
to predictions (Fig. 5E). By contrast, a "scaled" model built
from unit-variance scaled data incorporated far more signal-
ing variables into the response prediction, and the signals
were weighed more equally (Fig. 5F). This illustrates that the
scaled model drew from data across the CSR compendium,
whereas the unscaled model relied entirely on the highest
variance signals.
Both scaled and unscaled models predicted cell death re-
sponses with good accuracy for single treatments withheld
from the training set (squared Pearson correlation of 0.94 with
measured values). As a more stringent test of performance,
we examined how well the two models predicted death re-
sponses under conditions that were different from those used
to generate training data. A first set of test data was obtained
from cells treated with TNF in the presence of the EGFR-
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FIG. 5. Unit-variance scaling enhances small but important features in the signaling time courses. A-C, time courses of JNK1 activity
(A) and cleaved caspase-8 levels (B) in cells treated with 100 ng/ml TNF and of phospho-Akt levels from cells treated with 100 ng/ml EGF (C).
Normalized mean values from triplicate samples are shown in blue, and the values after scaling are shown in red. Error bars denote the S.E.
D, bar graph comparing the sum of all signal values at each time point from normalized data (Not scaled, blue) or from unit-variance scaled
data (Scaled, red). E and F, box-and-whisker plots showing the distribution of VIP for each signal in the PLSR models built using not scaled
(E) or scaled (F) data. For each signal, the median is represented by a red bar, and its non-parametric 90% confidence interval is represented
by the notches in the box. The box extends from the 25th to the 75th percentile values (blue), and the whiskers show the range of other data points
(black). Outliers are shown as red crosses. pAkt, phospho-Akt; KA, kinase assay; IB, immunoblot; AA, antibody array; pMEK, phospho-MEK; CIvC8,
cleaved caspase-8; ProC3, procaspase-3; ProC8, procaspase-8; tEGFR, total EGFR; pEGFR, phospho-EGFR; a.u., arbitrary units; ', minutes.
blocking antibody C225 (59), and the second was obtained that, at early times, the signaling and cell death response of
from cells treated with TNF in the presence of interleukin-1 cells to TNF is mediated in part by an TGF-a-EGFR autocrine
receptor (IL-1R) antagonist (IL-1ra) (60). We show elsewhere loop and, at later times, by an IL-•a-IL-1R autocrine loop 2;
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FIG. 6. Unit-variance scaling is required for the model to correctly predict apoptosis induced by perturbations of autocrine signaling.
A and B, heat maps of the signals (A) and cell death responses (B) measured in two test datasets where TNF-induced autocrine loops were
perturbed. Measurements were performed as in the single treatment experiments of the full compendium. Cells were stimulated with 100 ng/ml
TNF + 10 /g/ml IL-1ra (top') or with 5 ng/ml TNF + 10 /g/ml C225 (bottom). In each case, the signaling profile is compared with the profile
from the unperturbed treatment condition in the compendium. Averages from triplicate samples, normalized to the maximal value for that signal
in the original compendium, are plotted for each time point (signals: 0, 5, 15, 30, 60, and 90 min and 2, 4, 8, 12, 16, 20, and 24 h; responses:
12, 24, and 48 h; 0, green; 0.5, black; 1, red). C, table showing the normalized Euclidean distances between the independent variables vector
(time points and derived descriptors) of each of the test datasets and that of the corresponding unperturbed treatment before and after
unit-variance scaling of the variables. The distances were normalized to the shortest distance in the full compendium for that unperturbed
treatment. D, bar graph showing the least squares fitness of the apoptosis values predicted by the models to values measured in the two test
datasets. The model from unit-variance scaled data (red) accurately predicts the cell death responses in the test data, whereas the model from
data that was not scaled (blue) fails to predict the cell death responses from the C225 test dataset. Error bars denote the 90% confidence
interval in the fitness estimate. pMEK, phospho-MEK; pAkt, phospho-Akt; ProC3, procaspase-3; CIvC8, cleaved caspase-8; PS, phosphati-
dylinositol; Memb. perm., membrane permeability; N.S., not significant; CC3/CCK, cleaved caspase-3/cleaved cytokeratin.
C225 and IL-1 ra disrupt the TGF-a and IL-1 a autocrine loops,
respectively. Their importance for the current discussion is
that C225 caused fairly dramatic changes in signaling as early
as t = 15 min but only small changes in responses. Con-
versely IL-1ra elicited more modest changes in signaling
(mostly at t > 4 h) but caused substantial changes in TNF-
induced cell death responses (Fig. 6, A-C). When test data
from cells treated with TINF + C225 were used as independ-
ent variables in the scaled PLSR model, cell death response
predictions had a least squares fitness of 0.81 to experimental
values (a perfect prediction would yield a fitness of 1; see
"Experimental Procedures"). In contrast, the unscaled model
performed very poorly, exhibiting no significant correlation
between prediction and experiment (Fig. 6D). Although the
impact of scaling was less dramatic for TNF + IL-1ra test
data, we again found that the scaled model performed signif-
icantly better than the unscaled model (0.94 versus 0.81 least
squares fit; Fig. 6D). We conclude that important information
for predicting cell fate responses is contained in the small,
consistent variations of low dynamic range signals and inter-
mediate-to-late time points. Unit-variance scaling extracts
this information from the CSR compendium and enables ac-
curate prediction of cell death in treatments that are different
from those within the training set data.
Aspects of the Compendium That Contribute to
Prediction Accuracy and Model Robustness
The example above suggested a general approach for eval-
uating the importance of different aspects of the CSR com-
pendium design using PLSR modeling. Scaled models lacking
one or more data types were built and then compared with the
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full scaled model to judge their ability to predict apoptotic
responses in TNF + C225- and TNF + IL-1ra-treated cells.
The Value of Heterogeneous Signals Measured by Distinct
Assays-To test our assumption that it was valuable to sam-
ple multiple features of a signaling network (Fig. 1C) we built
PLSR models from subsets of the data. As expected, models
built on measurements on a single protein performed poorly
(Fig. 7A). More surprisingly, models built from multiple signals
gathered using a single type of assay (e.g. immunoblots) were
also inferior to the model based on the full compendium (Fig.
7B). For example, kinase activity data were as good as the full
model at predicting apoptosis following TNF + IL-1ra treat-
ment (0.94 least squares fit) but very poor at predicting the
outcome of TNF + C225 treatment (no significant fit; Fig. 7B).
Overall, immunoblot data yielded the best single assay model,
but this model was still significantly less predictive than the full
model (0.84 versus 0.94 for TNF + IL-1ra and 0.65 versus 0.81
for TNF + C225; Fig. 7B). We do not yet know whether the
limitations of single-assay data can be overcome simply by
measuring many more signals, using the same assay or whether
something more fundamental is at work. However, given current
technology, cell-signaling measurements are most powerful
when different techniques are used in combination.
Efficient Data Collection by Combination Cytokine Treat-
ments-In the design of a typical experiment, parameters are
changed one at a time. In contrast, the CSR compendium
included many treatments combining prodeath and prosur-
vival cytokines. To assess the value of combinatorial stimuli,
we identified two models trained on few treatments that were
still predictive of cell death in the test datasets: 1) a TNF-only
model containing subsaturating and saturating TNF-alone
treatments as well as the mock treatment and 2) a TNF-EGF-
insulin model built from the saturating TNF + EGF and satu-
rating TNF + insulin treatments (Fig. 7C). We then expanded
the training data for the two models by including the low
TNF + low EGF dataset. Both models predicted cell death in
test data as accurately as the full model (fitness of 0.90 for
model 1 and 0.94 for model 2; Fig. 7D). However, we rea-
soned that models trained on smaller datasets might be less
robust to measurement noise in the training data. When ran-
dom noise was added to the low TNF + low EGF signaling
data and the models were recalculated, the TNF-only model
performed poorly, whereas the TNF-EGF-insulin model and
the full model remained reliable (Fig. 7D). We therefore con-
clude that inclusion of signaling data from cells exposed to
multiple cytokines in combination yields models that are less
sensitive to experimental noise.
Contributions from Derived Metrics-The full PLSR model
was constructed using both signal measurements and de-
rived metrics as independent variables. Was it important to
include these derived metrics? Remarkably a model that in-
cluded derived metrics but excluded actual signal measure-
ments performed as well as the full model on both sets of test
data (Fig. 7E, "No time points"). In contrast, a model built from
signal measurements alone was unable to predict cell death in
the C225 test dataset (Fig. 7E, "Time points"). Moreover ac-
tivation rates and global descriptors of signaling dynamics
(area under the curve, mean, maximal, and steady-state val-
ues) were among the most heavily weighted variables in the
full model.4 Why are derived metrics so important for model
construction? In the PLSR approach described here, each
time point is treated as a separate independent variable, and
thus, derived metrics are the only variables that contain infor-
mation on how measurements were ordered in time. To as-
sess the relative value of each derived metric, we constructed
models from single metric types. Several of the models ac-
curately predicted apoptotic responses in the IL-1ra test data,
but only one (based on activation rate, or on-slope) yielded
predictions with a significant fitness to the measured apopto-
sis values in the C225 test data (Fig. 7E). Combining several
derived metrics therefore seems to yield the most predictive
power. Because derived metrics are more predictive than
measurements themselves, we conclude that information en-
coded in time-dependent signaling is a critical aspect of the
CSR compendium.
Predictive Information in Early and Late Signals--Can early
signals predict late responses? Surprisingly, early time points
between 5 and 90 min were predictive of cell death in the
combined test datasets 12-48 h later (Fig. 7F), although they
were significantly worse at predicting the C225 than IL-1ra
test data (data not shown). This suggests that protein activi-
ties at early times encode much of the information needed to
specify an apoptosis-survival cell fate decision. Late time
points (t > 12 h) also had good overall predictive power (Fig.
7F), but this is to be expected because caspase activation at
these late time points is mechanistically linked to cell death.
Strikingly, a clear drop was observed in the predictive ability
of the protein signals that were measured at t = 2, 4, and 8 h
(Fig. 7F). It seems unlikely that information is really lost be-
tween 2 and 8 h; rather it may be encoded in transcriptional
responses absent from our dataset (61). We hypothesize that
the inclusion of transcriptional data in the compendium will
reestablish the predictive power of models based on these
time points. Taken together, compendium-based modeling
results suggest that early signals immediately downstream of
receptors contain much of the information needed to specify
cell fate decisions up to 24 h later.
DISCUSSION
In this article, we describe the construction and validation of
a cytokine-signal-response compendium with which to inves-
tigate the regulation of cell fate in cells exposed to combina-
tions of the prodeath cytokine TNF and the prosurvival cyto-
kines EGF and insulin. The compendium contains more than
10,000 biochemical measurements on the states and activi-
ties of cell-signaling proteins and apoptotic responses in hu-
man cells. At the outset of the work described here it was
unclear whether heterogeneous data from immunoblots, an-
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FIG. 7. The PLSR model requires multiple, heterogeneous, time-dependent protein signals to predict apoptosis robustly. Shown are
bar graphs of the least-squares fitness of predicted-to-measured cell death responses in test datasets (IL-1 ra, green; C225, orange) for models
built from data subsets. Light green and orange horizontal bands mark the 90% confidence interval of the prediction fitness for the full
compendium for the IL-1ra and C225 test datasets, respectively. Least-squares fitness values less than zero are marked as non-significant
(N.S.). Error bars show the 90% confidence interval in the estimate. A and B, fitness values of predicted-to-observed cell death responses for
models built from time course data on single protein signals (A) or from signaling data generated by a single assay (antibody arrays (AA), kinase
assays (KA), or immunoblots (IB)) (B). Datasets that included cleaved caspase-8 (CIvC8 in A, and immunoblots in B) performed best because
this signal is the most directly linked, biochemically, to the outcomes. C, three-dimensional representation of the cytokine combinations used
in models with subsets of treatment conditions. Model 1 used data from mock, 5 ng/ml TNF, and 100 ng/ml TNF treatments, whereas model
2 was built from data on 100 ng/ml TNF with either 100 ng/ml EGF or 500 ng/ml insulin. D, comparison of the fitness of predicted-to-measured
apoptosis values in the IL-1 ra and C225 test datasets combined for models with (gray) or without (white) simulated random normally distributed
noise added to the 5 ng/ml TNF + 1 ng/ml EGF signal measurements. The fitness of models with noise represents the average predictive ability
of three instances each at five noise levels (10, 20, 30, 40, or 50% of the range of values for each signal). E, fitness values of predicted-to-
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tibody microarrays, kinase activity assays, and flow cytometry
could be effectively assembled into a single dataset. However,
we have now established that a carefully assembled CSR com-
pendium enables the construction of informative statistical
models and yields new hypotheses about the regulation of cell
fate by cytokines. Elsewhere we describe some specific biolog-
ical conclusions that can be inferred by mining compendium
data2; here we concentrate on more general issues associated
with the construction, validation, and mining of such datasets.
A key step in the construction of self-consistent datasets is
data fusion. Heterogeneous measurements acquired at differ-
ent times must be combined in such a way that they can be
compared quantitatively across the full dataset. Experimental
databases are common in genomics largely because se-
quence data are homogeneous and structured with a clear
beginning and end, and data fusion is therefore straightfor-
ward. In contrast, cell-signaling data are heterogeneous and
unstructured, lack an obvious completion point, and depend
heavily on biological context. These features make fusion of
signaling data challenging. Our approach to building a data
compendium started with the definition of an experimental
template that was applied repeatedly to the analysis of differ-
ent cytokine combinations. The template specified standard-
ized experimental protocols and optimized normalization pro-
cedures for determining the time-dependent activities of 19
protein signals and four cell death responses over a 48-h
period. The template was applied to data collected from cells
treated with 10 cytokine combinations and two combinations
of a cytokine and a receptor inhibitor. Overall the raw cyto-
kine-signal-response dataset contained -10,000 quantitative
measurements assembled from 12 independent experiments.
Accuracy and Self-consistency of the CSR Compendium -
To support reliable hypothesis generation, data fusion must
maintain measurement accuracy and self-consistency. A
number of procedures were used to ensure the accuracy of
the data, and these procedures were validated experimen-
tally. First, the linearity of each assay was verified, and meas-
urements were shown to be directly proportional to signal
strength. Experimental protocols, cell treatments, and re-
agents were standardized, and measurements were adjusted
for assay- and sample-specific fluctuations in factors such as
reagent activities and lysate concentrations. For each treat-
ment and time point, at least three replicate biological sam-
ples were measured, allowing formal statistical testing and
assessment of the magnitude of biological variation and
measurement noise.
Second, to rule out fluctuations in measurements during the
18-month data collection period, measurements in the pri-
mary compendium were compared with those in a validation
dataset. The validation dataset replicated a subset of the
compendium measurements but with an orthogonal experi-
mental design. Whereas the primary compendium consisted
of single treatments analyzed at different time points, valida-
tion data were collected at a single time from cells treated with
different cytokine combinations. For most signals and re-
sponses, validation data matched primary data very well. A
few signals could not be validated quantitatively because they
lacked sufficient dynamic range to distinguish real variation
from noise. Nonetheless we conclude that most signals and
responses were consistent throughout the data collection
process; validation experiments must be designed to maxi-
mize the number of signals showing significant variation
across treatments.
As a third self-consistency check we asked whether differ-
ent measures of the same biochemical process yielded similar
data. In DNA sequencing this type of quality control is
straightforward and involves checking the noncoding and
coding sequences for complementarity. However, verifying
the congruence of protein signals is more complex in part
because a mechanistic model relating the different biochem-
ical properties measured by each assay is necessary. For
example, we assayed the activation of Akt both by kinase
activity assay and by tracking its phosphorylation state at
Ser4 73, an activating site, using immunoblots and antibody
arrays. Perfect correlations between these assays would re-
quire that phospho-Ser473 be essential for kinase activity and
that all forms of phospho-Akt-Ser 473 be fully active. Although
kinase activity and phospho-Ser473 assays of Akt were gen-
erally well correlated, subtle discrepancies were observed.
These discrepancies are consistent with the known mecha-
nisms of Akt regulation (bisphosphorylated Akt is more active
than Akt singly phosphorylated at Ser4 73 or Thr308 (35, 36)),
but they also highlighted the challenges involved in validating
the merger of data from heterogeneous assays into a single
coherent representation.
Context-dependent Signaling Dynamics-The CSR com-
pendium allowed us to compare signaling dynamics within a
range of cytokine contexts. We used two approaches to mine
compendium data for interesting signaling patterns: heat
maps (see Supplementary Material) and cytokine-signal
maps.2 One surprising finding was that the treatment of cells
with EGF, but not with insulin, was strongly associated with
observed cell death responses in each test dataset for models built from single variable types. The variables were grouped by time point values,
global area under the curve (AUC), mean, maximal (max), or steady-state value over the time course, local area under the curve (AUC peaks),
slope of activation phase (On slope) or of down-regulation phase (Down slope), and instant derivatives at each time point (Deriv.). F, plot of
predictive ability of models built from single time point data as expressed by the least-squares fitness to the measured values for the two test
datasets combined. Similar trends were observed with each perturbation alone. Error bars denote the 90% confidence interval, and the trend
line (red) is a polynomial fit to the fitness values plotted against time. The 90% confidence interval in the fitness value for the full model is
marked in light gray. pMEK, phospho-MEK.
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phosphorylation of insulin receptor substrate 1 on Tyr""8 . The
sequence flanking IRS1-Tyr" 96 is a remarkably good match to
an EGF receptor consensus phosphoacceptor site, leading us
to hypothesize that EGF may be an important plRS1-Tyr8 96
inducer and that EGFR may modify IRS1 directly. This hypoth-
esis is now being tested experimentally. A second unex-
pected discovery was a lack of correlation between Akt acti-
vation and Ser2256 phosphorylation of the Forkhead
transcription factor, an Akt substrate (51, 52). The lack of
correlation leads us to hypothesize that FKHR-Ser256 may be
targeted by a kinase other than Akt in EGF- and TNF-treated
cells. Consistent with this idea, the basophilic kinase SGK has
recently been shown to modify the FKHR homologue FOXO3
on two phosphoacceptor sites previously thought to be Akt
substrates (56). These two findings illustrate the value of
comparing signal strengths quantitatively across a set of dif-
ferent biological conditions. Unexpected statistical correla-
tions observed among signals are suggestive of new mecha-
nistic links, whereas the absence of an expected correlation
suggests that existing links may require reinvestigation.
Experimental Requirements for Signaling Compendia--The
construction and validation of computational models of cell
signaling was our primary goal in generating the CSR com-
pendium. As a first step, we built a regression (PLSR) model
that relates protein signals to cell death responses.3 PLSR
models built from data scaled to unit variance extracted the
most information from the compendium and performed much
better than models built from unscaled variables. The best
PLSR data-driven model was surprisingly powerful: given sig-
naling information from test data not included in the training
set, the model predicted apoptotic responses to within the
range of error for experimental measurements.3 PLSR models
were used to analyze the design and assembly of CSR data
with the goal of developing optimized strategies for the con-
struction of future compendia.
Would a simpler experimental scheme with fewer signals,
treatments, or time points have yielded a CSR compendium
with a similar ability to support PLSR modeling? Although the
answer appears to be "yes" because some data scored low in
the VIP (Fig. 5F), statistical modeling clearly benefited from
heterogeneous measurements, information on signal dynam-
ics, and the analysis of cells treated with combinations of
cytokines. Models built from single signals were ineffective at
predicting apoptosis, consistent with the idea that cells weigh
the contributions from multiple signals when committing to
survival or death (62). More interestingly, models built from
any single type of assay were significantly less predictive than
models based on the full compendium. Among the single-
assay models, immunoblot data performed best probably
because immunoblots were used to assay two distinct bio-
chemical processes: protein phosphorylation and protein
cleavage. Most proteomic efforts to date (63) have centered
on the use of a single technology such as protein arrays (64)
or mass spectrometry (10). However, our results suggest that
it is highly advantageous to combine several different assay
methods to capture the diversity of protein signals that me-
diate cell fate decisions.
If the analysis of single proteins is insufficient to predict cell
fate, then how much coverage of a signaling network is re-
quired? The success of our CSR compendium shows that it is
not necessary to strive for complete coverage: apoptosis was
predicted within 94% accuracy given signaling information
from only 11 of the roughly 75 protein nodes shown in Fig. 1C
(15% coverage). However, we suspect that a sparse sampling
of a network will only yield predictive models when nodes are
repeatedly sampled under a variety of conditions. In a typical
experiment one usually decides to vary one parameter at a
time, but we have found that data from cells treated with a
combination of cytokines were more informative than data
from single cytokine treatments particularly when measure-
ments were noisy. Combinations of prodeath and prosurvival
cytokines evoke more complex signaling patterns than indi-
vidual stimuli, and it seems likely that this provides a broader
context within which to assess the role of each signal in cell
death responses.
Which signals should be measured in the protein network?
Although the answer clearly depends on the biological sys-
tem, we found that upstream signals (e.g. receptors and
adaptors) were easiest to relate to cytokine stimuli in statisti-
cal maps. For instance, IRS1 -Tyr 896 phosphorylation was
prominent as an EGF-dependent signal on the cytokine-signal
map.2 With the PLSR model, however, downstream signals
like ERK, JNK1, and MK2 were most predictive of apoptotic
responses.3 We also found that measuring connected nodes
in the network, initially thought to represent somewhat redun-
dant assays, provided useful insight into the propagation of
signals through particular pathways. Akt-FKHR is one exam-
ple of a densely sampled region of the network; another is the
dual measurements of ERK activity and phospho-MEK level
(Fig. 8B). The correlation between these two signals was
reasonable (Pearson coefficient of 0.68 overall), but more
in-depth analysis revealed that ERK and phospho-MEK were
best correlated at the earliest time point after cytokine addi-
tion, implying that their activation was coincident (Fig. 8A, 5
min). At later time points, MEK was inactivated more rapidly
than ERK, and the correlation was lost probably as a result of
differential dephosphorylation (Fig. 8, A and B) (65). The ERK-
MEK disparity was exacerbated under conditions of saturat-
ing TNF treatment (Fig. 8A, circles). Thus, TNF may activate
the Ser-Thr phosphatases that act on MEK or alternatively
inactivate the dual specificity and Tyr phosphatases that act
on ERK (Fig. 8B). Directed phosphomapping experiments and
phosphatase assays should be able to test this prediction.
More generally, the variability in MEK-ERK induction high-
lights how proteins that interact directly and function in the
same pathway can exhibit time-dependent changes in relative
activities.
Propagation of Signaling Information with Time -In the CSR
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FIG. 8. Differential regulation of MEK and ERK by phosphatases is context-dependent. A, scatter plots of pairwise comparisons of ERK
activity and phospho-MEK (pMEK) levels at 5, 15, and 30 min and at time points greater than 30 min as indicated. Values are means ± S.E.
of biological triplicate samples normalized to the maximal value in the compendium for that signal. Pearson correlations are noted in the upper
left corner when the dynamic range is greater than 2.5. B, schematic diagram showing the two measurement types, ERK kinase activity assays
(KA) and phospho-MEK levels by immunoblot (IB), the differential regulation of ERK and MEK by phosphatases. MEK is targeted only by
Ser-Thr phosphatases (SIT-P'ase) that may be activated by TNF treatment. ERK is additionally targeted by dual specificity phosphatases
(DS-P'ase) and Tyr phosphatases (Y-P'ase) that may be inhibited by TNF treatment. a.u., arbitrary units.
compendium, protein signals were encoded by two types of
variables: discrete measurements collected at 13 points over
a 24-h period and derived metrics describing the local and
global dynamics of signaling. We found that these derived
metrics were essential for constructing predictive PLSR mod-
els and that they could not be replaced by the measurements
from which they were derived. PLSR treats each time point
independently, and derived metrics were therefore the pri-
mary means by which time dependence was encoded. We
presume that this explains the importance of the metrics for
the PLSR model. Unexpectedly, however, when the CSR
compendium was modeled using a multilinear regression
technique (66) that constrains the sequence of time points by
explicitly ordering signaling network "snapshots" in time, we
were unable to construct predictive models.5 One explanation
for the success of derived metrics in PLSR and failure of
5 K. A. Janes and P. K. Sorger, unpublished observations.
multilinear regression is that critical signaling information is
imbedded in the cumulative activities and rates of change of
key signals, calculated as derived metrics, rather than in the
ordering of signaling events. For example, the cumulative
activity of caspase-8 is likely to be more important than the
time at which activity is first detected. Indeed molecular inte-
grators and differentiators have been previously identified in
both prokaryotic and eukaryotic signaling networks (21, 23,
67).
PLSR models based on single time point snapshots be-
tween 5 and 90 min or 12 and 24 h were able to predict
apoptotic responses with reasonable accuracy although not
as well as the full model. A clear loss of information was
observed with protein signals at t = 2-8 h. In HT-29 cells,
TNF-induced apoptosis is not apparent until -8 h after stim-
ulus addition,4 implying that cells must still be processing
apoptosis-survival cues at those time points. One explanation
for the loss of predictive power from 2 to 8 h is that informa-
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tion processing involves changes in gene transcription, which
were not measured in our experiments. Microarray experi-
ments are currently underway to test this idea. Nonetheless it
is clear that protein signals alone, when sampled over a time
course, are sufficient for predicting HT-29 apoptotic re-
sponses induced by cytokines. It will be interesting to deter-
mine whether PLSR models based on the current CSR com-
pendium will also be effective in predicting apoptosis induced
by other stimuli or in different cell lines.
Conclusion-The data in this article show that cytokine-
signal-response compendia should be constructed using
measurements that are well distributed across a signaling
network, although sparse coverage of the network is accept-
able. Nonetheless resampling a subset of nodes using multi-
ple assays helps to verify the consistency of heterogeneous
data. Experimental validation of measurements is best carried
out under conditions in which all signals have a sufficiently
large dynamic range for correlation coefficients to be mean-
ingful. In some cases this will involve two validation experi-
ments, for example one at an early time point and one later.
Measurement of signaling dynamics is clearly critical for CSR
compendia, and uneven spacing of time points makes it pos-
sible to sample adequately both transient and sustained sig-
nals. Within the context of the regression-based models used
here, it is important to rely not only on the data themselves but
also to compute metrics that describe signal dynamics. More-
over scaling data to unit variance is necessary to optimize the
extraction of information from compendium data.
In summary, we have described methods for compiling
validated, self-consistent data compendia describing time-
varying signals induced by cytokines and have demonstrated
the value of compendium data in the study of mammalian
signal transduction. We believe that similar CSR compendia
coupled with both regression-based and mechanistic models
will be valuable in the systematic analysis of other complex
biological networks.
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SUMMARY
Tumor necrosis factor (TNF) is a proinflamma-
tory cytokine that induces conflicting pro- and
antiapoptotic signals whose relative strengths
determine the extent of cell death. TNF receptor
(TNFR) has been studied in considerable detail,
but it is not known how crosstalk among
antagonistic pro- and antiapoptotic signals is
achieved. Here we report an experimental and
computational analysis of crosstalk between
prodeath TNF and prosurvival growth factors
in human epithelial cells. By applying classi-
fier-based regression to a cytokine-signaling
compendium of -8000 intracellular protein mea-
surements, we demonstrate that cells respond
to TNF both directly, via activated TNF receptor,
and indirectly, via the sequential release of
transforming growth factor-oa (TGF-ox), interleu-
kin-lo (IL-loc), and IL-1 receptor antagonist
(IL-1ra). We refer to the contingent and time-
varying series of extracellular signals induced
by TNF as an "autocrine cascade." Time-
dependent crosstalk of synergistic and antago-
nistic autocrine circuits may serve to link cellular
responses to the local environment.
INTRODUCTION
Cytokines and their receptors activate complex signaling
networks composed of diverse proteins whose overall
function is to control cell fate and function (Downward,
2001). Understanding these intracellular networks is com-
plicated in part because many receptors generate com-
peting, and even antagonistic, intracellular signals. For ex-
ample, tumor necrosis factor (TNF) promotes cell death by
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inducing activation of the cysteine proteases caspase-8
and caspase-3 (Nicholson and Thornberry, 1997) but
also promotes cell survival by activating the nuclear fac-
tor-KB (NF-KB) transcription factor (Karin and Ben-Neriah,
2000). In tissues, the connection between signals and cell
fate is even more complex because cells are exposed to
multiple cytokines that act together in synergistic and an-
tagonistic combinations. Conflicting stimuli often arise
when cells are exposed to paracrine cytokines from neigh-
boring cells together with autocrine cytokines secreted by
the cell itself. In colonic epithelia, for example, TNF se-
creted by inflammatory cells is a key mediator of inflam-
matory bowel disease (Rutgeerts et al., 2004) and can
lead to epithelial cell death, whereas locally produced epi-
dermal growth factor (EGF) and insulin-like growth factor
(IGF) are critical for cell division and repair of the mucosa
(Chailler and Menard, 1999; Singh and Rubin, 1993).
Individual cytokines and receptors have been studied
extensively, but relatively little is known about intracellular
processing of antagonistic signals. It is likely that crosstalk
between individual receptors and their downstream sig-
naling pathways is important. We reasoned that crosstalk
could be studied effectively by using a large-scale sys-
tematic approach in which cells were treated with antag-
onistic cytokines and multiple downstream signals were
then measured to create a data compendium. We antici-
pated that most crosstalk would be intracellular and in-
volve the joint regulation of signaling proteins such as
mitogen-activated protein kinases, caspases, etc. We
therefore assayed intracellular signaling proteins for which
reliable quantitative measurements were available (Janes
et al., 2003; Nielsen et al., 2003). By focusing on known
pathways and proteins, the compendium approach does
not seek to identify new signaling proteins but rather to
uncover how the activities of known molecules are coor-
dinated during a physiological stimulus. For TNF, our sys-
tematic analysis revealed the surprising importance of
crosstalk via extracellular autocrine signaling in specifying
cell fate.
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TNF is the prototypical member of a family of 19 related
proapoptotic and proinflammatory cytokines (Aggarwal,
2003; Chen and Goeddel, 2002). Trimeric TNF binds to
a TNF receptor (TNFR) trimer, leading to intracellular as-
sembly of two multicomponent death-inducing signaling
complexes, DISC-I and DISC-II (Figure 1A; Barnhart and
Peter, 2003; Micheau and Tschopp, 2003). DISC-I is an
early membrane bound complex that signals through the
NF-KB, JNK, and p38 pathways, whereas DISC-II is a later
cytoplasmic complex that activates caspases-8 and -3
(Micheau and Tschopp, 2003). NF-KiB signaling from
DISC-I antagonizes caspase signaling from DISC-II by in-
ducing transcription of survival factors, such as c-FLIPL,
which regulate caspase-8 activation (Micheau et al.,
2001, 2002). In many cell types, the proapoptotic func-
tions of TNF are also antagonized by mitogenic cytokines
such as EGF, insulin, and IGFs (Garcia-Lloret et al., 1996;
Qian et al., 2001; Wu et al., 1996). EGF, insulin, and IGFs
bind dimeric receptors that signal via adaptor proteins to
ERK, Akt, and other kinase pathways (Figure 1A; Avruch,
1998; Schlessinger, 2004). Growth-factor receptors re-
spond acutely to changes in exogenous ligands and also
transduce chronic signals arising from constitutive auto-
crine stimulation. Autocrine signaling is critically important
for the survival and the progression of many cancers
(Hambek et al., 2001; Torrance et al., 2000), and small-
molecule- and antibody-based therapies have therefore
been developed to disrupt receptor-ligand binding, recep-
tor dimerization, and signaling (Hofmann and Garcia-
Echeverria, 2005; Mendelsohn and Baselga, 2000). The
possibility that these drugs have secondary effects on
inflammatory signaling has not been investigated exten-
sively, despite evidence linking inflammation and cancer
(Karin and Greten, 2005).
In this paper, we combine conventional and high-
throughput experimental methods with numerical analysis
to uncover mechanisms of crosstalk involving pro- and
antiapoptotic signals induced by TNF. Time-dependent
profiles of 19 intracellular signals were measured in cells
costimulated with TNF and either EGF or insulin (two pro-
totypical survival factors) to create a cytokine-signaling
compendium of -8000 measurements. We describe else-
where the experimental methods used to collect, validate,
and systematize the compendium (Gaudet et al., 2005)
and focus here on the surprising finding that a large frac-
tion of TNF-induced crosstalk occurs extracellularly via
regulated shedding of autocrine cytokines. We find that
TNF activates a multistep, time-varying "autocrine cas-
cade" in which three secreted factors other than TNF
play pro- and antiapoptotic roles: transforming growth
factor-ca (TGF-m), interleukin-l a (IL-ia), and interleukin-1
receptor antagonist (IL-1ra). Intracellular signaling acti-
vated by these cytokines specifies the extent of TNF-
induced apoptosis in a self-limiting fashion. While elucida-
tion of the TNF-TGF-a-IL- x-IL-1ra autocrine cascade
involved statistical analysis of a large data compendium,
key hypotheses were independently validated using a
combination of neutralizing antibodies, small-molecule
drugs, and receptor antagonists. We conclude from both
large-scale and directed experiments that extracellular
autocrine crosstalk plays as important a role as intracellu-
lar crosstalk in coordinating cellular responses to TNF.
RESULTS
To explore crosstalk between conflicting mitogenic and
apoptotic signals, HT-29 human colonic adenocarcinoma
cells were stimulated with TNF in combination with either
EGF or insulin. The potency of TNF as a proapoptotic fac-
tor in epithelial cells is most apparent when combined with
immunostimulatory cytokines such as interferon-y (IFN-y;
Fransen et al., 1986). Thus, ten combinations of TNF, insu-
lin, and EGF, at either subsaturating ("low" or "L-") or sat-
urating ("high" or "H-") concentrations, were added to
HT-29 cells pretreated with IFN-y for 24 hr (see Experi-
mental Procedures; Figures 1 B-1 D). A "mock" treatment
("0"), in which cells were manipulated as in other experi-
ments but without added cytokine, served as a baseline
control (Figure 1B and data not shown). Triplicate cell ex-
tracts were prepared at 13 time points spanning 0 min
(before stimulus) to 24 hr, and 19 protein measurements
made from each extract. Since many kinase signals
Figure 1. Design and Collection of a TNF-EGF-Insulin Signaling Compendium
(A) Schematic of well-recognized intracellular signaling proteins shared by TNF, EGF, and insulin. Nineteen signals (parentheses) were selected
throughout the network and measured by high-throughput kinase assay (Janes et al., 2003), Western blotting, or antibody (Ab) microarray (Nielsen
et al., 2003). P/total EGFR (signal 6) and P/total Akt (signal 15) signals were defined by taking the ratio of the phospho- and total signals measured by
antibody microarray. Signals were defined as "T" signals (red or black), "E" signals (green), or "I" signals (blue) as described in the text. Dashed ar-
rows indicate transcriptional pathways.
(B) Dose response for HT-29 apoptosis induced by various concentrations of TNF. Apoptosis was measured at 24 hr by annexin V-propidium iodide
staining and flow cytometry as described in Experimental Procedures. Mock (0), low (L), and high (H) TNF concentrations were defined at 0, 5, and
100 ng/ml (red).
(C and D) Growth-factor antagonism of TNF-induced apoptosis. HT-29 cells were costimulated with 100 ng/ml TNF (H-TNF) and 100 ng/ml EGF
(H-EGF, [C]) or 500 ng/ml insulin (H-insulin, [D]) and compared against 100 ng/ml TNF alone (red) for apoptosis at 12, 24, and 48 hr as described
in (B). Percent survival was calculated as described (Janes et al., 2003). Baseline apoptosis values for H-TNF alone were 17%, 36%, and 60% at
12, 24, and 48 hr, respectively.
(E) Signaling network response to 100 ng/ml TNF (H-TNF) and 100 ng/ml EGF (H-EGF). Signals are referenced by number to the targets specified in
(A). Data are presented as the mean ± SEM of triplicate biological samples as described in Experimental Procedures. Nine combinations of TNF, EGF,
and insulin (shaded boxes, with H-TNF + H-EGF shaded dark gray), as well as a tenth combination of 0.2 ng/ml TNF + 1 ng/ml insulin, were similarly
measured and are available in the Supplemental Data.
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Figure 2. DPLSR Mapping of Intracellular Crosstalk in the Network Shared by TNF, EGF, and Insulin
Data were mapped as described in Experimental Procedures and in Figure S1 (Janes et al., 2004). The numbers, colors, and markers are identical to
those in Figure 1E, except for cleaved caspase-8 (signal 18), which has been changed from black to red for clarity. The gray box indicates the crosstalk
region shared by TNF, EGF, and insulin.
13
exhibit rapid changes between 0 and 30 min, whereas
caspases rise slowly in activity over many hours, the 13
time points were distributed unevenly, with seven "early"
time points concentrated at t = 0-2 hr and six "late" time
points spread from t = 4-24 hr. The net result was a multi-
dimensional data set describing time-dependent changes
in protein activities following the stimulation of cells with
ten distinct cytokine cues.
Considerable effort was expended to ensure the repro-
ducibility and self-consistency of the data (Gaudet et al.,
2005). The median coefficient of variation for biological re-
peats across the full data set was ~11%, making it possi-
ble to detect changes in protein state or activity as small
as +15%-25%, even between experiments performed
on different days. Inspection of the complete 7980-
measurement data set revealed several distinct time
courses of signaling. We observed fast-acting "transient"
signals, such as c-Jun N-terminal kinase 1 (JNK1) activity,
which peaked at 15 min and returned to baseline by 1 hr
(Figure 1E, signal 2). Many examples of "sustained" or
slow-rising signals were also observed, such as cleaved
caspase-8 levels, which began to increase at t > 2 hr
and remained high for the duration of the observation pe-
riod (Figure 1 E, signal 18). Based on information in the lit-
erature, the 19 measurements acquired at each time point
were roughly characterized as TNF-dependent ("T" sig-
nals), EGF-dependent ("E" signals), or insulin-dependent
("I" signals; see Figure 1A). Importantly, each cytokine
treatment elicited multiple classes of signals: high TNF ac-
tivated both T and E signals, and high TNF + high EGF elic-
ited T, E, and I signals (Figure 1 E and data not shown). We
therefore conclude that, as expected, TNF, EGF, and insu-
lin exhibit significant crosstalk at the level of intracellular
protein signals.
Mapping Intracellular Crosstalk onto a Shared
Cytokine-Signal Space
To visualize connections between intracellular signals and
cytokine treatments in a simple and intuitive way, we con-
structed a compact representation of the entire compen-
dium by using discriminant partial least squares regres-
sion (DPLSR; Janes et al., 2004). A DPLSR map was
created such that the signaling proteins and cytokines
were projected onto a set of "principal components"
that maximized covariation between the time-integrated
signaling profiles and the corresponding cytokine treat-
ment (see Figure S1 in the Supplemental Data available
with this article online for details). The first principal com-
ponent in the DPLSR map corresponded to a baseline that
distinguished all cytokine treatments from mock stimula-
tion, whereas the second and third principal components
discriminated among TNF, EGF, and insulin treatments
(Figure S1 and data not shown). The latter two principal
components therefore identified cytokine-specific signals
as well as instances where two or more cytokine pathways
had converged upon a common signaling protein.
By plotting cytokine treatments and integrated signals
along the two dimensions defined by the second and third
principal components, the extent of covariance among
signals and treatments could be evaluated. Some cases
of covariation were expected: For example, the cleavage
of caspase-8 mapped close to TNF (Figure 2, signal 18),
consistent with evidence that caspase-8 is activated by
TNFR via formation of DISC-II (Micheau and Tschopp,
2003). Similarly, three measures of Akt activity (signals
13-15) mapped close to insulin, which is a powerful
inducer of Akt signaling (Avruch, 1998). Sometimes, the
map position suggested unexpected biological regula-
tion: For example, the phosphorylation of IRS1 on Y896
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Figure 3. TNF Activates an Early-Phase TGF-oE Autocrine Circuit to Crosstalk through the EGFR-MEK-ERK Signaling Pathway
(A) Comparison of P-MEK (upper) and ERK (lower) signaling dynamics induced by 100 ng/ml TNF (H-TNF, left), 5 ng/ml TNF (L-TNF, center), and
500 ng/ml insulin (H-insulin, right). EGFR phosphorylation was similarly increased in response to TNF (data not shown).
(B) Comparison of P-MEK (upper) and ERK (lower) signaling dynamics induced by 100 ng/ml EGF (H-EGF).
(C) TGF-a release in response to 5 ng/ml TNF (L-TNF) in the presence of 10 ig/ml C225 pretreatment for 1 hr before stimulation. The control treatment
was a mock stimulation with carrier only. Similar results were obtained in the absence of C225 (data not shown).
(D and E) TNF-induced E signaling through EGFR. pMEK (D) and ERK (E) signaling were measured after stimulation with 5 ng/ml TNF (L-TNF) in the
presence or absence of 10 gg/ml C225 pretreatment.
(F) Perturbation of TNF-induced ERK activation by pretreatment with 10 pig/mi C225, 1 iM AG1478, or 10 1iM batimastat for 1 hr before stimulation
with 5 ng/ml TNF (L-TNF) for 15 min. 0.1 % DMSO was added as a control pretreatment (No pretx). ERK activity from untreated cells was included as
a baseline, and ERK activation was defined as the increase in ERK activity compared to these untreated cells.
Data are presented as the mean ± SEM of triplicate biological samples as described in Experimental Procedures.
(P-IRS1 (Y896); signal 10) was closely associated with EGF
but not insulin (Gaudet et al., 2005). Of greatest interest
was the clustering of signals midway between TNF,
EGF, and insulin, possibly implying covariance of the sig-
nals with two or more cytokines (Figure 2, gray box). When
the Euclidean distance between cytokine cues and signals
in this central cluster was calculated, E signals such as
EGFR (Figure 2, signal 4), ERK (signal 8), and MAPK-
ERK kinase (MEK, signal 7), were found to be roughly equi-
distant to TNF and EGF cytokine stimuli but significantly
farther from insulin (p < 0.05). Inspection of individual
cytokine time courses confirmed that TNF treatment acti-
vated EGFR, ERK, and MEK to a similar extent as EGF it-
self, whereas insulin did not (Figures 3A and 3B and data
not shown). Others have noted crosstalk between TNF
and EGF (Chen et al., 2004; Izumi et al., 1994), supporting
247
the paradoxical conclusion that TNF activates EGFR and
its downstream targets MEK and ERK with strength and
kinetics similar to EGF.
Rapid Activation of a TGF-oc Autocrine Circuit by TNF
A direct intracellular link from activated TNFR to ERK has
not been established, but TNF can induce the shedding of
EGF-family ligands in mammary epithelial cells following
24 hr of stimulation (Chen et al., 2004). HT-29 cells also
shed ligands of the EGF family (Anzano et al., 1989), so
we asked whether TNF could stimulate this shedding with
the rapid kinetics observed for MEK, ERK, and EGFR
activation (Figure 3A and data not shown). EGF-family
ligands known to act as autocrine factors include TGF-a,
amphiregulin (AR), and heparin binding epidermal growth
factor (HB-EGF). Quantitative ELISA measurements of
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EGF-family ligands in conditioned medium of HT-29 cells
before and after TNF addition showed all three to be pres-
ent, but only TGF-a was upregulated by TNF (Figure 3C
and Figure S2). TNF-induced TGF-oa release in HT-29 cells
was much faster than previously reported (Chen et al.,
2004), peaking 1 hr after TNF addition (Figure 3C). Thus,
TNF stimulation is associated with near-immediate
release of an EGFR ligand, TGF-a, into the medium. Al-
though transcriptional upregulation of TGF-a by growth-
factor signaling pathways has been reported (Schulze
et al., 2001), the rapidity of TGF-a release after TNF treat-
ment suggests a posttranslational mechanism.
Addition of exogenous EGF rapidly activated MEK and
ERK in HT-29 cells (Figure 3B). We therefore asked
whether TNF-stimulated release of endogenous TGF-ac
also activated MEK and ERK in an EGFR-dependent fash-
ion. When cells were treated with C225 antibody to block
the interaction of EGFR with its ligands (Figure S3), dra-
matic inhibition of both acute (t = 0-2 hr) and sustained
(t = 2-24 hr) MEK-ERK activation was observed after
TNF treatment (Figures 3D and 3E). The significant and
persistent reduction in MEK-ERK signaling following TNF
stimulation (4-fold lower at t = 30 min, p < 0.005 and
2-fold lower at t = 4-24 hr, p < 10-6) demonstrates a pre-
dominantly EGFR-dependent pathway. ERK activation
was also blocked by a small-molecule inhibitor of the
EGFR kinase (AG1478) and an inhibitor of the matrix me-
talloproteases that mediate TGF-ac shedding from the
plasma membrane (batimastat; Peschon et al., 1998; Fig-
ure 3F). Taken together, these data show that an autocrine
circuit involving TGF-a and EGFR is the primary mecha-
nism by which TNF activates MEK-ERK signaling at
both short (t < 1 hr) and long (t > 4 hr) timescales in
HT-29 cells. The delay between the peak of direct ERK
activation by EGF at t = 5 min and indirect activation by
TNF at t = 15 min is an estimate of the minimum time
required to establish the TNF-induced TGF-o autocrine
circuit (Figure 3A).
TNF Activates a Late-Phase IL-1oa Autocrine Circuit
Further inspection of the DPLSR map revealed that IKK
activity (Figure 2, signal 1) was also unexpectedly distant
from its presumed inducer, TNF. JNK1 and MK2 are two
well-recognized TNF-induced signals that, unlike IKK,
were close to TNF on the DPLSR map (Figure 2, signals
2 and 3; Wajant et al., 2003). We therefore compared the
dynamics of their activation to that of IKK. All three T sig-
nals were strongly induced 5-30 min after TNF addition,
but IKK was unique in exhibiting a second, sustained
phase of activation, rising from 4-24 hr (Figures 4A-4C).
In the classical TNF-induced pathway, IKK phosphory-
lates and inactivates IKB, an NF-KB inhibitor, which allows
NF-KB to translocate into the nucleus and induce gene ex-
pression (Karin and Ben-Neriah, 2000). By immunofluo-
rescence, we found that the p65 subunit of NF-KB-which
was largely cytoplasmic before TNF stimulation, reflecting
its sequestration by IKB (Figure 4D)-was present at high
levels in the nucleus in TNF-treated cells during early (t =
30 min) and late (t = 24 hr) peaks of IKK activation (Figures
4E and 4F). Thus, the two distinct phases of IKK signaling
both appear to activate NF-KB. However, since JNK1 and
MK2 activities had returned to low levels by t = 1 hr
(Figures 4A and 4B), it seemed unlikely that sustained
IKK and NF-KB signaling at t > 4 hr was mediated directly
by TNF.
One circumstance in which sustained NF-KB activation
is well described is in ultraviolet-irradiated keratinocytes,
where late NF-KB signaling is known to depend on sec-
ondary release of IL-1 a (Bender et al., 1998). Because
IL-1 cytokines are potent IKK agonists (Dinarello, 1997),
we asked whether TNF treatment of HT-29 cells might
lead to IL-1 release and whether IL-1 would provoke sus-
tained IKK activation. We observed an 8-fold increase in
soluble IL-1 a, but not IL- P1, in conditioned medium from
TNF-treated cells 12-24 hr after TNF addition (Figure 4G).
HT-29 cells are known to express the IL-1 receptor (IL-1 R;
Panja et al., 1998), and we found that exogenous IL-1 a
activated IKK at concentrations as low as 30 pg/ml (Fig-
ure 4H), consistent with the recognized ligand sensitivity
of IL-1R (Dinarello, 1997). Thus, HT-29 cells are IL-1 re-
sponsive and secrete IL-1 a after TNF stimulation, sug-
gesting that IL-1 a might constitute a TNF-dependent acti-
vator of IKK.
To determine whether IKK activation in TNF-treated
cells was dependent on secreted IL-1 a, IKK activity was
measured in cells treated with high TNF in the presence
of saturating levels of IL-1ra, a naturally occurring IL-1R
antagonist (Figure S3; Dinarello, 2000). We observed
that activation of IKK 15-30 min after TNF addition was un-
altered by IL-1ra, consistent with a direct pathway via
TNFR (Figure 41). However, sustained IKK activation
4-24 hr after TNF addition was significantly reduced by
IL-1 ra addition (p < 0.001; Figures 4C and 41). Substantial
reductions in TNF-induced IKK activity at 24 hr were also
observed with ALLM and PD150606, two structurally dis-
tinct calpain inhibitors that block processing and release
(H) IKK activity induced by recombinant IL-1 co. HT-29 cells were stimulated with various concentrations of exogenous IL-l a for 10 min and analyzed
for IKK activity.
(I) IKK response to 100 ng/ml TNF (H-TNF) with 10 pg/ml IL-lra cotreatment. Cells were treated and measured for IKK activity as shown in (C) but in the
presence of IL-lra.
(J) Perturbation of TNF-induced IKK activation by cotreatment with 10 [pg/ml IL-ira, 25 jM ALLM, 25 pM PD1 50606, or 1 lig/ml anti-lL-l ac during stim-
ulation with 100 ng/ml TNF (H-TNF) for 24 hr. IKK activity from untreated cells was included as a baseline, and IKK activation was defined as the in-
crease in IKK activity compared to these untreated cells.
(K) Timeline of TNF-induced TGF-a and IL-1 a autocrine circuits and autocrine-dependent signals.
For (A)-(C) and (G)-(J), data are presented as the mean ± SEM of triplicate biological samples as described in Experimental Procedures.
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of IL-1 a from cells (Kobayashi et al., 1990), as well as with
IL-l c-neutralizing antibodies (Figure 4J). Together, these
data show that IKK signaling at t < 4 hr is independent of
IL-l a but that sustained IKK activation at t > 4 hr (which
is quantitatively more significant in HT-29 cells;
Figure 4C) is mediated primarily by the binding of IL-ia
to IL-1R (Figure 4K). Thus, the early and late phases of
IKK activation in TNF-treated HT-29 cells involve distinct
direct and autocrine-indirect mechanisms.
Coupling of Sequential Autocrine Circuits
into an Autocrine Cascade
The data described above establish that TGF-a and IL-1 a
autocrine circuits play important roles in the activation of
MEK-ERK and IKK by TNF, but it remained unclear
whether autocrine-dependent signaling altered the activ-
ity of caspases directly implicated in apoptosis. To study
this, we blocked TGF-a- and IL-1 a-dependent circuits in-
dividually and measured the cleavage of caspase-8, an
important initiator caspase downstream of TNFR (Chen
and Goeddel, 2002). Blocking IL-1R with IL-1ra signifi-
cantly reduced TNF-stimulated cleavage of caspase-8
compared to TNF alone (p < 10-9; Figure 5A). Conversely,
blocking EGFR with C225 significantly increased TNF-in-
duced caspase-8 cleavage (p < 0.001; Figure 5B). Thus,
TNF-induced TGF-a and IL-l a exert opposing control on
caspase-8 (Figure 5C). To determine how broad an effect
EGFR or IL-1R blockade had on TNF-induced signaling,
full time courses were collected for the 19 signals after
TNF stimulation in the presence of IL-1ra or C225. When
autocrine-perturbed time courses were compared to
data in the original cytokine-signaling compendium, we
found that the durations or magnitudes of roughly half of
the measured signals were altered (Figures 5D and 5E).
Thus, discrete perturbation of an autocrine circuit causes
a system-wide alteration in the underlying intracellular sig-
naling network.
The opposing contributions of TGF-a and IL-1 a to TNF-
induced caspase-8 cleavage implied that blocking EGFR-
mediated signaling should decrease cell survival, whereas
blocking IL-1R-mediated signaling should decrease cell
death (Figure 5C). Consistent with this, we observed that
TNF was less effective as a prodeath stimulus when
IL-c a signaling was blocked with IL-1ra (Figure 5F). The
potency of IL-1ra as a prosurvival factor in TNF-treated
cells was comparable to that of saturating EGF or insulin
(Figures 1C and 1 D). In contrast, blocking TGF-a signaling
with C225 antibody did not substantially increase TNF-
induced cell death (Figure 5G). This was paradoxical
because it implied that the ability of autocrine TGF-a to re-
duce caspase-8 cleavage (Figure 5C) did not translate into
reduced cell death. In an attempt to resolve this paradox,
the 19 signals measured for TNF + C225 treatment were
examined more closely (Figure 5E). We observed that
IKK activity was reduced to baseline levels throughout
the time course, exhibiting neither early- nor late-phase
activation (p < 10-10; Figure 5H). The attenuation of late-
phase IKK signaling (t = 4-24 hr) by C225 was particularly
interesting because our results indicated that late-phase
IKK signaling required an autocrine IL-i a circuit (Figures
4C and 41). Therefore, it seemed possible that induction
of the IL-1 a circuit (and thus late IKK signaling) might de-
pend upon prior release of TGF-a. To determine whether
TGF-a and IL-i a release were linked, we blocked TGF-a-
EGFR signaling with C225 and measured IL-l a levels fol-
lowing TNF stimulation. EGFR blockade with C225 com-
pletely prevented IL-1 c release at low TNF concentrations
(Figure 51) and significantly reduced IL-1 a release at high
(C) Autocrine TGF-m (A-TGF-a) and autocrine IL-la (A-IL-la) exert opposing control on TNF-induced caspase-8 cleavage.
(D and E) Network-level changes in TNF-induced signaling in the presence of 10 pg/ml C225 pretreatment (D) or 10 gpg/ml IL-ira cotreatment. Selected
intracellular signals from C225- and IL-1ra-treated cells were integrated from 0-24 hr and compared to the integrated signals from 5 ng/ml TNF
(L-TNF) and 100 ng/ml TNF (H-TNF) treatments without autocrine perturbation, respectively. Uncertainty in the integrated signaling profiles was cal-
culated by bootstrapping with the original signaling replicates (Efron and Tibshirani, 1993).
(F) IL-1 i-mediated synergism with TNF-induced apoptosis. HT-29 cells were cotreated with 100 ng/ml TNF (H-TNF) and 10 pRg/ml IL-ira and com-
pared against H-TNF alone (red) for apoptosis at 12, 24, and 48 hr as described in Figure 1B (Janes et al., 2005). Baseline apoptosis values for H-TNF
alone were 17%, 45%, and 67% at 12, 24, and 48 hr, respectively.
(G) TGF-a-mediated antagonism of TNF-induced apoptosis. HT-29 cells were pretreated with 10 pg/ml C225, stimulated with 5 ng/ml TNF (L-TNF),
and compared against L-TNF alone (red) for apoptosis at 12, 24, and 48 hr as described in Figure 1B (Janes et al., 2005). Baseline apoptosis values for
L-TNF alone were 11%, 24%, and 47% at 12, 24, and 48 hr, respectively.
(H) IKK response to 5 ng/ml TNF (L-TNF) with or without 10 pig/ml C225 pretreatment.
(I) IL-la release induced by 0 or 5 ng/ml TNF with or without 10 pig/ml C225 pretreatment. The control treatment was a mock stimulation with carrier
only.
(J) TGF-a-mediated antagonism for TNF-induced apoptosis. HT-29 cells were treated with various concentrations of TGF-s and 5 ng/ml TNF (L-TNF)
and compared against L-TNF alone (red) for apoptosis at 24 hr as described in Figure 1B (Janes et al., 2005). Baseline apoptosis for L-TNF alone was
33%.
(K) IL-1ra release in response to 100 ng/ml TNF (H-TNF). The control treatment was a mock stimulation with carrier only.
(L) The IL-l a autocrine circuit is induced by TNF but not by TGF-a. HT-29 cells were treated with 100 ng/ml TNF (H-TNF) or 100 ng/ml TGF-a for 24 hr
and analyzed for IL-1 a release.
(M) The TGF-a autocrine circuit is induced by TNF but not by IL-la. HT-29 cells were treated with 100 ng/ml TNF (H-TNF) or 10 ng/ml IL- a for 24 hr
and analyzed for TGF-a release.
(N) The molecular logic of the TNF-induced autocrine cascade. TNF, TGF-s, and IL-l a are coupled via an "AND" gate.
For (A)-(B) and (F)-(M), data are presented as the mean ± SEM of triplicate biological samples as described in Experimental Procedures. For (D) and
(E), data are presented as the mean percent change ± SD from 1000 resamplings of the original data set.
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TNF concentrations (Figure S4). Thus, proper function of
the IL-1 a autocrine circuit was dependent on the prior es-
tablishment of an EGFR-mediated TGF-c circuit.
The observed coupling between TGF-c and IL-1 a auto-
crine circuits explains the inability of EGFR blockade to al-
ter TNF-induced cell death significantly. In TNF-treated
cells, C225 increased cleaved caspase-8 levels and re-
duced MEK-ERK signaling (which is generally regarded
as a prosurvival signal; Ballif and Blenis, 2001), but C225
also prevented IL-l a release (Figure 51), which mediates
proapoptotic signals via IL-1R (Figure 5F). The ability of
C225 to block the offsetting TGF-a- and IL-l c-dependent
pathways implied that conditions could be found in which
EGFR and IL-1R signals were not perfectly balanced. At
some concentrations, TGF-a might act as a prosurvival
factor and at others as a proapoptotic factor. To test this
idea, cells were exposed to TNF in combination with exog-
enous TGF-a at 0.3-100 ng/ml, and the fraction of dying
cells was measured. We observed that, at low concentra-
tions, TGF-a was proapoptotic in combination with TNF,
whereas at higher concentrations, it was prosurvival (Fig-
ure 5J), confirming our prediction.
The link between the TGF-a and IL-1 a autocrine circuits
raised the possibility that additional extracellular factors
might contribute to TNF signaling and cellular responses.
In recent microarray studies, we observed that transcrip-
tion of the IL-lra gene was strongly upregulated by TNF
(K.A.J. and P.K.S., unpublished data). ELISA measure-
ments on conditioned medium of HT-29 cells revealed
that IL-1ra protein accumulated to significant levels 12 hr
after TNF stimulation (Figure 5K). However, unlike IL-lca,
TNF-induced IL-1ra release was unaffected by pretreat-
ment with C225 antibody, indicating that IL-1 ra induction
does not require autocrine TGF-a (Figure S5). Thus,
IL-1ra constitutes a third TNF-inducible autocrine factor,
one with a prosurvival function (Figure 5F; Dinarello, 2000).
The successive waves of extracellular signaling circuits
induced by TNF suggest the existence of an autocrine
cascade involving TNF, TGF-a, IL-la, and IL-1ra. The
most interesting features of the cascade are the connec-
tions between individual autocrine circuits: TGF-c is re-
quired for IL-l1 release, and IL-1ra inhibits the action of
IL-ic. Is there a contingent logic underlying the order in
which these signals are released? We found that the link
between TGF-a and IL-l a (Figure 51) was not reciprocal
because addition of exogenous IL-1 a did not induce shed-
ding of TGF-a (Figure 5L). Moreover, exogenous TGF-a
was not sufficient to provoke IL-l a release (Figure 5M),
implying that signals from both TNFR and EGFR are re-
quired. The TGF-a and IL-la circuits are therefore linked
together unidirectionally. TNF and TGF-a comprise inputs
to an "AND" function that induces IL-la, which is subse-
quently inactivated by IL-1ra (Figure 5N).
Evidence for a TNF-Induced Autocrine Cascade
in Diverse Epithelial Cell Types
To examine whether TNF-induced autocrine cascades are
a conserved feature of TNF-responsive cells, we tested
other epithelial cell lines for the essential features of the
TGF-a-IL-c-IL-lra cascade. Specifically, we asked
whether TNF would stimulate (1) release of TGF-a (Fig-
ure 6A), (2) release of IL-l a in an EGFR-dependent manner
(Figure 6B), and (3) release of IL-1ra (Figure 6C). We fo-
cused on two human cell lines known to have receptors
for TNF, EGF, and IL-1: A431 epidermoid carcinoma cells
and nontransformed 184A1 human mammary epithelial
cells (HMEC; Chen et al., 2004; Masui et al., 1993).
Both A431 and immortalized HMEC cells were treated
with TNF, and cytokine levels were measured at t = 0, 2,
and 24 hr by ELISA (Figures 6D-61). We found that TGF-c,
IL-lac, and IL-1ra levels all increased in A431 cells after
TNF treatment. In particular, TGF-a release was nearly
as rapid as in HT-29 cells. TNF-stimulated IL-la release
in A431 cells was inhibited significantly but not completely
by C225, probably reflecting incomplete blockade of high
EGFR levels on the surface of these cells (Masui et al.,
1993). In analogous experiments with TNF-simulated
HMEC cells, we found that TGF-a levels increased dra-
matically over a 24 hr period, IL-ia levels increased
>2.5-fold, and IL-ra levels increased >4-fold. Moreover,
TNF-induced release of IL-la into the medium was
blocked almost completely by C225 anti-EGFR antibody.
Thus, all three extracellular components of the TNF-stim-
ulated TGF-a-IL-1 c-IL-1 ra autocrine cascade are present
in HMEC cells, and induction of the IL-ia circuit is almost
completely dependent on prior establishment of the TGF-
a-EGFR circuit. The primary difference between HT-29
and HMEC cells is in the timing of TGF-a release, which
was considerably slower in HMECs, perhaps reflecting
a requirement for protein synthesis. Together, these data
indicate that a TNF-induced autocrine cascade consisting
of TGF-c, IL-1 a, and IL-1 ra cytokines exists in multiple ep-
ithelial cell types.
DISCUSSION
In this paper, we show that TNF induces three successive
autocrine circuits, which together form an autocrine cas-
cade that plays out over 24 hr (Figure 7A). Working in com-
bination with TNF itself, the cascade adds layers of pro-
and antiapoptotic signaling to set the level of apoptosis
in a self-limiting fashion. Shortly after TNF addition, pro-
apoptotic signals immediately downstream of TNFR bind-
ing are induced. About 10 min later, an autocrine TGF-a
circuit is established, leading to prosurvival signaling
through EGFR. The combination of TNF and TGF-a causes
release of IL-1 i starting at 4 hr, which in turn activates pro-
death signaling through IL-1R. Finally, upregulation of the
IL-1R antagonist IL-1ra by 8-12 hr negatively regulates
IL-1R signaling and presumably constitutes a final anti-
apoptotic stimulus. Our work highlights the important
but underappreciated role of autocrine crosstalk in deter-
mining cell fate. Individual autocrine circuits have previ-
ously been studied in multiple cellular contexts. However,
extended connectivity between inducible autocrine cir-
cuits has not been reported previously, perhaps because
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Figure 6. The Basic Elements of the TNF-Induced Autocrine Cascade Are Present in Other Epithelial Cell Types
(A-C) Main elements of the TNF-induced autocrine cascade: release of TGF-a (A), release of IL- l in a TGF-a-dependent manner (B), and release of
IL-lra (C).
(D and E) The TNF-induced autocrine cascade exists in A431 cells. A431 cells were stimulated with 100 ng/ml TNF + 10 ig/ml C225 (H-TNF) (D-F) or
100 ng/ml TNF alone (E) and analyzed for TGF-a at 2 and 24 hr (D), IL-l a at 24 hr (E), and IL-1ra at 24 hr (F). The control treatment was a mock stim-
ulation with carrier only.
(G-l) The TNF-induced autocrine cascade exists in human mammary epithelial cells (HMEC). HMEC cells were stimulated with 100 ng/ml TNF (H-TNF)
(G-l) or 100 ng/ml TNF (H-TNF) + 10 Rig/ml C225 (H) and analyzed for TGF-a at 2 and 24 hr (G), IL-l1 at 24 hr (H), and IL-1ra at 24 hr (I). The control
treatment was a mock stimulation with carrier only.
For (D)-(I), data are presented as the mean ± SEM of triplicate biological samples as described in Experimental Procedures. n.d., not detectable.
such linkages are only evident when large, multidimen-
sional signaling data sets are examined.
Data, Statistical Mining, and Hypotheses
The construction of a systematic time-dependent com-
pendium of cellular signals has been essential to our anal-
ysis of TNF. The 7980-measurement compendium con-
tains quantitative information on 19 activities and states
of kinases, caspases, transcription factors, adaptors, and
other signaling proteins distributed across signaling net-
works downstream of TNFR, EGFR, and insulin receptor
(Figure 1A). An advantage of constraining measurements
to a limited number of proteins is that it becomes practical
to examine many different cytokine combinations at mul-
tiple points in time. The experimental precision and repro-
ducibility of the measurements also made it possible to
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study small (i.e., less than 2-fold) but biologically signifi-
cant differences in signals from one cytokine treatment
to the next. Our proteomic compendium is far from com-
prehensive, but, in the context of signal transduction, the
multicomponent, multicytokine time courses represent
a useful advance over more focused studies because
they place dynamic information within a broader physio-
logical context.
A major challenge with large experimental compendia is
generating experimentally testable biological hypotheses.
Here, we use DPLSR to derive a visually intuitive map from
time-integrated signals (Janes et al., 2004). In related
work, we construct alternative models that explicitly incor-
porate time-course data (Janes et al., 2005). Both analy-
ses show that a TNF-induced autocrine cascade is critical
in determining cell fate. However, it is important to note
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Figure 7. Model of TNF-Induced Extracellular Crosstalk
(A) Sequence of the time-dependent TNF-induced autocrine cascade
established by TGF-a, IL-1 a, and IL-1ra.
(B) Direct and autocrine-indirect intracellular signals activated by TNF.
(C) Approved pharmaceuticals that target different points of the TNF-
induced autocrine cascade.
that, despite the importance of compendium data for hy-
pothesis generation, critical features of the TNF-induced
autocrine cascade were confirmed by independent exper-
imentation without reference to DPLSR analysis. Hypoth-
esis-testing experiments took advantage of highly spe-
cific (and clinically important) inhibitors of EGF and IL-1
signaling.
Intracellular Regulators of the TNF-Induced
Autocrine Cascade
This study focuses on the role played by extracellular
crosstalk in the response of cells to TNF (Figure 7B). How-
ever, intracellular crosstalk is equally important for regu-
lating signaling proteins by two or more receptor types.
We estimate that -50% of signaling in HT-29 cells is
attributable to autocrine factors induced by TNF and
-50% is dependent on direct signals downstream of
TNFR. One clear point of intersection between internal
and external signals is the regulation of metalloproteases
and calpains, which cleave inactive membrane bound pre-
cursors to promote TGF-ac and IL-1 a shedding (Kobayashi
et al., 1990; Peschon et al., 1998). The importance of me-
talloprotease and calpain activity for the TNF autocrine
cascade is demonstrated by the effectiveness of small-
molecule protease inhibitors in blocking autocrine ligand
CUP&$"
Ias
release. Regulation of membrane proteases is an area of
active research (Goll et al., 2003), and increasing evidence
suggests a role for protease phosphorylation (Fan and
Derynck, 1999; Glading et al., 2004). However, current un-
derstanding of metalloprotease and calpain phosphoryla-
tion is insufficient to explain the dynamics of the TNF-
induced autocrine cascade in HT-29 cells. For example,
ERK has been implicated in cytokine-stimulated shedding
of TGF-a (Fan and Derynck, 1999). However, most TNF-
induced ERK activation occurs as a consequence (rather
than a cause) of TGF-a release. Detailed analysis of prote-
ase regulation will be critical to understanding the auto-
crine cascades described here.
Molecular Logic of the Autocrine Cascade
TNF is known to stimulate the release of many soluble fac-
tors, but most are thought to act in a paracrine fashion
(Pahl, 1999); very few studies have established a role for
TNF in autocrine signaling (Chen et al., 2004). Likewise,
crosstalk in intracellular networks is well recognized (Du-
mont et al., 2002), but extracellular crosstalk involving
multiple autocrine signals has not been explicitly docu-
mented. The most striking feature of the TNF-induced
autocrine cascade described here is its conditional "mo-
lecular logic." Activation of the IL-1 a circuit requires prior
TGF-a. release, but TGF-a-IL-I a interaction depends on
the presence of TNF because exogenous TGF-a alone
does not cause IL-I a release. TGF-a-IL-a crosstalk is
also unidirectional: exogenous IL-I a does not cause
TGF-a release. Likewise, IL-1ra is presumed to inhibit
IL-la signaling (Dinarello, 2000), but IL-1ra release is al-
most completely TNF dependent: it is only slightly de-
creased by EGFR blockade and only slightly induced by
exogenous IL-ol (K.A.J. and P.K.S., unpublished data).
These and other data reemphasize the complexity and
current lack of understanding of the metalloprotease and
calpain regulation in autocrine signaling.
Biological and Clinical Significance
Why does the response of cells to TNF involve complex
self-limiting extracellular signals? Overlapping positive
and negative feedback has been proposed as a means
to optimize the sensitivity and stability of biological sys-
tems (Stelling et al., 2004). A role for autocrine circuits in
sensing spatial ranges and local environmental cues has
also been documented (Wiley et al., 2003). In agreement
with this, we have found that the precise magnitude of au-
tocrine-dependent apoptotic responses is cell-density
dependent (J.G.A. and P.K.S., unpublished data). Our
data suggest that TNF-induced cytokines do not travel
far before rebinding to cells, but we have not yet estab-
lished whether they bind to the original secreting cell in
true-autocrine mode or whether they diffuse to adjacent
cells in a paracrine fashion. Regardless, it seems likely
that the TNF-TGF-a-IL-la-IL-1ra cascade functions to
link cell-death decisions to extracellular cues and thereby
achieve microenvironment-sensitive control over cell fate
(Figure 7A).
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In the current work, we rely entirely on immortalized
cells grown in vitro. It will now be important to study
TNF-induced autocrine cascades in primary cells, such
as hepatocytes and adipocytes, in which TNF has estab-
lished physiological and pathological roles (Ruan and Lod-
ish, 2003; Streetz et al., 2000). However, the TNF-induced
autocrine cascade discovered in HT-29 cells clearly oper-
ates in a variety of other transformed and nontransformed
cell lines. Like HT-29 cells, A431 and HMEC cells have in-
ducible TNF-TGF-a-IL-I -IL-1ra circuits, although the
timing and magnitude of each loop in the cascade appears
to vary. This suggests that the extent of crosstalk between
autocrine and intracellular networks, and their relative
physiological importance, may depend on cell type and
stimulus. The cell-type specificity of the TNF-induced au-
tocrine cascade clearly warrants further investigation.
Since its discovery three decades ago as an endotoxin-
induced serum factor with tumoricidal activity, TNF has re-
mained an important therapeutic target in a variety of hu-
man diseases (Carswell et al., 1975; Palladino et al., 2003).
Neutralizing anti-TNF antibodies (e.g., Remicade) and de-
coy receptors (e.g., Enbrel) are now used to treat inflam-
matory bowel disease and rheumatoid arthritis (Figure 7C;
Rutgeerts et al., 2004; Sfikakis and Kollias, 2003). How-
ever, clinical trials on sepsis and cancer, once promising
targets for TNF treatment, have been disappointing and
have highlighted the puzzling inefficacy and side effects
of cytokine-directed therapy (Anderson et al., 2004; Rein-
hart and Karzai, 2001). Our experiments provide some in-
sight into why therapeutics targeted against self-limiting
autocrine systems are so difficult to design. For example,
the treatment of TNF-stimulated HT-29 cells with the anti-
EGFR antibody C225 (known commercially as Erbitux)
does not increase the level of apoptosis, even though it
causes extensive changes in both intracellular and extra-
cellular signaling. It is not that Erbitux is inactive against
HT-29 cells, but rather that proapoptotic effects of block-
ing TGF-cz are offset by a reduction in IL-la levels. Under-
standing how autocrine cascades operate in normal and
diseased tissues seems likely to yield significant thera-
peutic insight, particularly with respect to multidrug thera-
pies. Indeed, combination treatments involving anti-TNF
biologics and IL-1ra are already being explored for the
treatment of rheumatoid arthritis (Zwerina et al., 2004).
EXPERIMENTAL PROCEDURES
Cell-Line Treatments and Lysis
HT-29 cells were grown, plated, and sensitized with IFN-y as de-
scribed previously (Janes et al., 2003). Sensitized cells were then
spiked with 0, 0.2, 5, 100 ng/ml TNF (Peprotech) + 0, 1, 100 ng/ml
EGF (Peprotech) or 0, 1, 5, 500 ng/ml insulin (Sigma) as a 20x stock
in serum-free medium. Triplicate plates were lysed at the indicated
times as described (Gaudet et al., 2005; Janes et al., 2003). For
TGF-a perturbation, C225, batimastat (both gifts from H.S. Wiley),
AG1478 (Calbiochem), and anti-TGF-a antibody (R&D Systems) were
added 1 hr before stimulation. For IL-l a perturbation, IL-1 ra (R&D Sys-
tems), ALLM, PD150606 (both from Calbiochem), and anti-IL-la
antibody (R&D Systems) were added at the same time as stimulation.
A431 cells (ATCC) and the HMEC line (Stampfer and Yaswen, 1993)
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were maintained in recommended growth medium, plated at 20,000
cells/cm2 , and sensitized and treated as described for HT-29 cells.
Network-Level Signaling Measurements
Kinase assays, Western blotting, and antibody microarrays were es-
sentially performed as described (Janes et al., 2003, 2004; Nielsen
et al., 2003). The full quantitative details of the network-level signaling
measurements are reported elsewhere (Gaudet et al., 2005). The final
processed data were normalized to the maximum value (across all
conditions) for that signal to aid comparison of signals with different
dynamic ranges.
DPLSR Mapping
Nine of ten cytokine treatments (all except 0.2 ng/ml TNF + 1 ng/ml in-
sulin) were used for the DPLSR mapping. The signaling network dy-
namics were integrated by trapezoidal rule to calculate a composite
metric for each signal within each time course. The integrated signals
and treatment classes were mapped by DPLSR as described previ-
ously (Janes et al., 2004) and in Figure S1.
Enzyme-Linked Immunosorbent Assays
Conditioned medium from HT-29, A431, and HMEC cultures was ana-
lyzed for TGF-a, AR, HB-EGF, IL-a, IL-1B, and IL-ira according to
manufacturer's recommendations (R&D Systems).
Indirect Immunofluorescence
Cells were fixed with 4% paraformaldehyde in PBS for 10 min at room
temperature, then permeabilized with Perm/Wash (BD Biosciences)
and stained with anti-RelA (Santa Cruz, 1:100) and Alexa 594 anti-
rabbit IgG (Molecular Probes, 1:250). Coverslips were mounted with
VectaShield, and imaging was performed with a 63x Plan-Apochro-
mat objective and a Photometrics CoolSnap HQ camera on a Delta-
Vision RT Restoration microscope. 0.2 ýim Z sections were acquired
and deconvolved using Applied Precision SoftWorx software. Images
are shown as individual slices from the reconstructed 3D image.
Apoptosis Measurements
Cells that scored double positive for cleaved cytokeratin (a caspase-3/
6/7 substrate) and cleaved-caspase-3 were measured by flow cytom-
etry or by annexin V-propidium iodide staining as described previously
(Janes et al., 2003). Changes in survival were calculated as before
(Janes et al., 2003).
Statistical Analysis
Covariations within the TNF-EGF-insulin network were calculated as
the Euclidean distance between the signals and the cytokine cues
on the DPLSR mapping (Figure 2); a Bonferroni-corrected Student's
paired t test was used to compare Euclidean distances. For comparing
two individual means, a Student's t test was used. For comparing two
time courses, a two-way analysis of variance was used. All tests were
performed at a significance level of m= 0.05 with Bonferroni correction
for multiple hypothesis testing when appropriate.
Supplemental Data
Supplemental Data include Supplemental References, five figures,
and three tables and can be found with this article online at http://
www.cell.com/cgi/content/full/l 24/6/1225/DC1/.
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A High-throughput Quantitative Multiplex
Kinase Assay for Monitoring Information
Flow in Signaling Networks
APPLICATION TO SEPSIS-APOPTOSIS*
Kevin A. Janes*, John G. Albeck§, Lili X. Pengf, Peter K. Sorgert§§,
Douglas A. Lauffenburgert§11, and Michael B. Yaffe*§1I
To treat complex human diseases effectively, a systems-
level approach is needed to understand the interplay of
environmental cues, intracellular signals, and cellular be-
haviors that underlie disease states. This approach re-
quires high-throughput, multiplex techniques that meas-
ure quantitative temporal variations of multiple protein
activities in the intracellular signaling network. Here, we
describe a single microtiter-based format that simulta-
neously quantifies protein kinase activities in the phos-
phatidylinositol 3-kinase pathway (Akt), nuclear factor-KB
pathway (IKK), and three core mitogen-activated protein
kinase pathways (ERK, JNK1, MK2). These parallel high-
throughput assays are stringently linear, redundantly spe-
cific, reproducible, and sensitive compared with classical
low-throughput techniques. When applied to a model of
sepsis-induced colon epithelial apoptosis, this approach
identified a late phase of Akt activity as a critical mediator
of cell survival that quantitatively contributed to the effi-
cacy of insulin as an anti-apoptotic cue. Thus, sampling
parallel nodes in the intracellular signaling network iden-
tified part of the molecular mechanism underlying the
efficacy of insulin in the treatment of human sepsis.
Molecular & Cellular Proteomics 2:463-473, 2003.
Complex patterns of signal transduction arise when cells
are exposed to combinations of extracellular cues that vary in
onset, duration, origin, and synchrony. Cells process these
cues through an interconnected network of multifunctional,
redundant molecules to elicit a set of phenotypic responses
that subsequently impact function at the cell, tissue, and
organ level. In order to develop a molecular understanding of
the complex pathophysiology underlying human diseases and
utilize this information for prognosis and therapy, a systems-
level, network-biology approach should be applied to the
signaling networks governing the relevant cell responses (1).
This approach will require frequent temporal sampling of pro-
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tein activity at critical nodes within parallel signaling pathways
inside the cell in a quantitative manner to characterize the flow
of information accurately. Such functional measurements are
likely to be as valuable, or more valuable, than measurements
of simple protein abundance. By quantitatively exploring the
functional response of the signaling network to distinct extra-
cellular cues and correlating these molecular events with phe-
notypic responses, one can construct predictive models of
cue-signal and signal-response relationships.
Evolving proteomic approaches to network biology have
largely focused on measuring abundances of many proteins
at only a few time points or under a limited number of exper-
imental conditions (2). Complementary information on func-
tional protein characteristics, such as enzyme activity, has
been lacking in these systematic analyses, in large part be-
cause there do not exist quantitatively robust, high-through-
put techniques that simultaneously measure multiple protein
activities in cells. Initially, this type of data collection on pro-
tein functional status should focus on frequent sampling of a
limited number of key molecules that sit at critical nodes in
different signaling pathways (Fig. 1A).
To begin to address this, we have developed a generalized
assay for the multiplex analysis of multiple protein kinase
activities in a 96-well format. The procedure utilizes parallel
kinase-specific immunopurification steps, followed by rapid
quantitative high-throughput activity measurements within the
linear-rate regime for each kinase. We applied this technique
to measure the activities of five kinases (extracellular-regulat-
ed kinase (ERK)1 (3), Akt, IK-B kinase (IKK), c-jun N-terminal
kinase 1 (JNK1), and mitogen-activated protein kinase-asso-
ciated protein kinase 2 (MK2)) in a sepsis/systemic inflamma-
tory response syndrome (SIRS) model system for tumor ne-
crosis factor-alpha (TNF-a)-induced colon epithelial cell
death.
1 The abbreviations used are: ERK, extracellular-regulated kinase;
IKK, IK-B kinase; JNK1, c-jun N-terminal kinase 1; MK2, mitogen-
activated protein kinase-associated protein kinase 2; PC, phospho-
cellulose; PI 3-K, phosphatidylinositol 3-kinase; SIRS, systemic in-
flammatory response syndrome; TNF-a, tumor necrosis factor-alpha;
DTT, dithiothreitol; IFN-y, interferon gamma; GST, glutathione
S-transferase; CPM, counts per minute.
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We chose this experimental model because, clinically, sep-
sis is the most common cause of death in critically ill patients
and is a prime example of acute, systemic disease mediated
by molecular network dysfunction (4, 5). Despite the multifac-
eted etiology of sepsis, the colonic epithelium represents a
common final effector organ and is a major site for pro-
grammed cell death following injury (6). Epithelial apoptosis is
believed to cause gut barrier dysfunction (7), leading to leak-
age of cytokines and possibly bacteria into the systemic
circulation, thereby exacerbating the inflammatory state.
Thus, the bowel has been postulated to be the "motor" driving
the septic state (8). TNF-a levels are drastically elevated in a
number of forms of human sepsis, and levels correlate with
increased mortality (9). The five kinases whose activities we
measured function downstream of TNF-a as canonical hubs
for signaling pathways that control cell survival, stress re-
sponses, and the onset of programmed cell death (Fig. 1A,
gray nodes) (10-13). Quantitative sampling of the activity of
these kinases in time with the high-throughput multiplex as-
says provided a window into the state of the signaling network
in this model of cytokine-induced human disease.
Due to the complexity of the disease, treatments for sepsis
have proven elusive, with certain monotherapies (e.g. TNF
antagonists (14)) actually worsening patient survival. Intrigu-
ingly, intensive insulin therapy has recently been found to
reduce morbidity in critical illness substantially (15), though
the mechanism underlying this effect is unknown (4). A num-
ber of possibilities have been proposed, including tight regu-
lation of glucose levels (16), antagonism of proinflammatory
molecules (17), and reduction of circulating C-reactive protein
levels (18).
At the molecular level, TNF-a and insulin activate a number
of common signaling pathways that are highly interconnected
(Fig. 1A), and it is difficult to predict a priori how these con-
flicting cues are processed intracellularly to determine cell
fate in physiologically relevant cell types. We hypothesized
that quantitative, dynamic measurement of information flow
through these critical signaling nodes might clarify how net-
work information is processed and reveal new signal-
response relationships involving insulin's mechanism of ac-
tion in sepsis.
We implemented an in vitro model of TNF-induced pro-
grammed cell death in a human colon epithelial cell line that
survives TNF-a treatment when costimulated with insulin. The
network response to TNF-a and insulin as combinatorial cues
in this model system was then explored by performing over
400 independent kinase activity measurements with the high-
throughput assays. A significant reduction in TNF-induced
colon epithelial death was observed upon insulin treatment.
This correlated with a profound change in the pattern of Akt
kinase activity, with only minor perturbations observed in the
activities of other kinases that were assayed. We were able to
attribute at least half of the insulin-induced survival effect to
the specific activation of the Akt pathway at late times. Im-
portantly, we found that the addition of insulin 4 h after TNF-a
addition provided sufficient late-phase Akt activity to elicit the
same survival effect as when insulin was added simulta-
neously with TNF-a, suggesting a molecular mechanism for
how insulin improves patient survival in sepsis even when
administered hours after the initial insult. The assay format
and approach that we report here provides a common plat-
form that can now be used to systematically probe multiple
signal transduction pathways at moderate sampling rates un-
der diverse experimental conditions of broad scientific and
medical interest.
EXPERIMENTAL PROCEDURES
Cell Culture, Stimulation, and Lysis--HT-29 and HeLa cells (ATCC,
Manassas, VA) were grown according to the manufacturer's recom-
mendations. For the time courses, HT-29 cells were seeded at 50,000
cells/cm 2, grown for 24 h, and then treated with 200 U/ml IFN-y
(Roche) for an additional 24 h. After sensitization, cells were rinsed
once with PBS and treated with 50 ng/ml TNF-a (Peprotech, Rocky
Hill, NJ) with or without 100 nM insulin (Sigma) for the indicated times.
Cells were washed once with ice-cold PBS and lysed in 1% Triton
X-100, 50 mM Tris-HCI (pH 7.5), 150 mM NaCI, 50 mM 3-glycerophos-
phate, 10 mM sodium pyrophosphate, 30 mM NaF, 1 mM benzamidine,
2 mM EGTA, 100 AM NaVO4 , 1 mM dithiothreitol (DTT), 1 mM phenyl-
methylsulfonyl fluoride, 10 Mg/ml aprotinin, 10 gg/ml leupeptin, 1
Aig/ml pepstatin, 1 gg/ml microcystin-LR. Whole cell lysates were
incubated on ice for 15 min, then clarified by centrifugation at
16,000 x g for 15 min at 4 °C. Protein concentrations of clarified
extracts were determined with a bicinchoninic acid assay (Pierce).
High-throughput Kinase Activity Assays-The microtiter-based ki-
nase activity assays were performed with the following antibodies:
anti-ERK1/2 CT (Upstate Biotechnology, Lake Placid, NY), anti-Akt
PH domain (Upstate Biotechnology), anti-JNK1 (Santa Cruz Biotech-
nology, Santa Cruz, CA), anti-IKKa/p (Santa Cruz Biotechnology) or
anti-MK2 (Upstate Biotechnology). Protein A or G microtiter strips
(Pierce) were coated overnight with 10 gg/ml anti-kinase antibody
and washed three times with blocking buffer (1% bovine serum
albumin (Sigma) in 50 mM Tris-HCI (pH 7.5), 150 mM NaCI, 0.05%
Triton X-100). Cell lysates (50 Mg for ERK, 500 gg for Akt, 200 gg for
JNK1, 200 Mg for MK2, 600 Mg for IKK) were added for 3 h (ERK, Akt,
JNK1, and MK2) or overnight (IKK), then washed two times with wash
buffer (50 mM Tris-HCI (pH 7.5), 150 mM NaCI) and two times with
kinase wash buffer (20 mM Tris-HCI (pH 7.5), 15 mM MgCI2, 5 mM
P3-glycerophosphate, 1 mM EGTA, 0.2 mM Na3VO4, 0.2 mM DTT). The
wells were resuspended in 20 •1 kinase wash buffer and warmed to
37 oC. Then 20 11 kinase assay buffer (kinase wash buffer plus 0.4 /M
protein kinase A inhibitor, 4 AM protein kinase C inhibitor, 4 AM
calmidazolium, 0-25 AM cold ATP, 1-5 MCi [y-32P]ATP) was added to
the wells, followed by 20 ll of substrate (40 Mg myelin basic protein
for ERK, 10 AM Aktide (19) for Akt, 3 Mpg lutathione S-transferase
(GST)-ATF2 (1-109) (20) for JNK1, 10 AM MK2tide 2 for MK2, 10 Mg
GST-IKBa (1-62) (21) for IKK) to initiate the reaction. The kinase
reactions were allowed to proceed for 15-120 min at 37 OC, then
terminated by 60 •1 75 mM H3PO4 or 20 mM EDTA. Exact conditions
for each kinase assay are detailed in Table I. For EDTA-terminated
reactions, 40 Ml of the terminated reaction was transferred to a
phosphocellulose filter plate (Millipore, Bedford, MA) containing 100
M1 75 mM H3PO 4 and mixed, whereas H3PO4-terminated reactions
were added directly to the filter plates. The terminated reaction con-
2 1. A. Manke and M. B. Yaffe, manuscript in preparation.
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TABLE I
Experimental conditions for the individual in vitro kinase assays
Other experimental parameters were maintained as described in "Experimental Procedures."
Kinase Antibody Substrate ATP (/iM) [y-32 P]ATP (/tCi) Reaction time (min) Termination
ERK Anti-ERK1/2 CT Myelin basic protein 25 1 60 H3 PO4
Akt Anti-Akt PH dom. Aktide 10 5 30 H3 PO4
JNK1 Anti-JNK1 GST-ATF2 (1-109) 10 2 60 H3 PO 4
IKK Anti-IKKa/p GST-IKBa (1-62) 0 5 120 EDTA
MK2 Anti-MAPKAP K2 MK2tide 25 2 15 EDTA
FIG. 1. A high-throughput assay of
multiple endogenous kinase activities
can monitor information flow through
critical nodes in a signaling network.
A, generalized network diagram describ-
ing pathways activated downstream of
TNF-a and insulin: activating interac-
tions (green arrows), inhibitory interac-
tions (red arrows), transcriptional inter-
actions (blue arrows). Gray nodes
highlight kinases that are measured by
the high-throughput multiplex kinase ac-
tivity assay. Red regions indicate apop-
totic pathways, green regions indicate
survival pathways, and orange regions
indicate stress pathways that can func-
tion to promote or inhibit apoptosis, de-
pending on context. Note the extent of
crosstalk in the network. Diagram is not
implied to be comprehensive (e.g. loca-
tion-dependent interactions have been
abstracted). B, general schematic of the
high-throughput multiplex kinase activity
assay format. Lysates are incubated
with Protein A or G microtiter wells pre-
coated with anti-kinase antibody. After
several washes, an appropriate sub-
strate and [y-3 2P]ATP are added to the
plate to initiate an in vitro phosphoryla-
tion reaction. The reaction is terminated
with H3PO 4 (for Akt and JNK1 assays) or
EDTA (for IKK and MK2 assays), and a
fraction of the reaction mix is transferred
to a PC filter plate and washed to re-
move free 32p.
tents were vacuum-filtered and washed five times with 75 mM H3PO 4
and three times with 70% EtOH. The filters were punched into vials
and the radioactivity incorporated was measured by liquid scintillation
(Cytoscint; ICN Pharmaceuticals, Costa Mesa, CA). The results from
blank wells, containing only lysis buffer during the immunopurification
step, were subtracted to remove nonspecific contributions, with the
exception of Akt, where this was not necessary.
Western Blotting--For determination of target capture, assays
were stopped before the kinase reaction step and resuspended in 40
/.l sample buffer (62.5 mM Tris-HCI (pH 6.8), 2% SDS, 10% glycerol,
100 mM DTT, 0.01% bromphenol blue). Wells were boiled for 5 min,
and the samples were resolved on a 10% polyacrylamide gel and
transferred to polyvinylidene difluoride (Millipore). Membranes were
blocked with 5% nonfat skim milk in 20 mM Tris-HCI (pH 7.5), 137 mM
NaCI, 0.1% Tween-20, and probed with the following primary anti-
•lPXATP
Incubate ansfr
bodies at 1:1000 dilution: anti-Akt (Upstate Biotechnology), anti-JNK1
(Santa Cruz Biotechnology), anti-MAPKAPK2 (StressGen Biotechnol-
ogies, Victoria, British Columbia, Canada), and anti-IKKa/3 (Santa
Cruz Biotechnology). The membranes were then probed with horse-
radish peroxidase conjugated anti-mouse or anti-rabbit secondary
antibody (Amersham Pharmacia Biotech) at 1:10,000 dilution and
visualized by enhanced chemiluminescence (Amersham Pharmacia
Biotech) on a FluorS (Bio-Rad) or Kodak Image Station (Perkin Elmer).
Bands were selected and quantified according to the manufacturer's
recommendations.
Autoradiography-Thirty microliters of the terminated kinase reac-
tions were mixed with 10 gl 4 sample buffer and resolved on a 10%
polyacrylamide glycine gel for protein substrates or a 16% polyacryl-
amide tricine gel for peptide substrates (22). The dye front was
excised, and the gel exposed overnight to a multisensitive BaFBr:
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FIG. 2. High-throughput multiplex kinase activity assays are optimally sensitive, quantitatively linear, and specific for the target
kinase. A, Left panel, Akt was immunopurified from 500 gg of HT-29 lysate on Protein G microtiter plates coated with 50 -Id of anti-Akt at
various coating concentrations. Plate-bound Akt was analyzed by Western blotting, as described under "Experimental Procedures," and
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EU2 + screen (Perkin Elmer). The screen was visualized using a Cy-
clone Storage Phosphor system (Perkin Elmer).
Cell Imaging- HT-29 cells were seeded in Delta T glass culture
dishes (Bioptechs). After 30 h, cells were pretreated with IFN-y as
described, then rinsed and treated with 50 ng/ml TNF-a or 50 ng/ml
TNF-a + 100 nM insulin for 18 h. Then 6 /g/ml Hoechst 33342
(Molecular Probes, Eugene, OR) was added to the medium, and
phase and fluorescence images were collected. Cells were then fixed
with 100% MeOH and stored at -20 "C overnight. After primary
staining with anti-cleaved caspase 3 (Cell Signaling, Beverly, MA) and
secondary staining with Alexa 594-conjugated anti-rabbit IgG (Mo-
lecular Probes), fluorescence images were collected.
Apoptosis Assays- HT-29 cells were seeded in 96-well plates and
sensitized with IFN-y as described. For inhibitor studies, 20 /M
LY294002 was added to the medium 1 h before or 3 h after cytokine
stimulation. During washout experiments, the medium was removed
and the wells washed once with PBS. The medium was then replaced
with medium conditioned by cells treated with the same cytokine
concentrations without inhibitor. After 18 h, cells were rinsed with
PBS and trypsinized. The supernatant and rinse were saved and
combined with the trypsinized cells to ensure capture of both floating
and adherent cells. The cells were washed with PBS, then fixed in
100% MeOH and stored at -20 OC. The fixed cells were stained with
a fluorescein-labeled monoclonal antibody against caspase-cleaved
cytokeratin (M30; Roche), plus anti-cleaved-caspase-3 (Asp 175; Cell
Signaling) with Alexa 647-conjugated anti-rabbit secondary (Molecu-
lar Probes), according to the manufacturers' instructions. Cells were
washed once after staining, then analyzed by flow cytometry (FACS-
calibur; Becton-Dickinson, Mountain View, CA). Cells positive for
cleaved cytokeratin, cleaved caspase-3, or both were scored as
apoptotic. Three separate biological samples were analyzed for each
treatment condition. Percent increased survival was calculated ac-
cording to the following formula: [1 - (% apoptotic cells in the
presence of insulin)/(% apoptotic cells in the absence of insulin under
the same pretreatment conditions)] x 100%.
RESULTS AND DISCUSSION
High-throughput Kinase Activity Assay Development-The
generalized assay format involves four steps, shown in Fig.
1B: i) parallel purification of endogenous kinase from whole
cell lysates by immunoprecipitation onto Protein A or G mi-
crotiter plates that have been precoated with kinase-specific
antibodies, ii) low stringency washes to remove nonpurified
lysate components, iii) addition of [y-32P]ATP and a kinase-
specific substrate to initiate an in vitro kinase reaction, and iv)
termination of the in vitro reaction either by H3PO 4 or EDTA
and liquid transfer to a 96-well phosphocellulose (PC) filter
plate to isolate phosphoproteins and remove free [y- 32 P]ATP.
We developed assays for ERK (3), Akt, JNK1, IKK, and MK2
activity in cell extracts after rigorous optimization and quan-
titative validation.
To develop the parallel immunopurification step, we exper-
imentally screened multiple commercially available products
and identified for each kinase a single, high-affinity antibody
that retained enzymatic activity. Coating conditions for each
anti-kinase antibody on Protein A/G microtiter plates were
individually optimized, revealing that the antibodies maximally
bound their intended targets when 50 tl of 10 p•g/ml antibody
was applied to each well (Fig. 2, A-D, left panels), consistent
with our estimates of the number of antibody binding sites on
the plate surface. Higher coating concentrations of polyclonal
antibodies (anti-JNK1, anti-IKKa/13, and anti-MK2) reduced
the solid-phase avidity for the kinase and caused a net de-
crease in purification efficiency (Fig. 2, B-D, left panels). At the
optimized coating concentration (Fig. 2, A-D, left panels, ar-
rows), the immunopurification was always linear in the amount
of kinase purified over a substantial range of lysate concen-
trations (Fig. 3, A-D). This demonstrates that the antibody
capture step linearly reflects kinase abundance in the lysate.
Next, kinase reaction conditions for each assay were opti-
mized by modifying the following in vitro parameters: choice
of substrate, concentration of substrate, radioactive-to-non-
radioactive ATP ratio, and reaction duration (see "Experimen-
tal Procedures"). When an individual kinase was determined
to phosphorylate multiple substrates effectively (Fig. 4, A, B,
and D and data not shown), the substrate showing the highest
quantified by densitometry of the band intensity to calculate a normalized volume. Middle panel, 50-600 gg of lysate from HT-29 cells treated with 1
MM insulin for 5 min was measured with the high-throughput Akt activity assay using 10 gM Aktide as substrate, as described under "Experimental
Procedures." The stimulated lysate (arrow) was compared with 500 Mg untreated control lysate (solid bar). Right panel, HT-29 cells were pretreated with
various concentrations of wortmannin (Sigma) for 1 h then stimulated with 1 gM insulin for 5 min and lysed. Akt activity was quantified as described under
"Experimental Procedures." B, Left panel, JNK1 was immunopurified from 200 Mg of HT-29 lysate on Protein A microtiter plates coated with 50 Ml of
anti-JNK1 at various coating concentrations and analyzed as described in A. Middle panel, 25-500 Mg of lysate from HT-29 cells harvested 30 min after
treatment with 30 J/m2 UV-C was measured with the high-throughput JNK1 activity assay using 3 Mg GST-ATF2 (1-109) as substrate, as described under
"Experimental Procedures." The stimulated lysate (arrow) was compared with 200 Mg untreated control lysate (solid bar). Right panel, plate-bound JNK1
from UV-stimulated HT-29 cells was incubated for 10 min with various concentrations of SP600125 (Calbiochem), and JNK1 activity was quantified asdescribed under "Experimental Procedures." C, Left panel, IKK was immunopurified from 800 Mg of HT-29 lysate on Protein A microtiter plates coated
with 50 •I of anti-IKKa/p at various coating concentrations and analyzed as described in A. Middle panel, 50-800 Mg of lysate from HeLa cells treated
with 100 ng/ml TNF-a for 10 min was measured with the high-throughput IKK activity assay using 10 Mg GST-IKBa (1-62) as substrate, as described
under "Experimental Procedures." The stimulated lysate (arrow) was compared with 600 Mg untreated control lysate (solid bar). Right panel, plate-bound
IKK from TNF-stimulated HeLa cells was incubated for 1 h with various concentrations of 15-deoxy-•l 2 ,14-prostaglandin J2 (15d-PGJ2 ; Calbiochem), andIKK activity was quantified as described under "Experimental Procedures." D, Left panel, MK2 was immunopurified from 200 gg of HT-29 lysate onProtein G microtiter plates coated with 50 M~ of anti-MK2 at various coating concentrations and analyzed as described in A. Middle panel, 10-400 gg
of lysate from HT-29 cells treated with 500 mM NaCI for 30 min was measured with the high-throughput MK2 activity assay using 10 pM MK2tide as
substrate, as described under "Experimental Procedures." The stimulated lysate (arrow) was compared with 200 gg untreated control lysate (solid bar).Right panel, HT-29 cells were pretreated with various concentrations of SB202190 (Calbiochem) for 1 h then stimulated with 500 mM NaCI for 30 min
and lysed. MK2 activity was quantified as described under "Experimental Procedures." All kinase activities are reported as the mean ± S.E. of triplicate
samples (error bars for the MK2 assay were smaller than the size of the marker). Western blots were repeated at least twice with similar results;
representative images are shown. Arrows indicate fixed experimental conditions for the adjacent experiment.
263
High-throughput Multiplex Kinase Assays for Cell Signaling
A Cell yswe (pg) B Cell lyate (pg)
300 400 500 00700 100 150 200 250
Akt: .... amI JNK :
at, d m 4as
A Akt
Aktlde Histones
- + -- +
- -- + - - 4
B JNK1
ATF-2 cjun
Lysuts - . + -. .
Insulin - - + - - -
12 - 1R2  0.96
> 0.8- > 0.8
0 o.4- 0.4
2 o0.0o 0.0
200 400 600 800 0 100 200 300
Cell lyste (pg) Cell lysate (pg)
C Cell yate (p) D Cell lyae (pg)
400 500 00 700 800900 50 100 150 200
IKK: 6MK2: 4
roll d • At ik ,
R2=0.97
S0.8 > 0.8
0. 0.4
z 0.0, Z0.0
400 800 0 100 200
Cell lysate (pg) Cell lysate (pg)
FIG. 3. Purification of endlogenous kinases is linear on antibody-
coated microtiter plates. A, 300-700 jig of HT-29 lysate was incu-
bated for 3 h on Protein G microtiter plates coated with 10 CIg/ml of
anti-Akt. Plate-bound Akt was analyzed by Western blotting, as de-
scribed under "Experimental Procedures," and quantified by densi-
tometry of the band intensity to calculate a normalized volume. B,
100-250 /Lg of HT-29 lysate was incubated for 3 h on Protein A
microtiter plates coated with 10 /tg/ml of anti-JNK1 and analyzed as
described in A. C, 400-900 jig of HT-29 lysate was incubated overnight
on Protein A microtiter plates coated with 10 g/g/ml of anti-IKKa//3 and
analyzed as described in A. D, 50-200 jig of HT-29 lysate was incu-
bated for 3 h on Protein G microtiter plates coated with 10 /ig/ml of
anti-MK2 and analyzed as described A. Western blots were performed
at least twice with similar results; representative images are shown.
specific activity (counts per minute (CPM)/Ixmol) was selected
to maximize sensitivity. Other reaction parameters, such as
buffer composition and reaction temperature, were intention-
ally kept constant to enable assays of different kinases to be
performed in parallel on the same microtiter plate in a single
step.
ERK, Akt, and JNK1 assays were terminated by adding an
equal volume of 75 mm H13PO 4 to the microtiter reaction well
and transferring the well contents to a parallel 96-well PC filter
plate for washing and quantitation. MK2 and IKK assays were
terminated by adding an equal volume of 20 mM EDTA to the
microtiter reaction well and transferring the contents to the
96-well PC filter plate preacidified with 75 mM H3PO 4 in each
well. SDS-PAGE analysis of the terminated reaction mixtures
transferred to the PC filter verified that phosphorylation was
only occurring on the added substrate (Fig. 4, A-E). Therefore,
individual filters in the wells of the PC plate could be punched
out for scintillation counting to accurately quantify kinase
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FIG. 4. Terminated in vitro reaction products specifically con-
tain the phosphorylated substrate. A, the high-throughput Akt as-
say, using 10 jM Aktide or 40 gg partially purified histones (Sigma) as
substrate, was analyzed by SDS-PAGE and autoradiography after
termination of the in vitro reaction as described under "Experimental
Procedures." Note that the phosphopeptide has run off the gel and no
other phosphorylated bands are evident. B, the high-throughput
JNK1 assay, using 3 jig ATF-2 or 2 jig c-jun (Upstate Biotechnology)
as substrate, was analyzed as described in A. Single asterisks indi-
cate 32P incorporation into partially cleaved substrates. C, the high-
throughput IKK assay, using 10 j/g IKBa as substrate, was analyzed
as described in A. Double asterisks indicate nonspecific 32 P incorpo-
ration (note that these bands are of equal intensity in the blank
sample, such that background subtraction will remove their contribu-
tion). D, the high-throughput MK2 assay, using 10 jgM MK2tide or 5 jig
Hsp27 (Upstate Biotechnology) as substrate, was analyzed as de-
scribed in A. Note that the phosphopeptide has run off the gel and no
other phosphorylated bands are evident. E, the peptide substrates (10
gM Aktide for the Akt assay and 10 jiM MK2tide for the MK2 assay)
were analyzed on a 16% tricine-polyacrylamide gel and autoradio-
graphed after termination of the in vitro reaction as described under
"Experimental Procedures." The migration position of a 5-kDa marker
is indicated.
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FIG. 6. IFN-sensitized HT-29 cells undergo programmed cell
death in response to TNF-a and can be rescued by cotreatment
with insulin. Main panels, phase contrast images of HT-29 cells
treated with 100 ng/ml TNF-a alone (left) and both 100 ng/ml TNF-a +
100 nM insulin (right) as described under "Experimental Procedures."
Note the increased number of shrunken cells with condensed nuclei
in cells treated with TNF-a alone (arrows). Insets, indirect immunoflu-
orescence images of cleaved caspase 3 (red) in HT-29 cells treated
0 4 8 12 with 100 ng/ml TNF-a alone 
(left) and both 100 ng/ml TNF-a + 100 nM
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FIG. 5. Kinetics of the in vitro kinase reactions are linear with
time. Assays were incubated with fixed amounts of HT-29 or HeLa
lysates treated with known activators of the pathway of interest (for
details, see Fig. 2, A-D). In vitro reactions were allowed to proceed for
the indicated times and analyzed as described under "Experimental
Procedures." A, Akt assay kinetics with Akt from 500 ptg of HT-29
lysate. B, JNK1 assay kinetics with with JNK1 from 200 /g of HT-29
lysate. C, IKK assay kinetics with IKK from 800 jg of HeLa lysate. D,
MK2 assay kinetics with MK2 from 200 jig of HT-29 lysate.
activity, eliminating the low-throughput, SDS-PAGE-and-au-
toradiography step required in classical immune complex ki-
nase assays.
To investigate the sensitivity, dynamic range, and linearity
of these assays, HT-29 and HeLa cells were treated with
known activators of each kinase, and the kinase activities
(CPM on the PC filter) measured as a function of different
dilutions of the activated lysates (Fig. 2, A-D, middle panels).
The 3 2 P incorporation was linear over at least an order of
magnitude in activity, and the absolute sensitivities of the
assays were always below 200 pIg, with some assays capable
of measuring activity from as little as 10-25 /g of total lysate.
This result is comparable to, or better than, existing assays
that usually require several hundred micrograms of lysate for
analysis (23-25). The aggregate sensitivity of the format was
more than sufficient to measure ERK, Akt, JNK1, MK2, and IKK
activity simultaneously from a single 10-cm plate of HT-29 cells.
The signal-to-noise and reproducibility characteristics for
each kinase assay were examined by selecting a single con-
centration in the middle of the dynamic range of each assay
(Fig. 2, A-D, middle panels, arrows) and comparing the kinase
activities between lysates from stimulated and unstimulated
cells. For each agonist, this revealed a relative activation of
each endogenous kinase that was comparable in magnitude
in all images to show nuclei.
to that reported in the literature, with intra-assay coefficients
of variation always -10%. Thus, the assays clearly reflected
activation of the endogenous pathways, and the end point
measures of activity were highly sensitive and reproducible.
In order for these assays to reflect information flow through
the signaling network accurately, it was crucial to confirm that
our end point CPM measurement linearly reflected the kinase
activity in the lysate. Therefore, the kinetics of the in vitro
reaction were examined in detail at a selecting fixed lysate
concentration within the linear range (Fig. 2, A-D, middle
panels, arrows). As shown in Fig. 5, A-D, each phosphoryla-
tion reaction displayed linear kinetics up to the time of termi-
nation, suggesting that neither the [y-32P]ATP nor the sub-
strate was significantly depleted over the course of the
reaction. Thus, the linearity at every step in the assay proce-
dure (kinase capture, in vitro reaction kinetics, and end point
CPM measurement) strongly suggests that these assays are a
linear reflection of endogenous kinase activity in vivo.
As a final confirmation of assay specificity, we examined the
effect of various small molecule inhibitors that have been
reported to be specific for each of the measured kinases or
the directly upstream kinase (26-29). At a fixed lysate con-
centration (Fig. 2, A-D, middle panels, arrows), a dose-
dependent decrease in the measured activity (Fig. 2, A-D,
right panels) was observed, consistent with the reported IC5o
values for the target kinase. Taken together with the redun-
dant antibody-kinase and kinase-substrate specificity inher-
ent to the measurement format, these results strongly suggest
that the assays specifically quantify the endogenous activity
of the intended kinase. We conclude that the high-throughput
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FIG. 7. TNF-a and TNF-a + insulin treatments elicit quantitatively distinct signaling patterns in HT-29 cells. Endogenous ERK (green),
Akt (red), JNK1 (blue), IKK (purple), and MK2 (orange) activities in HT-29 cells in response to: A, 50 ng/ml TNF-a (filled circles) and B, 50 ng/ml
TNF-a + 100 nM insulin (open circles). Lysates were generated at 0, 5, 15, 30, 60, 90 min and 2, 4, 8, 12, 16, 20, 24 h, then measured for kinase
activity with the high-throughput multiplex kinase assay. Results are plotted as the mean fold activation of three independent cell extracts. Error
bars are omitted for clarity, but are shown in panel C. C, comparison of ERK, Akt, JNK1, IKK and MK2 activities in response to TNF-a (filled
circles) and TNF-a + insulin (open circles) from A and B, plotted as mean fold activation + S.E. of triplicate samples.
multiplex assays provide reliable, quantitative measurements
that are directly reflective of specific protein kinase activities
in cell extracts.
Application to an In Vitro Model of Sepsis-induced Colon
Epithelial Apoptosis-HT-29 cells are a human colon carci-
noma cell line that die in response to TNF-a, following sensi-
tization with interferon gamma (IFN-,y) (30). We confirmed that
TNF-treated HT-29 cells exhibit many features of apoptosis,
such as cell shrinkage, membrane blebbing, nuclear conden-
sation, and caspase 3 activation (Fig. 6, left). Intriguingly, we
found that TNF-induced cell death can be reduced by -30%
if HT-29 cells are costimulated with insulin (Fig. 6, right), in
agreement with previous reports (31). Given the importance of
proinflammatory cytokines, such as TNF-a and IFN-y, in sep-
sis (4) and the emerging role of insulin as a therapeutic for
critically ill patients (15), we considered HT-29 cells as an
appropriate model system for exploring the signaling network
dynamics activated by TNF-a and TNF-a + insulin in relation
to a relevant cell phenotype: colon epithelial cell death, as
observed during the onset of sepsis (6).
IFN-sensitized HT-29 cells were treated with 50 ng/ml
TNF-a, in the presence or absence of 100 nM insulin cotreat-
ment, and triplicate lysates were prepared at 13 time points
over 24 h. Because much of the signaling induced by these
cues occurs shortly after cytokine addition, time points were
more densely sampled in the first 4 h (Fig. 7, A and B, inset).
From these cell extracts, quantitative measurements of ERK,
Akt, JNK1, MK2, and IKK kinase activity were performed
using the high-throughput multiplex kinase activity assays
(Fig. 7, A and B). To our knowledge, this set of time courses,
consisting of over 400 independent activity measurements,
represents the most comprehensive, rigorously quantitative
study of functional signaling dynamics performed to date. To
achieve this depth of quantitative, replicated network sam-
pling by traditional techniques would have been extraordinar-
ily laborious and technically impractical.
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FIG. 8. Insulin elevates two phases of Akt activity, and the late-phase of Akt activity provides a critical anti-apoptotic signal in HT-29
cells. A, hypothetical two-phase contribution to the sustained Akt activity that was observed in the presence of insulin (Fig. 7, B and C). B,
HT-29 cell death in response to no cytokines (0), 50 ng/ml TNF-a (), or 50 ng/ml TNF-a + 100 nM insulin (8) in the presence of 20 jiM
LY294002 (LY) at the indicated times. Cells were stained for cleaved cytokeratin and cleaved caspase 3 and analyzed by flow cytometry as
described under "Experimental Procedures." Values represent the percentage of apoptotic cells +_ S.E. of triplicate samples. C, HT-29 cell
survival in response to timed combinations of 50 ng/ml TNF-a, 100 nM insulin, and 20 /M LY294002. Values represent the percentage of
increased survival ± S.E. of triplicate samples, computed as described under "Experimental Procedures." The carrier (0.1% DMSO) was kept
constant for control experiments.
Furthermore, to deconstruct the effects of insulin therapy
on the signaling network in the context of TNF-a signaling, a
pairwise comparison was performed for each kinase under
TNF-a with and without insulin costimulation. As shown in Fig.
7C, the dynamics of activation of some pathways, such as the
ERK pathway (Fig. 7C, green), were essentially superimpos-
able. Thus insulin does not appear to influence activation of
the ERK pathway by TNF-a under these conditions. Other
TNF-induced kinase activities were affected by insulin in a
time-dependent manner. JNK1 activity, for example, was
larger at intermediate times (8-16 h), while IKK activity was
smaller at 16 h, and MK2 activity was larger at late times
(16-24 h). Although potentially important, these transient sig-
naling differences did not clearly reflect the insulin-induced
survival phenotype observed at the cellular level (Fig. 6).
Late-phase Akt Activity as a Critical Pro-survival Signal- In
contrast to the subtle influences of insulin on ERK, JNK1, IKK,
and MK2 signaling, it was readily apparent that insulin dra-
matically augmented Akt activity, inducing a rapid increase
within 5 min and sustaining activation for 24 h, whereas with
TNF-a alone, the Akt response was much smaller in magni-
tude (Fig. 7C, red). In addition to these quantitative differ-
ences, we noted that the dynamic TNF-induced Akt response
was also qualitatively different without insulin, in that the
course of activation was clearly biphasic, with a brief initial
peak, followed by a small (i.e. 2-fold), sustained increase in
activity after 4 h. If these data had not been rigorously quan-
titative, or had the signaling network not been sampled fre-
quently in time, this increase in activity would likely have been
missed. By virtue of the high-throughput activity assays, how-
ever, it was clear that Akt activity after 4 h was significantly
up-regulated in comparison to baseline activity (p < 0.05 for
all times after 4 h, Student's t test).
These findings suggested that a significant component of
the insulin-induced anti-apoptotic effect was mediated by the
high sustained Akt activity, and that this activity profile was
derived from the superposition of an early, elevated phase of
activity that was transient with a late, elevated phase of ac-
tivity that was sustained (Fig. 8A). Conversely, in cells treated
with TNF-a alone, these two phases were reduced in intensity
and separated in time. Because Akt is thought to provide
strong pro-survival signals (10), we hypothesized that one or
both of these temporal components of Akt activation were
involved in controlling the phenotypic response of HT-29 cells
to TNF-a and insulin.
To investigate this, we used a reversible, selective inhibitor
(LY294002 (32)) of phosphatidylinositol 3-kinase (PI 3-K), an
upstream activator of Akt. LY294002 was added or removed at
critical times to eliminate the early phase of Akt activity, the late
phase of Akt activity, or both, and apoptosis was quantified by
flow cytometry with an anti-cleaved caspase 3 antibody and the
M30 antibody (33) against caspase-cleaved cytokeratin. We
have found this double stain to be the most sensitive, quanti-
tatively reproducible measure of apoptosis in HT-29 cells.3
When LY294002 was added 1 h before cytokine addition
and tonically maintained to block Akt activity over the entire
time course, a dramatic increase in TNF-induced cell death
was observed (Fig. 8B, red). Surprisingly, if LY294002 was
present only for the first 3 h of TNF-a addition, thus permitting
only the late phase of Akt activity, there was no increased cell
death relative to treatments without inhibitor. In contrast,
when LY294002 was first added at 3 h after cytokine addition
to selectively abolish late-phase Akt activity, we observed an
increase in cell death equivalent to that observed when the
3 J. G. Albeck, unpublished observations.
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inhibitor was present for the entire 24 h. An identical pattern
was observed in response to TNF-a + insulin (Fig. 8B, green),
whereas LY294002 had only a small effect on basal apoptosis
(Fig. 8B, blue). These data suggest that late-phase Akt acti-
vation is necessary to restrain the percentage of cells under-
going programmed cell death in response to TNF-a in the
presence or absence of insulin.
The importance of late Akt activity in controlling TNF-in-
duced cell death, in conjunction with the strong, sustained
late Akt activation in the presence of insulin, led to the hy-
pothesis that the insulin-induced increase in cell survival was
due, in part, to this increase in late-phase Akt signaling. If true,
then addition of insulin up to 4 h after the pro-death stimulus
should elicit an equivalent reduction in the extent of TNF-
induced apoptosis. Indeed, this was observed; the delayed
addition of insulin 4 h following TNF-a addition resulted in the
same increase in HT-29 cell survival as observed when insulin
was added simultaneously with TNF-a (Fig. 8C). Moreover,
pretreatment with LY294002 1 h before insulin addition sig-
nificantly reduced the survival response, regardless whether
insulin was added simultaneously or 4 h after TNF-a treatment
(Fig. 8C).
These experiments strongly implicate late-phase signaling,
along a PI 3-K-dependent/Akt pathway, as a critical pro-
survival mechanism of insulin in colon epithelia. Excessive
apoptosis in the gut leads to disruption of the epithelial per-
meability barrier (7) that drives many of the complications of
the septic state (8). Our results provide a partial molecular
explanation why intensive insulin therapy, administered hours
after the initial septic insult, is capable of reducing sepsis-
induced apoptosis of gastrointestinal epithelia and improving
the prognostic outcome in critically ill patients.
We stress that it was the ability to robustly sample the
dynamics of multiple nodes in the signaling network with the
high-throughput multiplex kinase assay format described in
this paper that enabled the identification of Akt as an impor-
tant signal for modulating cell response. Other insulin-in-
duced, PI 3-K independent pathways must also attenuate the
TNF-induced apoptotic phenotype in HT-29 cells, because in-
hibition of PI 3-K/Akt by LY294002 did not completely abrogate
the rescue response of insulin (Fig. 8C). Thus, i) there may exist
additional response-determining pathways that our measure-
ments did not capture, or ii) the subtle, time-dependent quan-
titative differences we measured in the JNK1, IKK, and MK2
pathways (Fig. 7C) may modulate phenotypic response. We are
currently investigating both these possibilities.
The current knowledge of intracellular signal transduction is
staggeringly complex. To identify network-level properties
that affect cell function, it will be necessary to mathematically
model the dynamic, multivariate characteristics of signaling
proteins within cells (34). For such models to be realized,
quantitative experimental techniques that are both high-
throughput and multiplex are needed. The kinase activity as-
say format presented here represents a first step in this di-
rection. The 96-well, microtiter format is highly versatile, in
that it is amenable to scale-up and automated liquid handling,
yet tractable for individual scientists and more moderate stud-
ies. Importantly, these assays possess linearity, reproducibil-
ity, specificity, and sensitivity characteristics as good as, or
better than, the corresponding low-throughput technique. We
anticipate that these functional assays will complement exist-
ing proteomic approaches (2) and find broad applicability
toward biological and clinical problems involving signal trans-
duction and human disease.
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Appendix D
Improved fluorescent protein reporters
for observing the apoptotic network
This work was performed in collaboration with Bree Aldridge, who constructed the novel
caspase-3 reporter described here and performed the experiment shown in Fig. Dl with
my supervision
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Introduction
To examine the relationship of various signals in the apoptotic pathway, reliable
single-cell reporters are required. A reliable reporter must be 1) specific for the intended
molecular event, and 2) non-invasive, leaving endogenous signaling dynamics unaltered.
While several reporters for caspases (Luo et al. 2001; Rehm et al. 2002; Luo et al. 2003;
Takemoto et al. 2003; Kawai et al. 2004) and the mitochondrial pathway (Goldstein et al.
2000; Rehm et al. 2003; Munoz-Pinedo et al. 2006) have been previously described, it is
not clear that these reporters meet the requirements for specificity and signaling
neutrality. For example, the caspase FRET reporter containing the cleavage sequence
DEVD is often used as a reporter of caspase-3/7 activity, since DEVD is the optimal
cleavage sequence for caspase-3/7 (Thornberry et al. 1997). However, it is clear from
numerous publications that the sequence DEVD can serve as a substrate for other
caspases, most notably caspase-8 (Blanchard et al. 2000; Rehm et al. 2002). Thus, this
FRET reporter may not be a highly specific indicator of effector caspase activity. In the
case of the mitochondrial pathway, fluorescent protein fusions to cytochrome c, Smac,
and other mitochondrial intermembrane space proteins have been used to observe the
process of mitochondrial permeabilization (Goldstein et al. 2000; Rehm et al. 2003;
Munoz-Pinedo et al. 2006). It has been observed that each of these fusion proteins, like
the endogenous versions, are typically localized to the mitochondria but simultaneously
redistribute to the cytosol when the mitochondrial outer membrane is permeabilized in
response to pro-apoptotic stimuli. However, as the work in this thesis has indicated, the
kinetics of caspase activity are critically dependent on the levels and ratios of proteins
such as Smac that are released from the mitochondria. Consequently, overexpressing
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GFP-fused versions of these proteins is likely to have a significant effect on the
functioning of the system. Thus, there are several features of existing reporters that need
to be improved before in-depth studies of apoptotic signaling can be performed.
A caspase-3 reporter with improved specificity
To create a caspase-3/7-specific reporter, we turned to the literature to identify a
peptide sequence that would be an efficient substrate for the effector caspases but a poor
substrate for other caspases such as caspase-8. Caspase consensus sequences are
typically designed as tetrapeptide motifs whose C-terminal residue is the aspartate at
which the peptide backbone is cleaved. However, a detailed study of the specificity of
caspase-8 and caspase-3 for residues at each of the traditional four positions suggested
few possibilities that would screen out caspase-8 cleavage while allowing efficient
caspase-3 cleavage. We then examined the P(-1) position, which follows the tetrapeptide
motif, and has been shown to have significant influence on cleavage specificity
(Stennicke et al. 2000). In the original DEVD reporter (and most other published
reporters), the P(-1) position is occupied by G, which is the optimal residue for this
position for both caspase-3 and caspase-8 . However, if this G is converted to an R, the
kcat/Km for caspase-3 is reduced by -14-fold, while the kcat/Km for caspase-8 is
reduced by -300-fold (Stennicke et al. 2000). Thus, a peptide substrate with the
sequence of DEVDR should substantially increase its suitability as a substrate of caspase-
3 relative to caspase-8. Therefore, we constructed a new FRET reporter, in which ECFP
and Venus-YFP proteins were linked by a peptide containing the sequence DEVDR.
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To test the specificity of the DEVDR FRET reporter, we examined its behavior in
cells where caspase-8 was active but caspase-3 was not. In previous work, we noted that
in Bcl-2-overexpressing HeLa cells treated with TRAIL+CHX, caspase-3 was efficiently
cleaved by caspase-8, but the caspase-3/7 substrate PARP remained entirely uncleaved
due to the inhibitory activity of XIAP (Fig 2.2 F). Thus, a reporter that is highly specific
for caspase-3/7 activity would show no cleavage in Bcl-2 overexpressing cells, but would
be cleaved rapidly in wild type HeLa cells. Therefore, we transfected Bcl-2-
overexpressing HeLa cells with both the conventional DEVDG-containing FRET
reporter, and our DEVDR-containing FRET reporter and examined the change in FRET
ratio in response to TRAIL treatment. Under these conditions, a gradual but substantial
increase in cleavage of the DEVDG reporter was observed, indicating its cleavage by
caspase-8. Conversely the DEVDR reporter displayed very little increase in signal,
indicating that it is insensitive to caspase-8-mediated cleavage. In other work, we found
that in standard HeLa cells, both DEVDG and DEVDR reporters were cleaved with
similar kinetics. Thus, it appears that the DEVDR reporter effectively serves as a
caspase-3 reporter and is a substantial improvement over DEVDG in resisting cleavage
by caspase-8.
A caspase-8 FRET reporter with improved pH insensitivity
Reporters of caspase-8 activity have been previously reported (Luo et al. 2003;
Kawai et al. 2004). The cleavage sequence in these reporters is IETD, the optimal
peptide substrate for caspase-8. This sequence is a poor substrate of caspase-3 due to the
isoleucine in the P1 position (Thornberry et al. 1997). The general difficulty in creating
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caspase-8 reporters is that caspase-8 is catalytically less efficient than caspase-3; this
problem has been solved by including tandem IETD sites in the linker peptide, creating a
higher likelihood of linker cleavage by caspase-8 (Luo et al. 2003). This design for a
caspase-8 reporter is likely to be fairly specific to caspase-8 and other initiator caspases.
However, the existing reporters were constructed using an older version of YFP (EYFP)
that displays substantial sensitivity to pH changes, complicating the interpretation of its
behavior. Therefore, we constructed a FRET reporter using the tandem-IETD linker, but
in which the pH-insensitive YFP variant Venus was substituted for EYFP.
A non-invasive reporter for mitochondrial permeabilization
Another key even in apoptotic signaling is the permeabilization of the
mitochondria. One method that has long been used for observing mitochondrial events
during apoptosis is the use of dyes such as tetramethylrhodamine that are sensitive to the
mitochondrial membrane potential. Such dyes indicate a drastic drop in mitochondrial
membrane potential (membrane depolarization) that is simultaneous with effector caspase
activity. However, recent research has shown that mitochondrial permeabilization and
depolarization are two independent and separable events. Mitochondrial
permeabilization is the crucial first step in which signaling molecules such as Smac and
cytochrome c are released to the cytosol, while depolarization is a later event that is at
least partially dependent on effector caspase activation. Thus, to observe the signaling
behavior of the mitochondria, it is crucial to measure permeabilization rather than
depolarization. Permeabilization can be observed by tracking proteins such as
cytochrome c and Smac fused to fluorescent proteins. However, as noted above,
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apoptotic behavior is highly sensitive to the expression levels of these proteins.
Therefore, it would be advantageous to develop a non-signaling version of such proteins,
which could act as indicators without altering signaling behavior. One such possibility is
presented by Smac. The precursor of Smac is transported into the mitochondria by an N-
terminal signal peptide of 60 amino acids. Once inside the mitochondria, this peptide is
cleaved to generate mature Smac; this cleavage is necessary for Smac activity, since the
XIAP-binding motif of mature Smac, consisting of the four residues immediately
following the signal peptide, is only functional when this motif has been exposed by
cleavage (Verhagen et al. 2000; Zou et al. 2003). To create a non-signaling reporter of
Smac localization, we generated a gene fusion in which the signal sequence of Smac is
immediately upstream of monomeric red fluorescent protein (RFP). In theory, this fusion
protein would be imported into the mitochondrial intermembrane space by the signal
peptide, where it would be cleaved to generate free RFP. Since permeabilization appears
to be a non-selective event in which all soluble proteins in the mitochondrial
intermembrane space are released through large pores, RFP should also be released
simultaneously with endogenous Smac, cytochrome c, and other proteins. However, this
fusion protein would not affect signaling, since it lacks the XIAP-binding motif and all
other signaling domains of mature Smac. We named this reporter IMS-RFP, since it
generates RFP localized to the intermembrane space of the mitochondria.
To test the ability of IMS-RFP to accurately report mitochondrial
permeabilization, we transiently transfected HeLa cells with this construct. As expected,
IMS-RFP displayed a predominantly mitochondrial localization pattern and co-localized
with cytochrome c, as assessed by immunofluorescence for cytochrome c (Fig D2 A).
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When IMS-RFP-expressing cells were treated with TNF, the localization pattern of both
cytochrome c and IMS-RFP changed, reflecting release from the mitochondria to the
cytosol. Importantly, all cells in which cytochrome c was redistributed to the cytosol also
showed IMS-RFP release, indicating that release of IMS-RFP and cytochrome c were
simultaneous (Fig D2A). However, in contrast to cytochrome c, some mitochondrial
localization of IMS-RFP was retained even after release. This suggests that, unlike
cytochrome c, IMS-RFP is not completely released upon permeabilization; a potential
explanation is that IMS-RFP is not efficiently cleaved within the mitochondria and thus
cannot be fully released. Nonetheless, IMS-RFP could be expressed at high levels
without toxicity, and in time-lapse image sequences, the first frame of IMS-RFP release
could be clearly identified in every case (Fig D2 B). This frame indicates the onset of
mitochondrial permeabilization, a key event in apoptosis; it can be inferred that this time
point also marks the onset of the release of endogenous Smac, cytochrome c, and other
proteins of the intermebrane space. (Janes et al. 2003; Gaudet et al. 2005; Janes et al.
2006)
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"Caspase-3" activity by FRET
Figure D1. A FRET reporter containing the sequence DEVDR provides improved
specificity for caspase-3. Bcl-2-overexpressing HeLa cells were transfected with the
plasmids pECFP-DEVD-Venus or pECFP-DEVDR-Venus. Cells were then treated with
TRAIL, and reporter cleavage was monitored by measuring the CFP/YFP ratio by live-
cell microscopy.
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Figure D2. IMS-RFP release from the mitochondria coincides with cytochrome c release
and indicates the onset of mitochondrial permeabilization. A. HeLa cells transfected
with pExchangel-IMS-RFP were treated with TNF+CHX for 4 hours. Cells were then
fixed, and cytochrome c was detected by immunofluorescence and compared to IMS-RFP
fluorescence. B. HeLa cells transfected with pExchangel-IMS-RFP were treated with
TNF+CHX, and IMS-RFP was tracked by live cell microscopy. Numbers in each panel
indicate the time, in minutes, relative to the first frame in which IMS-RFP release is
apparent (red bar).
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Appendix E
A MATLAB routine for generating simulated flow cytometry data
based on a hypothetical population of cells
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To simulate the expected flow cytometry patterns of cPARP cleavage, the following
Matlab procedure was used:
First, the number of cells, c, in the simulation is defined. Most cytometry experiments
measure 10,000 cells.
cells=10000;
Each single cell will be represented by a Boltzmann equation, as described in Chapter 2.
First, we choose a characteristic time (tchar) and a maximum fraction of PARP cleaved
(Fmax); these parameters will be applied to all cells in the population, since single-cell
experiments indicate little cell-to-cell variation in these parameters.
tchar=20; % (minutes)
Fmax=1.0; %(fraction, ranging from 0 to 1)
Next, we define the mean and standard deviation for a distribution of delay times. For
each cell, a delay time will be chosen randomly from a normal distribution with these
parameters, to reflect the experimentally observed approximately normal distribution of
delay times in cells treated with 50 ng/ml TRAIL.
meandelay=200; %(minutes)
delaystdev=40; %(minutes)
delays=meandelay+delaystdev*randn(c, );
The number of timepoints for flow cytometry measurement (in addition to the zero time
point), and the spacing between timepoints, are defined:
numtimepoints=3;
timespacing=120; %(minutes)
Initialize a matrix to hold the raw signal (the fraction of PARP cleaved) of each cell at
each timepoint. Then, at each time point, determine the raw signal of each cell by
calculating the value of the Boltzmann equation for that cell's delay, tchar, and Fmax.
rawsignals=zeros (c,numtimepoints);
for t=0:numtimepoints
for i=l:cells
rawsignals (i,t) = (Fmax- (Fmax) / (l+exp( (t*timespacing-
delays (i)) / (tchar/4)) ) ) ;
end
end
Next, we need to account for the processing of signals by the flow cytometer.
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Our flow cytometry measurements were made on a flow cytometer with a 4-decade
logarithmic amplifier with 1024 detection channels.
channels=linspace(0,4,1024);
The voltage of the amplifier can be adjusted, so that cells with a raw signal of 1 may fall
at any arbitrary point in the amplifier's range. In most of our experiments, the
fluorescence intensity of cells with complete PARP cleavage was around 1000.
amplification=1000;
All cells have background fluorescence, so that even cells with a raw signal of 0 display a
non-zero fluorescence intensity; in our experiments, this value was approximately 10.
background= 10;
Instrument noise and cell-to-cell variation in cell size and staining intensity lead to a
distribution of measured signals centered around the actual raw signal. This distribution
is approximated by a lognormal distribution. Empirically, the variance of this lognormal
distribution ranges from 0.4 to 0.5. We then assign a noise value for each cell chosen at
random from this distribution.
noisevariance=0. 4;
noisevalues=lognrnd(0,noisevariance,c,numtimepoints);
We then calculate the actual observed signal for each cell by adding the background
signal to each and multiplying by the noise value:
measuredsignals=noisevalues.*(rawsignals.*amplification+background);
The measured signals are then binned into the appropriate channels, and the resulting
histogram is plotted.
for tf=0:numtimepoints
subplot(numtimepoints+l,1,tf+l);
p=hist(logl0(measuredsignals(:,tf+l)),channels);
hold on;
axis([0,1024,0,histy]);
set(gca, 'xtick', [0,256,512,768,1024]);
end
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To facilitate comparisons to actual experiments, gates are created to contain the negative,
intermediate, and positive cells. This is done by defining the boundaries for each gate. A
matrix named 'frequencies' is created to hold the percentage of cells in each gate at each
timepoint.
neg_start=1;
negend=420;
int start=421;
int end=580;
pos start=581;
posend=1024;
frequencies=zeros (3,numtimepoints+1);
The fraction of cells falling into each gate is calculated by simply summing across the
appropriate regions of the histogram.
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for t=0:numtimepoints
temphist=hist(loglO(x(:,t+l)),bins);
popgates (, t+l) =sum(temphist (neg_start:neg_end) )/cells;
popgates(2,t+l)=sum(temphist(int_start:intend))/cells;
popgates (3,t+l) =sum(temphist (posstart:pos_end) )/cells;
end
These frequencies are then plotted:
popgates(2,:)=-popgates(2,:);
bar (popgates', 'grouped');
axis([0.5 4.5 -11000 11000]);
For actual experimental data, gate positions were determined as follows. First, the
intermediate gate was defined to be 160 channels wide, and was positioned on control
samples to lie between the positive and negative peaks at a point where the number of
cells in the intermediate gate was approximately at a minimum. Negative and positive
gates were then defined as the remaining regions below and above the intermediate gate,
respectively.
A graphical interface was created that produces simulated data for any input set of
parameters. This interface was used to adjust the parameters to best match the
experimental data, providing an estimate of single cell parameters.
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From these simulations, we can also produce the expected results of a western blot time
course experiment. Since a western blot of PARP cleavage represents the average
fraction of PARP cleavage across the entire population, this type of data can be simulated
by summing the raw signals of all cells at each time point and then dividing by the total
number of cells to obtain the population average:
for t=O:numtimepoints
for i=l:cells
rawsignals (i,t) = (Fmax- (Fmax) / (l+exp ( (t*timespacing-
delays (i)) / (tchar/4)) ) ) ;
end
popavg (t) =sum (rawsignals)/cells;
end
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Note that the population average does not contain all of the information that is present in
flow cytometry data. For example, the population average data resulting from cells in
which tchar is 20 minutes is nearly identical to poplation average data from cells with a
tchar of 100 minutes. Moreover, partial cleavage of PARP at the single cell level in the
entire population cannot be distinguished from complete cleavage at the single cell level
in only some of the population. For example, consider the two cases below. In the first
case, Fmax is 0.2, and thus 20% of PARP is cleaved in each cell, resulting in a population
average of 20% PARP cleavage. In the second case, Fmax is 1.0, but due to the broad
distribution of delay times centered at x hours, only -20% of the cells have responded at
4.5 hours. Therefore, the population average PARP cleavage is again 20%, even though
the situation at the single-cell level is entirely different.
Many more examples like this may be found by simply exploring the simulated behavior
of flow cytometry and western blot data using the graphical interface, underscoring the
need for examining both population average and single-cell data to correctly assess the
behavior of PARP cleavage in the cell. The Matlab tool presented here may be a useful
resource for those examining the relationship of flow cytometry, single-cell, and
population data.
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